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The early B cell response to antigen is analyzed, probing the mechanisms of 
divergent differentiation into plasmablasts or germinal centre (GC) B cells. 
Heterozygous QMxB6 mice, in which 5% of B cells are specific for the hapten 4-
hydroxy-3-nitrophenol (NP), were immunized with NP-Ficoll. Varying the antigen 
dose altered the proportion of B cells that entered the extra follicular or GC 
responses and the amount of class switch recombination (CSR). The expression of 
phenotypic markers and switched antibody protein in parallel with gene array 
analysis and single cell real time RT-PCR in responding B cells was used to identify 
GC and plasmablast precursors and when and where CSR occurred. 
 The results suggest CSR occurs in B blasts before GC B cells or 
plasmablasts emerge in both thymus dependent and thymus independent type II 
responses. The protein IRF4, which is essential for CSR and plasmablast 
differentiation, is expressed in all responding cells immediately after immunization 
and selectively upregulated to high levels in plasmablasts. A hierarchy of gene 
expression was identified as B cells differentiate into plasmablasts whereby high 







Firstly, I would like to thank Professor Ian MacLennan for giving the fantastic 
opportunity to work with him on this project and for all his advice and support. I would 
also like to thank Kai- Michael Toellner for his time, patience and help with all things 
fluorescent. My thanks to all the members of the MacLennan group, especially 
Mahmood Khan.   
Jo, I would not be here without you. Thank you for propping me up, cheering 
me on and always being there. Alex, that you are proud of me means everything.  
Gemma Ryan, Louise Clough, Ewan Ross and Sian Lax all provided me with 
escapism and gumption, I am indebted. Thank you to Saeeda Bobat, Omar Qureshi, 
Claire Manzotti, Natalie Chirimuuta and Carrie Willcox for making the lab and the 
office great places to work.    
Finally, I would like to thank Jennifer Hills. Thank you for everything.
 iv 
Table of contents 
1. Introduction .......................................................................................................... 1 
1.2. The structure of the spleen. ............................................................................. 4 
1.2.1. The T zone ................................................................................................ 5 
1.2.2. The follicles ............................................................................................... 7 
1.2.3. The marginal zone .................................................................................... 8 
1.3. The development of B cells.............................................................................. 8 
1.3.1 The production of the B Cell Receptor ....................................................... 9 
1.4. B cell subsets and their roles ......................................................................... 12 
1.4.1. Recirculating follicular B cells .................................................................. 12 
1.4.2. Marginal Zone B cells .............................................................................. 13 
1.4.3. The development of B1 cell subsets ....................................................... 15 
1.4.4. Memory B cells ........................................................................................ 17 
1.5. B cell responses to antigen ............................................................................ 18 
1.5.1. T cell independent B cell responses ........................................................ 19 
1.5.2. Binding antigen induces B cells to migrate to the T zone follicular 
boundary ........................................................................................................... 20 
1.5.3. B cells receive differentiation signals at the boundary of the T zone and 
follicle ................................................................................................................ 20 
1.5.4. The formation of germinal centres ........................................................... 21 
1.5.5. Class switch recombination ..................................................................... 23 
1.6. Plasmablast and extrafollicular foci development .......................................... 27 
1.6.1. Blimp1 ..................................................................................................... 28 
1.6.2. Interferon regulatory factor 4 and plasma cell development .................... 29 
1.7. B cell responses to 4-hydroxy-3-nitrophenol (NP) conjugates ....................... 29 
1.7.1 The Response to NP-Ficoll ...................................................................... 30 
1.7.2. Quasi monoclonal mice ........................................................................... 31 
 v 
1.8. Aims of the project ......................................................................................... 32 
Chapter 2: Methods and materials 33 
2.1. Animals .......................................................................................................... 33 
2.1.1. Primers and concentrations for genotyping PCR .................................... 33 
2.2 Immunizations................................................................................................. 33 
2.3 Extraction of cells ex vivo ............................................................................... 34 
2.4. In vitro cell culture .......................................................................................... 34 
2.5. Flow cytometry ............................................................................................... 35 
2.6. Histology ........................................................................................................ 35 
2.6.1 Primary antibodies ................................................................................... 36 
2.4.2 Secondary and tertiary reagents .............................................................. 36 
2.7 Real time RT-PCR .......................................................................................... 37 
2.8 PCR Arrays ..................................................................................................... 38 
2.9 Single cell PCR ............................................................................................... 38 
2.9.1. Primers and concentrations for single cell RT2-PCR .............................. 39 
2.9.2 Probes for single cell RT2 PCR ................................................................ 39 
2.10 Quantification of cells following histology ...................................................... 40 
2.11 Cell proliferation calculations ........................................................................ 40 
2.13 Quantification of B blast location at 48 hours in the carrier primed response 43 
Chapter 3: ............................................................................................................... 46 
Divergent B cell differentiation induced by 30g NP-Ficoll ................................ 46 
3.1. Immunohistological analysis of the early response to 30 g NP-Ficoll .......... 47 
3.1.1. Activated NP binding B cells move from the MZ to the T zone of the 
spleen within 8 hours of immunization .............................................................. 47 
3.1.2. The NP-specific B cells become blasts in the T zone and remain in the 
white pulp throughout the 2nd day after immunization. ...................................... 47 
3.1.3. Germinal centres and abundant AFCs appear on the 3rd day. ................ 49 
 vi 
3.2. NP binding B cells responding to NP-Ficoll divided into subsets according to 
their B220 and CD138 expression. ....................................................................... 49 
3.3. Microarray analysis of mRNA expression within bulk-sorted NP-specific B 
blasts and plasmablasts identified by flow cytometry............................................ 53 
3.3. Microarray analysis of mRNA expression within bulk-sorted NP-specific B 
blasts and plasmablasts identified by flow cytometry............................................ 54 
3.3.1. NP-binding sorted populations form distinct populations at the mRNA level
 .......................................................................................................................... 54 
3.3.2 At 72 hours the B220 intermediate CD138+population expresses mRNA 
associated with plasmablast differentiation and has down regulated mRNAs for 
proteins of the BCR complex............................................................................. 55 
3.3.2 At 72 hours the B220 intermediate CD138+population expresses mRNA 
associated with plasmablast differentiation and has down regulated mRNAs for 
proteins of the BCR complex............................................................................. 56 
3.3.3. mRNA from cells in the B220 high CD138- B blast population includes 
mRNAs associated with germinal centre B cells ............................................... 64 
3.3.4. The CD138- B220 intermediate cells at 72 hours have downregulated GC-
associated genes including DNA repair genes .................................................. 64 
3.3.5 Within 24 hours genes associated with CSR and DNA repair are 
upregulated ....................................................................................................... 69 
3.3.6 At 48 hours the B220 intermediate population is distinguished by the 
expression of CD30L and CX3CR1 ................................................................... 72 
3.3.7. The limitations of gene expression profile analysis ................................. 72 
3.4. The use of single cell analysis to define the cells that undergo class switching 
in the extrafollicular response and where and when B Blasts differentiate either to 
germinal centre cells or plasmablasts. .................................................................. 74 
3.4.1 Class switching in the extrafollicular response occurs in the T zone B 
blasts before they differentiate into AFC. .......................................................... 75 
3.4.2. Characteristics of the plasmablast cells induced by 30g NP-Ficoll. ....... 77 
3.4.2. Characteristics of the plasmablast cells induced by 30g NP-Ficoll. ....... 78 
3.4.3 Germinal centre precursors first appear in the B220 high CD138- subset at 
72 hours ............................................................................................................ 78 
 vii 
3.4.4. The significance of Bcl6 mRNA expression in naïve B cells in the absence 
of Bcl6 protein. .................................................................................................. 80 
3.5. IRF4 expression throughout the response to 30g NP-Ficoll ........................ 80 
3.5.1 IRF4 expression in the NP binding cells during the first day of their 
response to NP-Ficoll. ....................................................................................... 81 
3.5.2. IRF4 expression in relation to the formation of plasmablasts,germinal 
centre cells and switching as assessed by co-expression of AID and Bcl-6 on 
the second and third days of the response ....................................................... 85 
3.5.2. IRF4 expression in relation to the formation of plasmablasts,germinal 
centre cells and switching as assessed by co-expression of AID and Bcl-6 on 
the second and third days of the response ....................................................... 86 
3.6. Discussion ..................................................................................................... 91 
3.6.1 Class switching in the plasmablast response ........................................... 91 
3.6.2 The hierarchy of IRF4, Blimp1 and CD138 expression in plasmablast 
development...................................................................................................... 92 
3.6.3. The identification of germinal centre cells and their precursors ............... 93 
3.6.4 The role and origins of the CD138+ B220 intermediate population ........... 94 
Chapter 4: ............................................................................................................... 96 
Varying the proportion of cells becoming plasmablasts and switching in the 
extrafollicular response to study molecules influencing these processes ...... 96 
4.1. A low dose of NP-Ficoll induces B blasts and by 96 hours has induced 
plasmablasts but these have not undergone class switch recombination and only 
small or no germinal centres are formed. ............................................................. 98 
4.1.1 The characteristics of the B blasts located in the T zone at 48 hours after 
1g NP-Ficoll .................................................................................................. 100 
4.1.1 The characteristics of the B blasts located in the T zone at 48 hours after 
1g NP-Ficoll .................................................................................................. 101 
4.1.1 The characteristics of the B blasts located in the T zone at 48 hours after 
1g NP-Ficoll .................................................................................................. 102 
4.1.2 A lack of B blasts expressing AID mRNA in the response to 1ug NP-Ficoll 
is consistent with the observed lack of switching ............................................ 108 
4.1.3. Why do more 48 hour NP+ cells express Bcl6 mRNA in the 1μg than the 
30g response? .............................................................................................. 108 
 viii 
4.1.4 Probing the relationship of high level IRF4 expression to plasmablast 
development.................................................................................................... 110 
4.1.5. Why is there a reduction in the B220int population in response to 1μg NP-
Ficoll? .............................................................................................................. 112 
4.1.6. Discussion ............................................................................................. 113 
4.2. If there is a higher proportion of switched AFC at 96 hours is this reflected in a 
higher proportion of B blasts expressing AID at 48 hours after immunization? ... 116 
4.2.1. Co-immunization with poly I:C and NP-Ficoll increases the proportion of 
switched AFC .................................................................................................. 117 
4.2.2. Co-immunization increases the amount of switching without an increase in 
AID expression at 48 hours ............................................................................. 122 
4.2.3. Expression of Bcl6 at 48 hours is greater than that observed in the 
response to NP-Ficoll alone ............................................................................ 123 
4.2.3. Expression of Bcl6 at 48 hours is greater than that observed in the 
response to NP-Ficoll alone ............................................................................ 124 
4.2.4 None of the CD138 population in response to co-immunization expresses 
Bcl6 ................................................................................................................. 124 
4.3 Discussion .................................................................................................... 125 
4.3.2. The effect of TLR co-stimulation on class switch recombination and 
plasmablast proliferation. ................................................................................ 125 
4.3.3. What role does Bcl6 play in the co-immunized response? .................... 126 
4.3.4. The low proportion of B200int NP+ B blasts at 48 hours in the combined 
response ......................................................................................................... 127 
Chapter 5 ............................................................................................................... 129 
B blasts in a germinal centre-biased response ................................................. 129 
5.1 The development of a germinal centre-biased B cell response model .......... 129 
5.1 The carrier primed response to NP-CGG is biased towards germinal centres 
with few plasmablasts. ........................................................................................ 131 
5.2 NP-CGG induces NP-specific B cells to migrate to follicles and associate with 
follicular T cells in CGG-primed mice that have received QM B cells ................. 134 
5.3. Cell activation and differentiation as assessed by flow cytometry................ 137 
5.4 The expression of Bcl6 and AID mRNA in germinal centre precursors ......... 142 
 ix 
5.5 Class switching and AID expression occur in the absence of Bcl6 expression in 
the NP+ carrier primed response......................................................................... 145 
5.6 Expression of Blimp1 in occasional CD138- NP+ cells .................................. 145 
5.7 Discussion .................................................................................................... 146 
5.7 Discussion .................................................................................................... 147 
5.7.1. B cells interact with follicular T cells prior to the infiltration of germinal 
centres in the response to NP-CGG ................................................................ 147 
5.7.2. The effect of precursor cell number on B cell migration within the carrier 
primed NP-CGG response. ............................................................................. 149 
6. Conclusions and Future Work ........................................................................ 150 
6.1 The location of B cells 24 hours after antigen engagement is dependent on the 
type of response induced and the help available ................................................ 150 
6.1.1  Weak BCR signalling induced by low-dose NP-Ficoll generates some B 
blasts that die without maturing into either plasmablasts or GC B cells .......... 151 
6.2. Transcriptional changes within the first 24 hours may yet reveal plasmablast 
and germinal centre precursors. ......................................................................... 152 
6.3 Expression of AID at 48 hours allows class switch recombination to occur in 
undifferentiated B blasts ..................................................................................... 153 
6.4 The B220 intermediate population at 48 hours – a meaningless distinction or a 
relevant phenotype? ........................................................................................... 155 
6.5 The level of expression of IRF4 indicates plasmablast precursors at 48 hours 
but does not obviously identify germinal centre precursors ................................ 157 
6.6 Bcl6 mRNA expression is continuous in inactive B cells and does not identify 
GC precursors or the outcome of the response. ................................................. 158 
Appendix ............................................................................................................... 160 
i. Buffers: ............................................................................................................ 160 
Tris Buffer pH 7.6 ............................................................................................ 160 
Tris Buffer pH 9.2 ............................................................................................ 160 
Peroxidase Substrate ...................................................................................... 160 
Alkaline Phosphate Substrate ......................................................................... 160 
ii. Array contents: ................................................................................................ 161 
 x 
Plasma Cell Specific ....................................................................................... 161 
Chemokine receptors ...................................................................................... 162 
GC specific ...................................................................................................... 162 
Both ................................................................................................................. 163 
Bibliography ......................................................................................................... 165 
 
 xi 
List of Figures 
Figure 1.1 The structure of the white pulp of the spleen............................................. 6 
Figure 1.1: Counting the location of NP+ B blasts at 48 hours in the carrier primed 
response……………………………………………………….……………………………44 
Figure 2.2: The cumulative ratio of NP+ cells in the inner/outer follicle at 48 hours 
during the carrier primed response………………………………………………………45 
Figure 3.1 The early redistribution of NP specific cells in response to NP-Ficoll…...48 
Figure 3.2: The expansion of NP specific cells in the splenic white pulp during the 
second day after immunization…………………………………………………………...50 
Figure 3.3: Germinal centre and plasmablast development in the QMxB6 response to 
NP-Ficoll…………………………………………………………………………………….51 
Figure 3.4: FACS analysis of the cells responding to 30g NP-Ficoll………………..53 
Figure 3.5: Combined gene expression data from low density RT-PCR arrays…….55 
Figure 3.6: Plasmablast associated genes are upregulated in the CD138+ population 
at 72 hours………………………………………………………………………………….57 
Figure 3.7: Further genes upregulated in the CD138+ population at 72 hours……..58 
Figure 3.8: Genes associated with the BCR are downregulated at 72 hours in the 
CD138+ population………………………………………………………………………...60 
Figure 3.9: Further genes downregulated at 72 hours in the CD138 population……61 
Figure 3.10: Further genes downregulated at 72 hours in the CD138 population….63 
Figure 3.11: Genes upregulated in the B220high population at 72 hours are 
associated with germinal centres………………………………………………………...65 
Figure 3.12: Genes downregulated in the B220 intermediate population at 72 hours 
are associated with germinal centres and DNA repair…………………………………67 
Figure 3.13: Genes downregulated in the B220 intermediate population at 72 hours 
are associated with germinal centres and DNA repair…………………………………68 
Figure 3.14: Genes upregulated in the 24 hours of the response are associated with 
DNA repair, CSR, cell cycle and cell movement………………………………………..70 
Figure 3.15: Additional genes that show mRNA level changes during the first 24 
hours of the response……………………………………………………………………..71 
 xii 
Figure 3.16: Genes that show significant mRNA level changes during the second day 
of the response……………………………………………………….……………...........73 
Figure 3.17: Switch recombination to IgG3 in the response to 30g NP-Ficoll……..76 
Figure 3.18: Expression of AID and Bcl6 at the single cell level during the response 
to NP-Ficoll………………………………………………………………………………….77 
Figure 3.19: Plasmablast populations in the QMxB6 response to 30g NP-Ficoll….79 
Figure 3.20: IRF4 expression in NP binding cells 8 hours after NP-Ficoll…………...82 
Figure 3.21: IRF4 protein is present prior to immunization but increases after NP-
Ficoll immunization………………………………………………………………………...83 
Figure 3.22: IRF4 mRNA expression does not follow IRF4 protein levels during the 
first 24 hours of the response to 30g NP-Ficoll……………………………….……….85 
Figure 3.23: IRF4 expression by FACS in NP binding cells after immunization…….87 
Figure 3.24: IRF4 expression in responding NP+ populations at 48 and 72 hours…88 
Figure 3.25: IRF4 and AID mRNA are co-expressed in CD138- cells at 48 and 72 
hours ………………………………………………………………………………………..90 
Figure 4.1: Low dose NP-Ficoll produces an extrafollicular plasmablast response 
with minimal germinal centre formation or Ig class switching………………………..100 
Figure 4.2: Plasmablasts are present at 96 hours in response to 1g NP-Ficoll….101 
Figure 4.3: At 48 hours the 1g NP-Ficoll response induces B blasts at the T 
zone/follicular boundary………………………………………………………………….103 
Figure 4.4: The B blast response to 1g NP-Ficoll consists of a large B220high, 
IRF4neg population ……………………………………………………………………….106 
Figure 4.5: Single cell RT2-PCR analysis of NP+ cells shows low AID expression at 
48 hours that correlates with reduced class switching at 96 hours…………………109 
Figure 4.6: Expression of IRF4 precedes CD138 expression at 48 hours…………111 
Figure 4.7: Co-immunization with 30g NP-Ficoll and 10g poly I:C induces germinal 
centre, plasmablasts and a larger switched response………………………………..118 
Figure 4.8: The germinal centre and plasmablast response to 30g NP-Ficoll with 
polyi:c or alone in QMxB6 mice …………………………………………...……………119 
Figure 4.9: The co-immunized response has an advanced plasmablast response 
compared to 30g NP-Ficoll alone……………………………………………………..121 
 xiii 
Figure 4.10: Single cell RT2-PCR on NP-Ficoll and polyI:C co-immunized NP+ cells 
at 48 hours shows lower AID expression than that seen in response to 30gNP-Ficoll 
alone……………………………………………………………………………………….123 
Figure 5.1: The carrier primed response to NP-CGG is biased towards NP+ germinal 
centres……………………………………………………………………………………..132 
Figure 5.2: The NP+ carrier primed response to NP-CGG is predominantly germinal 
centre biased although some early plasmablasts are induced………………………133 
Figure 5.3: NP binding cells appear at the edge of the follicle at the border with the T 
zone 24 hours after immunization with NP-CGG……………………………………..135 
Figure 5.4: NP binding cells are Ki67 and some are associated with CD3 T cells at 
the boundary of the T zone and the red pulp…………………………………………136 
Figure 5.5: The location of NP-binding cells in the follicle at 48 hours during the 
carrier primed response 50g NP-CGG or 30g NP-Ficoll………………………….138 
Figure 5.6: The proportion of B220 and CD138+ subsets in NP binding cells reflects 
the small number of plasmablasts and large numbers of germinal centres produced 
by the response…………………………………………………………………………..139 
Figure 5.7: Expression of IRF4 reflects the small number of plasmablasts and large 
numbers of germinal centres produced by the carrier primed response to NP-
CGG………………………………………………………………………………………..141 
Figure 5.8: A comparison of Bcl6, AID and Blimp1 expression in NP+ cells in the QM 
x B6 response to 30g and 1g NP-Ficoll and the carrier primed NP response to NP-
CGG and NP-Ficoll………………………………………………………………………143 
Figure 5.9: Class switch recombination to 1 and 3 in NP+ B cells participating in the 











List of Tables 
Table 2.1 The number of NP+ B cells at the stated time after immunization with NP-
Ficoll ......................................................................................................................... 41 
Table 2.2 The percentage of spleen area occupied by NP+ plasmablasts at the 
stated time after immunization with NP-Ficoll ........................................................... 42 
Table 4.1: The proportions of NP-specific cells in the three QMxB6 immunization 
protocols that at 96 hours after immunization (a) had undergone switch 
recombination to IgG3, (b) had entered germinal centres, or (c) had become 





AFC  Antibody forming cell 
AID   Acitvation induced cytidine deaminase 
2m   beta-2 microglobulin 
B cell  Bursa of Fabricius cell 
Bcl6   B cell lymphoma 6 
BCR  B cell receptor 
Blimp1 B-lymphocyte-induced maturation protein 1 
Btk  Bruton tyrosine kinase 
C57Bl6 C57BL/6J 
CDR  Complementarity determining region 
CGG  Chicken gamma globulin 
CSR  Class switch recombination 
D  Diversity 
DNA  Deoxyribonucleic acid 
Ds  Double stranded 
Fig  Figure 
F  Follicle 
 xvi 
FDC  Follicular dendritic cell 
GC   Germinal Centre 
Ig  Immunoglobulin 
Int  Intermediate 
IRF4  Interferon regulatory factor 4 
J  Joining 
  Kappa
  Lambda
LPS  Lipopolysaccharide 
MZ  Marginal Zone 
N  Nucleotide 
NFB Nuclear factor of kappa light polypeptide gene enhancer in B-cells 
NK  Natural Killer cell 
NP  4-Hydroxy-3-nitrophenylacetyl 
Pax5  Paired box gene 5 
Poly I:C Polyinosinic:polycytidylic acid 
QM  Quasi Monoclonal 
QMxB6 C57B6 mice heterozygous for the QM heavy chain (Section 2.1) 
Rag  Recombination activating genes 
 xvii 
RNA  Ribonucleic acid 
RT2 PCR Real-time reverse-transcriptase polymerase-chain-reaction 
S  Switch 
Ss  Single stranded 
SHM   Somatic hyper mutation 
STAT  Signal transducers and activators of transcription  
T cell  Thymus cell 
TCR  T cell receptor 
T zone T cell zone or Periarteriolar lymphoid sheath 
TD   Thymus dependent 
Tdt  Terminal deoxynucleotidyl transferase   
TI   Thymus independent 
UNG  Uracil-DNA glycosylase 
V  Variable  




This thesis is concerned with the differentiation of B cells as they respond to antigen; 
their location, gene expression at the protein and mRNA level and how this 
influences the outcome of the B cell response. B cells are effectors of the adaptive 
immune system through their production of antibody and activation factors. In this 
way B cells play an important role in the resolution of a wide range of infections. 
Antibody in the blood and tissue fluids acts in a wide range of ways: directly through 
neutralization of virus particles and toxins and indirectly by activating complement as 
well as a range of cellular effectors including macrophages, neutrophils, eosinophils, 
mast cells, platelets and natural killer (NK) cells. 
There are several different types of B cells and these participate in different 
types of response. This introductory section will provide a brief didactic outline, 
without references, of topics covered later.  
B lymphocytes are characterized by their expression of surface bound 
antibody. This, complexed with other associated proteins, forms the B cell receptor 
(BCR). Antibody is composed of two heavy chain molecules covalently bound to 
each other. Each is bound to a light chain molecule. During development B cells 
undergo rearrangement of the variable regions of their heavy and light chain 
immunoglobulin (Ig) genes, a process that endows each B cell with one of an almost 
limitless number of possible receptors. As this process can produce antibodies that 
are reactive to self antigens, elaborate mechanisms act which serve to eliminate, 
alter the BCR specificity or render such B cells inactive. 
The expression of antibody on the BCR enables the specific recruitment of B 
cells into antibody responses. The simplest and most rapid form of antibody 
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response is the extrafollicular response. In these responses B cells are induced to 
proliferate as B blasts before differentiating into proliferating antibody-secreting cells 
– plasmablasts, and then into non-proliferating antibody secreting cells – plasma 
cells. All of the types of antigen discussed below can evoke extrafollicular responses. 
Antigens that induce antibody responses have been classified according to whether 
the responses they evoke are thymus dependent (TD) or thymus independent (TI). 
The latter can operate in congenitally athymic mice, which lack thymus-processed T 
cells. TD antigens, by contrast, require cognate interaction between thymus-
processed T cells and B cells in order to proceed. Thymus indepedent responses 
have been suclassified into type 1 and 2 on the basis of whether they can occur in 
CBA/N mice which lack the X-linked Bruton tyrosine kinase. TI-1 antigens can evoke 
responses in this mouse, while TI-2 antigens cannot. All three types of response, TD, 
TI-1 and TI-2 are characterized by a bias in the types of B cells that respond and 
also in their outcome.  
T cell independent type 2 responses (TI-2) are typically, but not exclusively, 
evoked by antigens that contain polysaccharide chains that contain repeating 
sequences. These are typified by the polysaccharides that form the capsules of 
pneumococci and meningococci. The repeating sequences in these antigens can 
cross link many BCRs on the same B cell producing a larger signal sufficient to 
induce a proliferative antibody response. By contrast TI-1 responses are induced by 
antigens that trigger innate signalling receptors on B cells as they activate the BCR. 
The most obvious example of this is the effect of the lipopolysaccharide (LPS) of the 
outer layer of the outer cell membrane of gram negative bacteria. Toll-like receptor 4 
(TLR4) on B cells binds the invariant lipid A of LPS and, if the BCR recognises the 
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polysaccharide of the LPS moiety, which varies between different types of bacteria a 
response may be evoked.  
T cell dependent antigens require specific activation of both T and B cells for 
a response to be generated. The activation of naïve T and B cells by antigen induces 
them to relocate into a common area of lymphoid tissue and acquire characteristics 
that enable them to interact with each other. T cell dependent antigens 
characteristically induce germinal centres (GC) in addition to extrafollicular 
responses. In GC B cells undergo proliferation and activate a process of Ig Variable 
(V)-region gene-directed hypermutation. This is followed by antigen and T cell-
dependent selection; GCs can result in a substantial increase in the affinity of the 
antibody produced by their constituent B cells. A proportion of selected GC B cells 
differentiate into plasma cells that can be long-lived and some become memory B 
cells. Whilst basic scientific research tends to focus on T cell dependent or T cell 
independent antigen pathogens frequently present a variety of antigens and may 
invoke a range of responses. For example, salmonella produce a TD B cell response 
to flagellin and a TI response to outer membrane proteins. Similarly, sheep red blood 
cells in mice evoke both TD and TI responses. 
Developmental and phenotypic features have been used to define two major 
subsets of B lymphocytes – B1 and B2 cells. Most naïve B cells in the secondary 
lymphoid tissues of adults are B2 cells and these have been subclassified into 
IgM+,IgDhigh,CD23high,CD21+, B220high recirculating B cells and IgM+,IgDlow/-,CD23low/-
,CD21high, B220high marginal zone (MZ) B cells. B1 cells are characteristically 
IgM+,IgDlow/-,CD23low/-,CD21low, B220int and in mice they have been subclassified into 
B1a cells which express CD5 and B1b cells which are CD5 negative. Memory B cells 
from GC differ from naïve B2 cells in terms of their responsiveness and their 
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quantity. In addition, the participation of B1 cells in memory responses has recently 
been described. Neither B1 nor B2 memory will not be considered further at this 
stage.  
TD responses may recruit B cells from the recirculating and MZ pools. It is 
less clear whether they can also recruit cells from the B1 compartment. TI-2 antigens 
typically induce a response in B1 cells as well as MZ B cells. By contrast 
recirculating B cells are not recruited into responses to TI-2 antigens. The 
recruitment of B cells into TI-1 responses depends at least in part upon whether they 
express Toll-like receptors and analogous receptors. B1 and MZ cells are more likely 
to express these receptors than recirculating B cells.  
This study examines the differentiation of B cell blasts into early plasmablasts 
or GC cells in the spleen. Whilst this thesis is mostly concerned with the TI-2 
response to NP-Ficoll the study begins the process of examining the role of key 
transcription factors in a TD response. This introduction will describe the structure of 
the spleen, the development of B cells and the B cell receptor (BCR). The different 
types of B cells that exist will then be described followed by a résumé of the 
response to antigen and the differentiation of B cells into GC and antibody producing 
cells.  
1.2. The structure of the spleen.  
My studies have focused exclusively on the mouse spleen. In essence the 
spleen is formed as a continuum of tissue perfused by blood sinusoids – the red pulp 
- in which islands of more compact tissue – the white pulp areas – are suspended. 
This organ has at least four groups of functions in the adult mouse. Firstly 
macrophages on the cords of Billroth within the red pulp blood sinusoids remove 
 5 
from the blood pathogens and time-expired or opsonised blood cells (Schmidt, et al, 
1988). Second the red pulp in mice, in contrast to that of humans, contains 
haemopoietic tissue (Johnson, et al, 1975). Third, the red pulp contains poorly-
characterized niches that sustain plasma cell survival (Sze, et al, 2000). The fourth 
and most important splenic function in the context of this thesis relates to the 
secondary lymphoid tissue which is located in islands of the white pulp. This 
secondary lymphoid tissue hosts the B and T cell responses of the spleen. At the 
centre of each island of white pulp there is a central arteriole (Schmidt, et al, 1988), 
and surrounding this is the T zone, or PALS (perioarteriolar sheath) characterised by 
the presence of T cells and antigen-presenting dendritic cells (DC) (Fig 1.1). The T 
zone is cupped by B cell areas - follicles, which are in turn surrounded by the MZ. 
Small areas of the T zone between the follicles abut the red pulp directly; these are 
called bridging channels. Bridging channels are the point of exit of recirculating B 
and T cells from the white pulp (Bajenoff, et al, 2008) and also an exit point for 
plasmablasts generated in extrafollicular antibody responses that grow in 
extrafollicular foci in the adjacent red pulp (Jacob, et al, 1991b; Toellner, et al, 1996).  
1.2.1. The T zone 
At the centre of each white pulp island lies the T Zone. Recirculating T cells 
leave the blood in the MZ blood sinusoids and the migrate into this area (Howard, et 
al, 1972) where they interact with the resident DC, testing their T cell receptor (TCR) 
against the antigen presented by the DC (Stoll, et al, 2002). T cells that have a TCR 
that recognizes antigen presented in the context of MHC class I or II molecules or 
CD1d form a synapse with the DC and start the process of T cell priming (Austyn, et 
al, 1988; Mempel, et al, 2004). After about 30 hours these T cells enter cell cycle and 
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Figure 2.1 The structure of the white pulp of the spleen 
The murine white pulp consists of a T cell area, the T zone (T), partially 
encapsulated by the B cell rich follicles (F). The follicles are separated from the 
marginal zone (MZ) by the marginal sinus (MS). Where the red pulp abuts the T 
zone extra follicular foci (EF) are formed at the bridging channels during early 




















 over the next 18 hours migrate to the boundary of the T zone and the follicle 
changing their expression of CCR7 and CXCR5 (Hardtke, et al, 2005). It is at the 
boundary of the T zone and follicle where they interact with B cells that have taken 
up and processed antigen via their BCR (Toellner, et al, 1996; Okada, et al, 2005). B 
cells are induced to migrate to the boundary of the T zone and the follicle regardless 
of whether the response is TI or TD (Okada, et al, 2005; Hsu, et al, 2004). Analysis 
of how B cells responding to TI antigen behave in the T zone is a major topic of this 
thesis.  
1.2.2. The follicles  
The follicles, B cell areas that partially surround the T zone, are predominantly 
composed of recirculating B cells along with follicular dendritic cells (FDC) (Tew, et 
al, 1997). When follicles contain no GC they are known as primary follicles. 
Secondary follicles contain GC and the recirculating cells form a rim, the follicular 
mantle, around the part of the GC that does not abut the T zone. Recirculating B 
cells are found throughout primary follicles and they are in a constant state of 
migration between the follicles of secondary lymphoid tissues (Niewenhuis and Ford, 
1976). Characteristically, recirculating B cells are IgDhigh, IgM+, CD23high, CD21+, 
B220high (Gray, et al, 1984; Ling et al, 1987; Coffman and Weissman, 1986).  
Follicular dendritic cells take up antigen from transporting B cells (Brown, et 
al, 1970; Phan, et al, 2007) and can retain this antigen for months (Tew and Mandel, 
1978). During a TD response GC B cells with a corresponding BCR may take up 
antigen from FDC and present this to follicular T cells (Kosco, et al, 1988). Recently 
evidence has been presented that indicates recirculating B cells can take up antigen 
from FDC in the first few days following antigen administration (Suzuki, et al, 2009)  
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1.2.3. The marginal zone 
The MZ is a band of cells in the spleen that surround that part of the B cell 
follicles that does not abut to the T zone. The MZ contains B cells (Kumararatne, et 
al, 1981), macrophages that can localize neutral polysaccharides (Humphrey, 1979: 
Humphrey and Grennan, 1981) and metallophilic macrophages. In rats and mice the 
entire marginal zone is perfused by blood sinusoids, while in humans only the outer 
portion has a sinusoidal blood supply. It is separated from the follicular areas by the 
marginal sinus – a thin band of MadCAM expressing cells that mark the inner limit of 
the MZ blood sinusoids (Kraal, et al, 1995). The cells in the MZ come into direct 
contact with the blood from the marginal sinuses (Schmidt, et al, 1988). MZ B cells 
are discussed in detail in section 1.4.2.1.  
The marginal sinus is the point at which both recirculating T and B cells enter 
the spleen and T zone. They migrate to the edge of the follicles where they meet 
bridging channels (Howard, et al, 1972; Niewenhuis and Ford, 1976). The T cells 
then migrate to the DC in the central T zone while the B cells move to the follicles via 
the outer T zone (Niewenhuis and Ford,1976). If these T or B cells fail to encounter 
an antigen they recognise they leave the white pulp after about a day via MZ 
bridging channels (Nieuwenhuis and Ford,1976). 
1.3. The development of B cells 
The B cell compartments in mice are not fully formed at birth. B cells are 
produced in the foetal liver, the spleen from late foetal life and shortly after birth 
(particularly in the first 3 months although B lymphopoiesis can continue for longer in 
the spleen) (Johnson, et al, 1976). B lymphopoiesis occurs in the bone marrow from 
late foetal life onwards (Johnson, et al, 1976). In mouse and human the B cell subset 
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formed depends upon the stage of development, with the evidence from 
reconstitution experiments pointing to B1 lymphopoiesis being confined to the fetal 
liver, while B2 lymphopoiesis occurs mainly in the bone marrow. Recently evidence 
has been presented that indicates in mice B1a lymphopoiesis in post natal life is 
confined to the spleen, while B2 lymphopoiesis predominantly procedes in the bone 
marrow (Rosado, et al, 2009). Whilst debate persists around whether the different B 
cell subsets originate from a common precursor or from different development 
pathways, all B cells rearrange their B cell receptor (BCR). This section will describe 
first how the BCR is formed and then the development of the different B cell subsets.   
1.3.1 The production of the B Cell Receptor  
Each B cell produces its own BCR (Raff, et al, 1973). This is produced 
through the rearrangement of the immunoglobulin heavy chain genes by a process 
of somatic recombination with imprecise splicing and, particularly in the bone 
marrow, the insertion of additional nucleotides (N) in the joining region. These 
processes can yield almost limitless Ig V region structures and hence a very 
extensive repertoire of BCR. The first recombination is between a diversity (D) 
segment, of which there are twenty five, and one of the six joining (J) segments in 
each Ig heavy chain allele (Alt, et al, 1984). This occurs simultaneously on both 
heavy chain gene sets (ten Boekel, et al, 1995). Secondly, this combined DJ region 
on one of the heavy chain gene complexes is joined to one of the variable region 
genes to produce the completed variable section of the BCR (ten Boekel, et al, 1995; 
Early, 1980). Should the rearrangement be unproductive then the other heavy chain 
will be rearranged (Alt, et al, 1984; Jung, et al, 2006). In addition to the permutations 
produced through the combination of V, D and J segments, nucleotides can be 
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inserted at the joins through the action of terminal deoxynucleotidyl transferase (Tdt) 
(Komori, et al, 1993). Mice deficient for Tdt have a restricted repertoire but 
homology-directed recombination increases variability (Gilfillan, et al, 1993). 
Terminal deoxynucleotidyl transferase is not expressed during development in the 
foetal liver (Li, et al, 1993) and this provides a bias in the type of BCR produced 
(Gilfillan, et al, 1993) e.g MZ B cells seeded from the immature B cell pool show a 
bias for cells that lack N insertions in the complementarity determining region (CDR) 
(Carey, et al, 2008). 
This rearrangement of the heavy chain variable region genes is dependent 
upon the production of a recombinase complex involving both recombination 
activating genes (RAG) (Oettinger, et al, 1990) and 53BP (Difilippantonio, et al, 
2008). A failure to produce a successful Ig heavy chain and light chain 
rearrangement, or in T cells a TCR with rearranged  or  chain genes, results in a 
lack of B and T cells. However, this can be overcome through the insertion of 
transgenic pre-arranged heavy and light chains (Reichman-Fried, et al, 1990).  
The newly formed heavy chain is combined into the pre-BCR with surrogate 
light chain (SLC) and the BCR-associated transmembrane signalling molecules Ig 
and  This pre-BCR is expressed on the developing B cell (Lanig, et al, 2004; 
Keyna, et al, 1995). Signalling from a preBCR surrogate induces a reduction in Tdt, 
Rag1 and Rag2 expression and is independent of the SLC (Galler, et al, 2004; 
Wasserman, et al, 1997). Thus further re-arrangement is at least temporarily 
prevented. This pre-BCR signalling is dependent upon IgGaller, et al, 2004) and 
oligomerization of the complex rather than antigen recognition (Bankovich, et al, 
2007).   
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The expression of the rearranged heavy chain with the SLC induces a period 
of proliferation followed by the rearrangement of the light chain (Rolink, et al, 2000). 
Unlike the production of the heavy chain Tdt is not expressed during rearrangement 
of the light chain (Grawunder, et al, 1995; Wasserman, et al, 1997). In addition, the 
light chain rearrangement consists of only the J and V regions (Bernard, 1978). One 
kappa light chain is rearranged first, and if this is not successful the second kappa 
chain genes are rearranged. If neither can form a BCR with the heavy chain then the 
lambda chain genes are rearranged one after the other (Brauninger, et al, 2001).  
On the production of a BCR, there are a number of outcomes for the B cell. 
Most newly-produced immature B cells leave the bone marrow and migrate via the 
blood to the T zone of the spleen (Lortan, et al, 1987). However, some immature B 
cells will have autoreactive BCR. These cells can be eliminated, become tolerant or 
anergic (Rolink, et al, 1998). At the newly-formed B cell stage BCR ligation can 
trigger receptor editing which may produce a non-auto-reactive BCR (Tiegs, et al, 
1993). Whilst non reactive B cells tend to become recirculating B cells, some weakly 
autoreactive cells become MZ B cells or B1 cells (Chen, et al, 1997; Kanayama, et 
al, 2005; Xing, et al, 2009).  
In un-manipulated conditions BrdU studies show that apoptosis occurs in 90% 
of immature B cells after 3-4 days in the periphery (Chan and Maclennan, 1993; 
Fulcher and Basten, 1997; Rolink, et al, 1998; Opstelten and Osmond, 1983). B2 cell 
survival and maturation is promoted through the expression of other factors such as 
B cell-activating factor (BAFF) (Schneider, et al, 2001, Schiemann, et al, 2001). 
There is evidence that newly produced B cells compete with recirculating B cells to 
gain access to the recirculating pool (MacLennan and Chan, 1993). The average 
lifespan of recirculating B cells is in the order of 6 weeks (MacLennan and Gray, 
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1986; Fulcher and Basten, 1997), indicating that mature recirculating B cells are only 
being replaced at a slow rate. Thus in steady state conditions immature B cells only 
have a small chance of displacing a recirculating B cell. On the other hand, if the 
recirculating B cell pool is depleted then immature B cell recruitment into the pool is 
massively increased (Bazin, et al, 1985). Conversely in the absence of immature B 
cell input recirculating B cell lifespan is extended indefinitely (Sprent, et al, 1991). 
Anergic autoreactive B cells fail to compete with non-autoreactive immature B cells 
for follicular niches (Cyster, et al, 1994). MZ B cells have a slightly shorter average 
lifespan than recirculating B cells, in the order of around a month (MacLennan and 
Grey, 1986; Hao and Rajewsky, et al, 2001). 
1.4. B cell subsets and their roles  
As mentioned above all B cells have their own BCR and can be induced to produce 
antibody given the correct stimuli. However, B cell subsets have been identified on 
the basis of their location and functional differences that reflect their different 
phenotypes. The main subdivision is between B2 cells, which include MZ and 
recirculating B cells, and B1 cells. B1 cells can be divided into CD5+ B1a and CD5- 
B1b subsets.  
1.4.1. Recirculating follicular B cells  
The largest of the B cell populations in mature mice are recirculating follicular 
B cells. These can be identified through their phenotype - IgDhigh, IgMint/low, CD23high, 
CD21-, B220high (Ling, et al, 1987; Grey, et al, 1984; Coffman and Weissman,1986). 
These develop in the bone marrow and as described above a small proportion are 
selected in the spleen either to join the recirculating pool of B cells or become MZ B 
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cells (Section 1.3.1). Once selected into the recirculating pool these cells enter a 
constant state of migration between follicles of the secondary lymphoid organs 
(Niewenhuis and Ford 1976). The process ceases only if the B cells engage antigen 
through their BCR and are recruited into an antibody response. Although it is likely 
that recirculating in the blood or lymph B cells can bind fluid-phase antigen there is 
evidence that specialized macrophages or DC can trap and present intact antigen to 
B cells (Balazs, et al, 2002; Wykes, et al, 1998). Recent data using in vivo imaging 
indicate that recirculating cells in the follicles can take up antigen from antigen-
trapping macrophage-like cells located in subcapsular sinus of lymph nodes (Phan, 
et al, 2007; Carrasco and Batista, 2007). Also in the first few days after antigen 
administration recirculating B cells can pick up antigen that has been localized on the 
surface of FDC (Suzuki, et al, 2009). 
1.4.1.1. The function of recirculating follicular B cells  
Recirculating follicular B cells respond to T cell dependent antigen. In doing 
so they can be recruited to make an extrafollicular or follicular response or both of 
these (a brief description of the follicular response is found in section 1.5, 
extrafollicular responses are described in section 1.6). In addition recirculating 
follicular B cells may respond to Thymus independent type 1 (TI-1) antigens if they 
express the appropriate accessory receptors e.g. TLR4 will respond to bacterial 
outer cell wall lipopolysaccharide associated with many TI-1 antigens (Zhang, et al, 
1988; Meyer-Bahlburg, et al, 2007). Conversely, recirculating follicular B cells do not 
appear to respond to TI-2 antigen (Lane, et al, 1986).  
1.4.2. Marginal Zone B cells  
Marginal zone B cells have been characterised as being IgMhigh or switched 
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Ig+, IgDlow/neg, CD21high, CD23int/low (Ling, et al,1987; Grey, et al, 1984) and express 
CD35 (Molina, et al, 1996). Marginal Zone B cells are recruited through a number of 
processes. Firstly, directly from immature B cells (Carey, et al, 2008). There is also 
evidence from studies both in rats (Kumararatne and MacLennan, 1981; Bazin, et al, 
1985) and mice (Vinuesa, et al, 2003) that recirculating follicular B cells can 
differentiate into MZ B cells by a proliferation and antigen-independent process. 
Memory B cells from GC will also enter the MZ in rats (Liu, et al, 1988; Liu, et al, 
1991) and humans (Dunn-Walters, et al, 1995). Evidence for or against the presence 
of memory B cells in the proportionately much smaller MZ of mice is still 
inconclusive. Development of the MZ has been shown to be dependent upon Notch 
signalling (Song, et al, 2008). Indeed, mice heterozygous for Notch 2 show a 
reduction in B1a, B1b and MZ cells despite splenic structure remaining sound (Witt, 
et al, 2003). Marginal zone B cells are absent in mice that lack signalling through 
pyk-2, a tyrosine kinase which may compromise responses to chemokines and B cell 
adhesion (Guinamard, et al, 2000).  
1.4.2.1. The function of marginal zone B cells 
How MZ B cells behave upon engagement with antigen depends upon the 
ligand with which the antigen is bound.  Marginal zone B cells that bind antigen with 
their BCR are induced to migrate to the boundary of the follicle and T zone and 
participate in the immune response (Liu, et al, 1988; Liu, et al, 1991). During the 
response to antigen MZ B cells can induce both early antibody production in extra 
follicular foci in responses to TD, TI-1 and TI-2 antigens (Liu, et al, 1991; Oliver, et 
al, 1999) or form productive GC (Song and Cerny, 2003). This process, and the 
subsequent onset of proliferation and differentiation in the T zone, will be considered 
in detail in the results section of this thesis.  
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Marginal zone B cells may also bind antigen, or immune complex, via their 
complement receptors and be induced to move into the follicle (Gray, et al, 1984). 
This migration is essential for immune complex transport to FDC in the spleen 
(Brown, et al, 1970; Gray, et al, 1884; Kroese, et al, 1986). Recently it has been 
shown that MZ B cells that transport antigen shuttle back and forth between the MZ 
and the follicle (Cinamon, et al, 2008). The movement of MZ B cells between the 
follicle and MZ is dependent upon the cyclical upregulation followed by down 
regulation of CXCR5 which enables movement towards CXCL13, produced in the 
follicles. This alternates with upregulation and downregulation of SIP-1 which senses 
S1P1 – a chemokine present in the blood in the MZ sinusoids (Lu and Cyster, 2002; 
Cinamon, et al, 2004; Cinamon, et al, 2008). The strong signals delivered by LPS 
which was used by Gray, et al (1984) and Petterson, (1967) to induce MZ B cell 
migration, may well inhibit temporarily the expected S1P1-driven migration back to 
the MZ, for the MZ is largely emptied for a day or so.  
1.4.3. The development of B1 cell subsets 
The two subset of B1 cells recognized in mice are distinguished by the 
expression of CD5 by B1a cells (Hayakawa, et al, 1984) and the lack of CD5 
expression by B1b cells (Solvason, et al, 1991). Because of this marker B1a cells 
were extensively studied before B1b cells. Unlike B2 cells B1a and B1b cells are self 
replenishing (Lalor, et al, 1989; Hsu, et al 2006). Whether a B cell becomes a B1 or 
a B2 cell is dependent upon a number of factors that are not absolute: 
1) The BCR expressed: – B1 and B2 cells show characteristic BCR and, if a 
mouse is engineered to express only one type, or the other, only B1 or B2 cells will 
result (Lam, et al, 1999) 
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2) The strength of signalling from the BCR and BCR associated proteins 
(Casola, et al, 2004; Haas, et al, 2005; Hayakawa, et al, 1986; Carvalho, et al, 2001) 
3) The age of the mouse: - In mice B1 development occurs mainly in the 
foetal liver (Hayakawa and Hardy, 1985), spleen (Rosado, et al, 2009) and omentum 
(Solvason, et al, 1991). The primary production of B1a cells has mainly been 
associated with the foetal liver (Esplin, et al, 2009; Wortis and Berland, 2001), 
although the recent findings of Rosando et al suggest this may continue after birth in 
the spleen. B1b by contrast do not appear to be produced during foetal life and seem 
to be produced later during development (Hardy and Hayakawa, 1991; Kantor, et al, 
1992).  
There has also been a hunt to find markers for a proposed B1 precursor. 
Montecino-Rodriguez (2006) reported that a CD45low-neg CD19+ population includes a 
B1 specific progenitor. This was followed by a report from Tung (2006) of CD138+ 
and I-A denoting a B1a specific precursor cell in embryonic mice. Furthermore, 
transfer experiments have suggested that B1 cells can be derived from both early 
lymphoid and common lymphoid progenitors (Esplin, et al, 2009).  
Recently there has been a trend to describe CD11bperitoneal B1 cells as 
B1c (Malkiel, et al, 2009; Hastings, et al, 2006). Whether this is an accurate portrayal 
of B1 development is contested (Ghosn, et al, 2008). Complicating things yet further, 
there has also been some discussion as to the production of B1 cells in wild type 
mice and how the B1, subset should be defined (Thiriot, et al, 2007).   
1.4.3.1 The role of B1 cells 
B1 cells are mostly found in the peritoneal cavity; however, a few B1a cells 
reside in the spleen (Hayakawa, et al, 1983; Hayakawa, et al, 1985) and lymph 
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nodes (Hsu, et al, 2006). There is relatively little known about the details of B1 cells 
responding to antigen. They can form plasmablasts that proliferate in extrafollicular 
foci in the spleen and they can give rise to plasma cells in the spleen (Hsu, et al, 
2006) omentum (Ha, et al, 2006; Ryan, 2009) and lamina propria of the gut (Rosado, 
et al, 2009).  
B1a and B1b cells have been shown to participate differently in response to 
antigens. B1a cells constitutively produce “natural antibody” (Baumgarth, et al, 1999) 
the amount of which regulates the cell numbers present (Baker and Ehrenstein, 
2002). Natural antibody is the term given to that found in profoundly antigen-deprived 
mice, i.e. germ free mice fed on chemically defined diets and reared in stainless 
steel cages. (Bos, et al, 1989a and b). B1a cells can respond to LPS (Yang, et al, 
2007), streptococcal polysaccharides (Wardemann, et al, 2002) and influenza (Choi 
and Baumgarth, 2008). B1b cells provide long lasting humoral T cell independent 
immunity to the model antigen NP-Ficoll (Hsu, et al, 2006; Obukhanych and 
Nussenweig, 2006) and respond to bacterial antigens such as Borrelia hermsii 
(Alugupalli, et al, 2004) and and are responsible for the early response to Salmonella 
Typhimurium (Gil-Cruz, et al, 2009).  
1.4.4. Memory B cells 
Memory B cells provide early antibody against recurrent infection (Liu, et al, 
1991; Song and Cerny, 2003). Their participation allows a secondary response to 
antigen to occur with greater speed than the primary infection (Toellner, et al, 1996). 
Memory B cells are classically produced by GC, and frequently but not always, 
express switched antibody isotypes (Coico, et al, 1983). Indicative of their GC origin 
they frequently contain mutations in their CDR (Dunn-Waters, et al, 1995; Anderson, 
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et al, 2007). In mice CD80+ memory B cells are found in the blood, MZ and the 
follicle (Anderson, et al, 2007). In humans and rats the location of memory cells is 
less controversial than in mice. Memory cells have been identified in the rat and 
human MZ (Liu, et al, 1988; Dunn-Walters, et al, 1995) but they also reside in the 
bone marrow (Lausen, et al, 2004). CD27, a marker which is associated with 
switched and mutated cells (Klein, et al, 1998; Maurer, et al, 1992) is found on B 
cells in the blood (Agematsu, et al, 1997). However, the use of CD27 as a marker of 
human memory B cells, is questionable as memory B cells have been found in 
children with hyper IgM syndrome associated with CD40L deficiency. These children 
have very little switched antibody and probably do not produce GC suggesting not all 
memory cells are post GC (Weller, et al, 2004; Weller, et al, 2001).  
 Recent studies in mice have shown that in response to TI-2 antigen B1b cells 
can form long lived memory cells (section 1.4.3.1). As my thesis is concerned with 
the early response to antigen the production of memory cells is not investigated. 
1.5. B cell responses to antigen 
There are two pathways that a B cell may follow after antigen engagement. 
The B cell may proliferate and then differentiate into plasmablasts that produce 
antibody from three or so days after immunization. These plasmablasts proliferate 
and differentiate into plasma cells in extra follicular foci adjacent to the T zone 
(MacLennan, et al, 2003) Alternatively, after a short period of proliferation in T zones, 
the antigen-activated B cell may undergo an extended period proliferation in follicle 
centres, where they undergo somatic hyper mutation (SHM) of the variable regions 
of the antibody heavy and light chains (Jacob, et al, 1991a; Toellner, et al, 2002). 
This GC response is followed by antigen-and CD4 T cell driven selection which may 
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result in B cells producing a higher affinity antibody for the antigen (Berek, et al, 
1985; Jacob, et al, 1991a). B cells that leave the GC go on to form antibody 
secreting plasma cells in the bone marrow (Blink, et al, 2005) or memory B cells 
(Coico, et al, 1983).  
Whilst different types of B cells may have a greater predisposition to one 
pathway or the other it has been shown that in TD responses, and some TI 
responses in IgH knock-in mice, both extrafollicular and GC cells are likely to arise 
from the same subset of B cells with the same BCR (Jacob and Kelsoe, 1992; de 
Vinuesa, et al, 2000). It is still unclear if a single B cell can proliferate in response to 
antigen and give rise to some cells that form GC and others that become 
extrafollicular plasmablasts. 
1.5.1. T cell independent B cell responses 
Experiments in neonatally thymectomised mice, which lack thymus-processed 
T cells, show that antibody can be produced in response to certain antigens in the 
absence of T cell help (Davies, et al, 1969; Davies, et al, 1970). These T cell 
independent (TI) responses are typically carried out by MZ and B1 cells (Balazs, et 
al, 2002; Vinuesa, et al, 2003; Hsu, et al, 2006). As already mentioned, T 
independent antigens can be divided into two types – TI-1 and TI-2. T cell 
independent type 2 antigens are defined by their inability to induce a productive 
antibody response in mice deficient in Bruton's tyrosine kinase (Amsbaugh, et al, 
1972; Scher, et al, 1975a; Scher, et al, 1975). T cell independent type 1 antigens can 
evoke productive responses in the absence of this kinase. TI-1 antigens, such as 
LPS (Cohen, et al, 1976), when given in high doses can induce polyclonal B cell 
responses through TLR4 ligation. Much lower doses of LPS are required for specific 
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B cell activation that comes from LPS cross-linking TLR-4 with the BCR. Type 2 
antigens induce a B cell response through cross linking of many BCR molecules on 
one B cell. They characteristically possess long carbohydrate or in some cases 
protein chains with repeating epitopes, e.g. NP-Ficoll (Cohen, et al, 1976).  
Without T cell help GC are formed in only very exceptional circumstances, for 
example in the response of mice with an NP-specific transgenic BCR to high dose 
NP Ficoll (de Vinuesa, et al, 2000). These GC involute after 5 days, without 
producing plasma cells or memory B cells, probably as a result of failed selection of 
GC B cells, for these cells cannot process and present carbohydrate-based antigens 
to GC T cells. Ig variable region mutation does occur in these GC, but at a far lower 
rate than in TD GC (Toellner, et al, 2002).  
1.5.2. Binding antigen induces B cells to migrate to the T zone follicular boundary 
Marginal zone and follicular B cells are induced to migrate to the T 
zone/follicular boundary once they have engaged antigen and express CXCR5 to 
allow travel into the follicle (Cinamon, et al, 2008; Okada, et al, 2005). B cells travel 
along the CCL19/21 gradient to the boundary of the T zone and expression of CCR7 
maintains their position (Reif, et al, 2002; Okada, et al, 2005).  
1.5.3. B cells receive differentiation signals at the boundary of the T zone and follicle 
In the T zone responding B cells are induced to proliferate as B blasts. They 
do not enter their first mitosis until around 24 hours after BCR ligation and then 
undergo some 3 cell divisions during the second day of the response (Hsu, 2004). It 
is at the boundary of the T zone and follicle that, in a T cell dependent response, B 
cells receive T cell help through making cognate interaction with primed CD4 T cells 
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(Okada, et al, 2005). This can occur within twelve hours of the B cells first engaging 
antigen (Toellner, et al, 1996). In TI responses B cells may receive signals from 
resident NK cells (Gao, et al, 2008) and DC (Wykes, et al, 1998; Litinskiy, et al, 
2002) that induce class switch recombination (CSR) or differentiation towards 
forming antibody producing cells. This takes place through the action of TNF family 
molecules such as BAFF, which promotes B cell survival, and IL-10 (Xu, et al, 2008; 
Litinskiy, et al, 2002). After the period of proliferation in the T zone some B cells may 
differentiate into plasmablasts and migrate to extra follicular foci where they continue 
proliferating for some time before coming out of cell cycle and differentiating into 
mature plasma cells (Sze, et al, 2000; Section 1.6).  
1.5.4. The formation of germinal centres 
Germinal centres form in a specialised area of the follicle where the VDJ 
regions of participating B cells are mutated in a process called somatic hyper 
mutation (SHM) (Jacob, et al, 1991a; Toellner, et al, 2002). This random process 
may result in an increase in affinity for the antigen that induced the GC formation. On 
the other hand the affinity may fall or alter and in some cases become autoreactive. 
A selection process described below serves to select positively those cells that attain 
a higher affinity for the antigen that induced the GC, while resulting in the death of 
other GC B cells.  
Germinal centres are oligoclonal being founded by as few as 3 B cells 
(Kroese, et al, 1987; Liu, et al, 1991; Jacob, et al, 1991b). GC are not a closed unit, 
for new GC-founding B cells can enter a GC after it has been formed and participate 
in the response (Vonderheide, et al, 1990; Schwickert, et al, 2007). In GC B cells 
undergo proliferation and mutation of their DNA in the dark zone before migrating to 
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the light zone where they undergo apoptosis within a few hours unless they can 
obtain positive selection signals. These signals result firstly from binding antigen 
through their BCR (Liu, et al, 1991) and secondly making cognate interaction with 
local CD4 T cells after processing and presenting this antigen (MacLennan, 1994). 
Those B cells that receive appropriate signals from T cells are induced to follow one 
of three pathways. They may leave the GC and form AFC that may find niches in the 
red pulp of the spleen, but more typically migrate to the bone marrow, where they 
can become long-lived plasma cells (Benner, et al, 1981). Secondly they may 
become memory B cells (Coico, et al, 1983), or revert to become GC blasts that 
undergo further proliferation, mutation and selection (MacLennan, et al, 1997; de 
Vinuesa, et al, 2000). B cells that do not have a BCR that can bind available antigen, 
or cannot make cognate interaction through their BCR undergo apoptosis in situ (Liu, 
et al, 1991; Kawabe, et al, 1994). Although, the above hypothetical model for B cell 
affinity maturation and selection in GC is compatible with available data it remains a 
model that requires further testing. For example, the understanding of the way GC B 
cells are selected to follow one of at least 3 differentiation pathways is at best only 
partially understood. More recently, mathematical modelling coupled to in vivo work 
investigated the likely rate-limiting steps in GC reactions and the forces that drive 
affinity maturation (Meyer-Hermann, et al, 2009). 
B cells in GC are characterized by the expression of the protein B cell 
lymphoma 6 (Bcl6) (Catoretti, et al, 1995) whilst the processes of SHM and CSR in 
GC are dependant upon the expression of activation-induced cytidine deaminase 
(AID) and a variety of other co-factors (Cascalho, et al, 1998). As Bcl6 and AID are 
used for markers of GC cell fate in my study they are now discussed in greater detail 
(Sections 1.5.4.1 and 1.5.4.2 respectively).  
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1.5.4.1 Expression of Bcl6 and the formation of germinal centres 
B cell lymphoma-associated molecule 6 was first identified as a protein 
encoded by a gene that was dysregulated by translocation in certain B cell 
lymphomas (Baron, et al, 1993). The expression of Bcl6 protein is predominantly 
associated with B cells in GC (Cattoretti, et al, 1995). Further evidence for the crucial 
role of Bcl6 has been provided by the transfer of Bcl6-/- B cells which can not 
differentiate into GC (Fukuda, et al, 1997). The continued expression of Bcl6 
counters differentiation of B blast in to an antibody producing cell (Shaffer, et al, 
2004; Phan, et al, 2005). This occurs through the repression of B-lymphocyte-
induced maturation protein 1 (Blimp1) (Reljic, et al, 2000; Tunyaplin, et al, 2004), X-
box binding protein (XBP-1) and other genes involved in guiding differentiation 
towards plasmablasts and plasma cells. Bcl6 expression has been shown to be 
enhanced through the proteins Signal transduction and transcriptional activation 
(STAT) 3 and STAT 5 as well as Activator protein 1 (Scheeren, et al, 2005; Arguni, 
et al, 2005).  
In order for a B cell to differentiate into an antibody producing cell Bcl6 must 
be downregulated (Catoretti, et al, 2005). It has been reported that this occurs 
through the expression of Blimp1 (Shaffer, et al, 2002) and Interferon regulatory 
factor 4 (IRF4) (Saito, et al, 2007).  
1.5.5. Class switch recombination 
The efficacy and function of antibody can be modified in two ways. Firstly the 
variable region of the antibody can be altered so as to provide a higher affinity for the 
antigen and, as described above, this occurs in GC (section 1.5.4). Secondly, the 
class or subclass of the antibody produced can be changed and consequently its 
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functionality may be altered – for example, IgA which is predominantly secreted in 
the gut, or IgE which is secreted mainly in the tissues at the exposed internal or 
external surfaces of the body, i.e. the skin as well as the respiratory and intestinal 
tracts (Rabbits, et al, 1980; Cory, et al, 1980).The process by which the isotype of 
the antibody produced is changed is called class switch recombination (CSR). In the 
mouse, B cells can undergo CSR of the rearranged V region genes to any one of the 
downstream heavy chain genes. These are located in order from the  and  genes: 
- C3, IC1, C2a (or C2c in C57B6 mice), C2b, C and C. The isotype to which the 
cell switches depends upon the stimulus provided to the cell. For example, TI-2 
antigens characteristically induce switching to IgG3 (Garcia de Vinuesa, et al, 1999), 
whereas T cell dependent antigens that evoke Th2 responses induce switching to 
IgG1, while those causing Th1 differentiation typically result in switching to IgG2a and 
IgG2b (Toellner, et al ,1998). Switching patterns can be modified in a range of 
different ways by a variety of innate immune signals and cytokines (Le Bon, et al, 
2001). 
Class switch recombination occurs in GC (Liu, et al, 1996; Pape, et al, 2003), 
prior to the extrafollicular response (Garcia de Vinuesa, et al, 1999), in mucosal sites 
(Takhar, et al, 2005) and in vitro (Muramatsu, et al, 2000). As such, whilst it can be 
induced through BCR stimulation alone it can also be triggered by signalling from 
other cells and through other receptors on the B cell (Gao, et al, 2008; Xu, et al, 
2008; Liu, et al, 1991; Jacob, et al, 1991b).  
1.5.5.1. The mechanism of CSR 
Class switch recombination occurs through the juxtaposition of the VDJ region 
of the BCR with the immunoglobulin CH gene to which the cell is to switch. The 
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process proceeds through a number of stages. Firstly, transcription through the 
switch (S) region in both the locus and the destination locus (Kataoka, et al, 1980; 
Nambu, et al, 2003; Shinkura, et al, 2003). These germline switch transcripts are 
processed removing the introns (Hein, et al, 1998) and are essential but not 
sufficient for the process of CSR (Lorenz, et al, 1995). Class switch recombination is 
dependent upon the action of the enzyme AID on single stranded DNA (ssDNA) (Yu, 
et al, 2005). It has been postulated that these areas of ssDNA are induced during 
transcription of the switch region through hybridisation of the germline DNA with the 
RNA produced (Yu, et al, 2003). These R loops provides access to the DNA for AID 
and uracil-DNA glycosylase (UNG) and nicks in the exposed strand to be made (Yu, 
et al, 2003; Yu, et al, 2005; Huang, et al, 2007). There is further discussion of the 
function and role of AID in the following section.  
In the next stage DNA in between the target switch region and the VDJ is 
excised through the formation of a switch circle (Matsuoka, et al, 1990; von 
Schwedler, et al, 1990). The ends are joined through the nonhomologous end joining 
pathway. Once recombination has occurred switched transcripts are produced and 
the antibody secreted by or expressed on the surface of the cell will be of new 
isotype. 
1.5.5.2 Activation Induced Cytidine Deaminase 
Activation Induced Cytidine Deaminase is an enzyme that removes the amine 
group from cytidine in single stranded DNA (Petersen-Marht, et al, 2002). This 
process leaves behind a uracil:guanine mismatch in the DNA which may be repaired 
through excision by the enzyme UNG (Schrader, et al, 2005; Petersen-Marht, et al, 
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2002). This produces single stranded breaks in the DNA where recombination or 
DNA repair can occur (Faili, et al, 2002; Petersen-Marht et al, 2002).  
The importance of AID has been elucidated through a combination of both in 
vitro and in vivo experiments. In AID knock-out animals neither CSR nor SHM occur 
(Nagaoka, et al, 2002; Muramatsu, et al, 2000). By removing the DNA repair 
mechnisms (UNG and MutS homolog 2) it has been shown that AID induces 
mutations along S regions of the immunoglobulin loci prior to CSR (Xue, at al, 2006). 
The AID dependent excisions occur on both DNA stands (Schrader, et al, 2005; Xue, 
et al, 2006) and if two are close enough together a double stranded break can result 
(Chaudhuri, et al, 2003; Rush, et al, 2004). A complex containing AID (Li, et al, 2006) 
is targeted to the switch regions through a number of processes- histone acetylation, 
transcription of switch transcripts as well as the sequence of the DNA itself (Nambu, 
et al, 2003; Wang, et al, 2006; Rogozin and Diaz, 2004).  
Because of it’s ability to produce mismatches during transcription and thus 
increase the mutation rate in a cell when it is present in the nucleus the cellular 
location of AID protein is very important (Ramiro, et al, 2003; Mcbride, et al, 2004). 
Visualisation of AID in the human tonsil has shown that it is strongly expressed in the 
cytoplasm of GC cells and in a small proportion of their nuclei (Muramatsu, et al, 
1999; Cattoretti, et al, 2006). In addition, it has been reported that the exit of AID 
from the nucleus is an active process via a nuclear exit signal whilst it has been 
suggested that entry into the nucleus is a passive process. This restricts the time 
that AID can have access to DNA (Brar, et al, 2004; Mcbride, et al, 2004; Ito, et al, 
2004). The phosphorylation state of AID has also been shown to be important as it 
allows interaction with replication protein A, a single stranded DNA binding protein 
(Basu, et al, 2005). However it has been reported that phosphorylation, whilst 
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increasing the speed and efficiency of CSR, is not essential for this process 
(Mcbride, et al, 2008).   
Not surprisingly, the expression of AID is tightly regulated. Most recently the 
association of miRNA 155 has been shown to downregulate AID expression (Teng, 
et al, 2008; Rodriguez, et al, 2007) whilst miRNA 181b has also been shown to 
inhibit AID expression and subsequently CSR to 1 (de Yebenes, et al, 2008). The 5’ 
promoter region of the AID sequence has been shown to be bound by both Nuclear 
factor of kappa light polypeptide gene enhancer in B-cells (NF-B) and STAT6 
allowing CSR to be induced after CD40 or IL-4 stimulation respectively (Dedeoglu, et 
al, 2004). It must be mentioned that whilst the action of AID to deaminate cytidine 
has been widely reported and inferred there are some reports of AID independent 
double stranded DNA breaks (Zan and Casali, 2008). 
1.6. Plasmablast and extrafollicular foci development 
As discussed, B cells are induced to form plasmablasts either directly from the 
T zone in TI responses, or after a period of mutation and cell division in the GC (Liu, 
et al, 1991; Jacob, et al, 1992). Plasmablasts in extrafollicular responses divide 
rapidly for around three days before differentiating further into antibody producing 
plasma cells (Sze, et al, 2000). In the spleen available evidence is consistent with 
the extended survival of plasmablasts and plasma cells being dependent upon the 
limited stroma that supports these cells. Those cells that do not gain access to this 
stroma and consequently fail to receive sufficient survival signals undergo apoptosis 
(Sze, at al, 2000).  
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In order for a B cell to differentiate into a plasmablast it has to instigate a 
genetic programme involving the key regulatory genes Blimp1, IRF4 and XBP1 
(Shapiro-Shelef, et al, 2003; Shaffer, et al, 2004; Soro, et al, 1999; Klein, et al, 
2006). In my study plasmablasts were identified through their expression of CD138 
with intermediate (int) or low levels of B220 (Smith, et al, 1996). Because of their role 
in the differentiation of B cells to plasmablasts and plasma cells Blimp1 and IRF4 are 
used as key markers of differentiation in this study. 
1.6.1. Blimp1 
B-lymphocyte induced maturation protein 1 is a transcription factor that is 
essential for the differentiation of B cells into antibody secreting cells (Soro, et al, 
1999; Shapiro-Shelef, et al, 2003). It is necessary and sufficient for plasmablast 
differentiation (Shaffer, et al, 2002). In an analogous but reciprocal way to Bcl6, 
Blimp1 acts as a terminal repressor; it inhibits a variety of genes that are involved in 
preventing differentiation and increasing proliferation, such as myelocytomatosis 
oncogene (c-Myc) and Paired box gene 5 (Pax5) and Bcl6 (Lin, et al, 1997; Nera, et 
al, 2006; Shaffer, et al, 2004; Shaffer, et al, 2002). Through the inhibition of Pax-5 
Blimp1 also downregulates expression of the BCR associated proteins CD79, 
CD79 and CD19 (Hagman, et al, 2000; Nutt, et al, 1997). Besides acting as a 
repressor it is also responsible for the up-regulation of a number of genes that 
promote differentiation into an antibody secreting cell, such as XBP-1 (Shaffer, et al, 
2004). Because of its important role in the terminal differentiation of B cells Blimp1 is 
used in these studies as a marker of terminal differentiation into an antibody 
producing cell. 
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1.6.2. Interferon regulatory factor 4 and plasma cell development 
Interferon regulatory factor 4 (IRF4) knock out mice have been shown to 
develop normally until 4-5 weeks at which point they lose serum IgM levels and no 
antibody responses are produced (Mittrucker, et al, 1997). Expression of IRF4 has 
been reported to be induced through IgM cross linking (Matsuyama, et al, 1995). 
Conditional knock out mice have shown that plasma cell development from both GC 
and extrafollicular pathways is dependant upon IRF4 (Klein, et al, 2006). Indeed 
IRF4 is reported to be expressed at high levels in those plasma cells and B cells 
that, it has been inferred, are about to leave the GC (Falini, et al, 2000). The process 
of CSR is also inhibited in the absence of IRF4 (Klein, et al, 2006). Consequently it 
has been suggested that the level of IRF4 protein in the responding B cell may 
determine the induction of CSR at low levels or differentiation at higher levels 
(Sciammas, et al, 2006). The expression of IRF4 in GC-derived B cell lines, 
regardless of whether Bcl6 is being expressed, induces upregulation of Blimp1 and 
downregulation of Bcl6 and Pax5 (Teng, et al, 2007). Interferon regulatory factor 4 
protein has been shown to be directly upstream of both Bcl6 and Blimp1, at least in 
the context of human CD32 gene expression (Gupta, et al, 1999; Gupta, et al, 2001). 
This indicates that IRF4 is a key protein in the B cell response and an ideal 
candidate for study in the induction of CSR and the regulation of GC and 
plasmablast formation. 
1.7. B cell responses to 4-hydroxy-3-nitrophenol (NP) conjugates 
The studies presented here utilise the well reported Quasi-monoclonal (QM) 
mouse system in combination with hapten 4-hydroxy-3-nitrophenol (NP) conjugated 
to either a long chain polysaccharide or a protein carrier. The epitope NP conjugated 
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to a variety of carriers has been used for a number of decades in mouse studies to 
induce immune responses (Bothwell, et al, 1981). It is predictable - the antibody 
response induced has a bias towards λ light chain and the Ig heavy chain V segment 
V168 (Bothwell, et al, 1981). Because of this restricted repertoire it is an ideal hapten 
for studies of SHM (Bothwell, et al, 1981; Blier and Bothwell, 1988). By changing the 
conjugate to which NP is bound the type of response induced can be varied, for 
example, the conjugation of chicken gamma globulin (CGG) (or another protein) to 
NP induces a TD response (Azuma, et al, 1986). However, the use of a 
polysaccharide such as Ficoll provokes a TI-2 type response (Maizels, et al, 1988).  
1.7.1 The Response to NP-Ficoll 
The C57B6 mouse response to NP-Ficoll is characterised by a strong 
extrafollicular plasmablast response (Garcia de Vinuesa, et al, 1999). Twenty four 
hours after immunisation NP specific B cells are located in the outer T zone and by 
48 hours these cells have produced germline switch transcripts to IgG3 (Garcia de 
Vinuesa, et al, 1999). Plasmablasts are located in extrafollicular foci by 72 hours and 
these may persist there for months (Hsu, et al, 2006). These long-lived foci contain 
both switched and non switched antibody producing plasma cells (Maizles, et al, 
1988). During the first 48 hours of this response the majority of NP-binding B blasts 
are located in the T zone but some are found in the follicle, in addition some 
plasmablasts may also be found in the red pulp (Garcia de Vinuesa, et al, 1999).  
The NP-binding blasts in the follicles reflect the inability of the responding cells to 
form GC. It has also been shown that B1b cells will respond to NP-Ficoll and as well 
as giving rise to extrafollicular plasmablasts memory cells induced that are seen 
mainly in the follicle (Hsu, et al, 2006). It seems likely that the sustained plasmablast 
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response to NP-Ficoll is mainly attributable to B1b cells, which like MZ cells, respond 
first by proliferating in the T zone and then producting plasmablasts in the 
extrafollicular foci (Hsu, et al, 2006). Unlike the B2 response, repeat exposure to 
antigen does not increase the affinity of B1b cells to the antigen (Azuma, et al, 
1986). 
1.7.2. Quasi monoclonal mice 
Quasi Monoclonal mice were devised to have a heavy chain specific for the 
hapten NP when combined with a lambda light chain. The J chain sequences were 
replaced with a fully rearranged heavy chain (VDJ 17.2.25) identified in an NP-
specific hybridoma (Cascalho, et al, 1996). The BCR only recognises NP when there 
is a productive  light chain rearrangement. Consequently the original QM mouse 
which was designed to be monoclonal also had inactivated light chain genes. As 
implied by the name some editing of the transgenic heavy chain occurs so, even in a 
homozygous mouse on a kappa light chain deficient background, only around 60% 
of the B cells are NP-specific. There is evidence that this editing occurs in heptamer 
sequences in the IgV region (Cascalho, et al, 1997; Bertrand, et al, 1998; Han, et al, 
1997). This is presumably as a result of not removing the endogenous V and D 
sequences before inserting the complete BCR sequence. 
In the present study QM x C57B6 F1 hybrid mice have been used. These 
mice have one functional set of kappa chain genes. As the QM heavy chain rarely 
has NP-specificity when paired with an endogenously rearranged  light chain only 
around 5% of B cells are NP-specific (Vinuesa, et al, 2001).  
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1.8. Aims of the project 
This project was designed to study the differentiation of NP-specific B cells as they 
diverge to form either GC or antibody forming cells with particular reference to Ig 
class switching. By using immunohistochemistry, to locate cells throughout the 
response, in combination with flow cytometry to sort B cell populations as they 
differentiate it was possible to perform PCR on single and bulk sorted cells. This 
provided a means to define, at the genetic level, when and where cells differentiate. 
The behaviour of B cells was tested in both TI and TD contexts to identify consistent 
model for the B cell response to antigen in the spleen. 
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Chapter 2: Methods and materials 
2.1. Animals  
QMXB6 mice contain one copy of the NP-specific (VH17.2.25-DSP2.3-JH4) Ig 
heavy chain segment of QM mice. These were generated by crossing QM mice 
(Cascalho, et al, 1996) to C57BL/6J for 10 generations, selecting for the NP-specific 
heavy chain. QMxB6 and C57BL/6J mice were maintained in the Biomedical 
Services Unit, University of Birmingham under specific pathogen free conditions. To 
test for NP specific BCR and the kappa light chain, the following primers were used: 
2.1.1. Primers and concentrations for genotyping PCR 
Primer  Sequence      
-actinF  GTGGGGCGCTCTAGGCACCA 
-actinR CGGTTGGCCTTAGGGTTCAGGGGGG 
NPF   TTCAGAGGTTCAGCTGCAGCAGT 
NPR   CTYACCTGAGGAGACDGTGA 
Jh-F   TCGCCTTCTATCGCCTTCTT 
Jh-R   GCCCCAACTATCCCTCCA 





kappaWTR  CAGGACGCCATTTTGTCGT 
2.2 Immunizations 
T cell independent responses were induced through immunization with 30μg 
4-hydroxy-3-nitrophenol (NP)- Ficoll (Biosearch, Santa Cruz, USA) in 200μl of sterile 
phosphate buffered saline (PBS) (pH 7.4) in to the peritoneum (i.p.). For early time 
points 30μg NP-fluorescein-Ficoll in 200l PBS was used. Increased class switching 
was induced by co-immunizing with 30μg NP-Ficoll and 10μg Polyinosinic–
polycytidylic acid (polyI:C) (Sigma Aldrich, Dorset, UK) in 200μl PBS i.p..  
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A T cell dependant response was induced in C57Bl/6J mice as follows. 
Chicken gamma globulin (CGG) (Jackson Laboratories, Suffolk, UK) was 
precipitated in alum (aluminium potassium sulphate (Sigma Aldrich, Dorset, UK)). 
Briefly, 150μl CGG (1mg/ml) was mixed with 150μl 9% alum and the pH was 
adjusted to 6.5 using 10M sodium hydroxide. The solution was mixed at room 
temperature in the dark for 30 minutes before three washes in excess sterile PBS. 
Mice were immunized with 50μg CGG and 105 heat inactivated Bordetella Pertusis 
i.p. (LEE laboratories, Georgia, USA). Five weeks after immunization mice were 
complemented with 5x105 – 2x106 NP positive splenocytes i.v. 24 hours after transfer 
mice were immunized with NP-CGG i.p. 
2.3 Extraction of cells ex vivo 
Single cell suspensions of splenocytes were obtained by maceration of the 
spleen in 10% foetal calf serum (FCS, Invitrogen, Paisley, UK) and 1% 
penicillin/streptomycin (Invitrogen) supplemented RPMI media (Invitrogen) and 
filtration through a 70μm nylon mesh. 
2.4. In vitro cell culture 
Single cell suspensions of splenocytes were prepared as before and at all 
times were kept on ice (except for during incubation periods). Cells were treated with 
cyclohexamide at 2.5μg/ml (Calbiochem). Subsequent to this treatment they were 
stained and washed in cyclohexamide supplemented medium. Cells were plated at 
2x106 cells per ml in 96 well plates. NP-Ficoll was used to stimulate cells at a 
concentration of 1μg/ml.  
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2.5. Flow cytometry 
Immunostaining of single-cell splenocyte suspensions took place at 4oC for 20 
minutes in a 1%FCS PBS buffer. Optimized concentrations of the following 
antibodies B220-FITC (eBioscience), CD138-biotin (BD Biosciences), and NP-
phycoerythrin (Biosearch Technologies), followed by streptavidin-APC (BD 
Biosciences) were used following NP-Ficoll immunization. After NP-fluorescein-Ficoll 
immunization cell suspensions were incubated with B220-APC (BD Biosciences) and 
NP-phycoerythrin. Intracellular staining was obtained using the Cytofix/Cytoperm kit 
(BD Biosciences) according to the manufacturers’ instructions, anti mouse IRF4 
(Santa Cruz Biotech, CA, USA) and goat anti mouse Cy5 (Jackson Laboratories). 
Samples were acquired on a FACSCalibur (BD Bioscience) and were analyzed with 
FlowJo software (TreeStar, Oregon, USA). Cell sorting was done on a MoFlo cell 
sorter (DakoCytomation). Post sort populations were checked for purity and 
immediately frozen at -80oC. 
2.6. Histology 
Tissues were snap frozen in liquid nitrogen and stored at –80oC until required. 
Prior to sectioning tissue was mounted in OCT compound and quickly frozen. 6μm 
sections were cut using a cryostat (Bright Instruments, Huntingdon, UK) on to 
multispot slides (Hendley Essex Ltd, Loughton). Sections were left to air dry for one 
hour before fixation for 20 minutes in 4oC acetone and stored at –20oC. For RNA and 
protein analysis 20μm sections were cut and immediately frozen in liquid nitrogen.  
Immunohistochemisty was carried out as described in Toellner, et al, (1996). 
In brief, slides were brought up to room temperature and hydrated in tris pH7.6 buffer 
(for composition see Appendix ii). Sections were subsequently kept in tris buffer at all 
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times. Primary antibodies were added at the optimum dilution for one hour and the 
slides were washed. Secondary antibodies were applied for 45 minutes (section 
2.6.1 and 2.6.2). If required streptavidin complex with alkaline phosphatase was 
added (Dako, Glostrup, Denmark), after further washing, for 30 minutes. 
Peroxidase and phosphotase reagents were developed sequentially (see 
appendix for buffer and substrate composition). Photographs for spleen sections 
were taken using a Leica CTR6000 microscope (Leica, MiltonKeynes, UK) and 
QCapture software. Images were processed using ImageJ (http://rsbweb.nih.gov/ij/).  
2.6.1 Primary antibodies    
Target Isotype  Dilution Manufacturer 
CD3  Rt anti Ms  1/2000 BD Biosciences 
IgD  Shp anti Ms  1/300  The Binding Site, Birmingham 
IgM  Rt anti Ms  1/600  Serotech, Oxford, UK 
NP  NP conjugated Rb 1/2500 Prof. P. Lane, Birmingham 
Syndecan-1 Rat anti Ms  1/200  BD Biosciences 
IgD  Rat anti Ms  1/1000 BD Biosciences 
IgG1  Rat anti Ms  1/400  Serotech 
IgG3  Rat anti Ms  1/300  Serotech 
Bcl-6  Rb anti Ms  1/30  Santa Cruz Biotechnology, CA 
IRF4   Gt anti Ms  1/400  Santa Cruz Biotechnology, CA 
CGG  Biotin   1/500  Prof P. Lane 
 
2.6.2 Secondary and tertiary reagents     
Target   Dilution Manufacturer 
Rb anti Rat biotin  1/600  Dako 
Rb anti Rat PX  1/50  Dako 
Dnky anti Shp biotin  1/100  The Binding Site 
Dnky anti Shp PX  1/100  The Binding Site 
Goat anti Hamster Ig [H+L] 1/50  Vector Labs, Peterborough, UK 
Shp anti Rt biotin  1/400  The Binding Site 
Swine anti Rb IgGs  1/100  Dako 
Swine anti Rb biotin  1/400  Dako 
Rabbit PAP   1/100  Dako 
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2.7 Real time RT-PCR 
RNA was extracted from cell pellets using the RNeasy Mini or Micro kits 
(Qiagen, Crawley, UK), eluted in water and reverse transcribed using 1g of oligo-
dT12-18 (Amersham Pharmacia Biotech, High Chalfont, UK) and Moloney murine 
leukemia virus reverse transcriptase (Invitrogen, Paisley, UK). Relative quantitation 
of specific cDNA species to β-actin message was carried out in a multiplex PCR on 
the ABI 7900 real time PCR machine (Applied Biosystems, Warrington, UK) as 
described (Cunningham et al, 2002). To detect the occurrence of Ig class switching 
to IgG3 recombined Iμ-γ3 recombined heavy chain transcripts were detected by real-
time PCR. As Iμ is expressed constitutively (Li, et al, 1994; Lennon, and Perry, 1985) 
Ig class switch recombination from IgM to IgG3 should immediately be followed by 
transcription of recombined Iμ-γ3 heavy chain transcripts. Primers were in the first 
exon of IgM germline heavy chain RNA (TCTGGACCTCTCCGAAACCA) and the 
reverse primer (ACCGAGGATCCAGATGTGTCA, MWG Biotech, Ebersberg, 
Germany) and a probe in the first exon of the IgG3 heavy chain (FAM-
CTGTCTATCCCTTGGTCCCTGGCTGC-BHQ1, Eurogentec, Seraing, Belgium). 
This was amplified in multiplex with β2-microglobulin as a housekeeping gene 
control with intron-spanning primers (CATACGCCTGCAGAGTTAAGCA, 
ATCACATGTCTCGATCCCAGTAGA, MWG Biotech) and a Yakima-Yellow Black 
Hole Quencher 1 labeled probe (CAGTATGGCCGAGCCCAAGACCG, Eurogentec). 
Relative quantification of signal per cell was done as described (Cunningham, et al, 
2002). Thresholds within the logarithmic phase of the PCR for Iμ-γ3 recombined 
heavy chain transcripts and β2-microglobulin were set and the cycle number at 
which the threshold was reached (Ct) was determined using SDS 2.2.2 software 
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(Applied Biosystems). Ct for β-actin was subtracted from the Ct for Iμ-γ3 recombined 
heavy chain transcript. The relative amount was calculated as 2–ΔCt. 
2.8 PCR Arrays 
TaqMan low-density real-time PCR arrays (Applied Biosystems) were 
designed in a 96-gene format. Genes were chosen that were reported to be 
differentially expressed during early plasmablast or germinal centre cell 
differentiation (Shapiro-Shelef and Calame, 2004; Underhill, et al, 2003; Tarte, et al, 
2003; Klein, et al, 2003). These are listed in the appendix (Appendix ii). RNA was 
isolated as above and mixed with QuantiTect Probe PCR Kit (Qiagen). This was 
added to the TaqMan Low-Density Array, and PCR was performed in a 7900HT 
Real-Time PCR System (Applied Biosystems) according to manufacturer’s 
recommendations. Array data was analyzed using TMEV (Saeed, et al, 2003; 
http://www.tm4.org) and Applied Biosystems SDS 2.2.2 software. Relative signal per 
cell was calculated as above with β2-microglobulin as the house keeping gene 
control.  
2.9 Single cell PCR 
Using an automatic cell cloning unit of a MoFlo cell sorter single cells were 
sorted into wells of 384-well PCR plates containing 1μl nuclease-free water. Serial 
dilutions of 2 to 32 cells per well served as positive controls, one row of wells without 
cells as negative controls. After sorting plates were stored at -80ºC. Blimp-1, AID, 
BCL-6, IRF4, or β2-microglobulin mRNA were detected by triplex real-time RT2-
PCR.  
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2.9.1. Primers and concentrations for single cell RT2-PCR 
Primer  Sequence     Concentration  
Blimp-1F  CAAGAATGCCAACAGGAAGTATTTT  80 nM  
Blimp-1R  CCATCAATGAAGTGGTGGAACTC  100 nM  
AIDF   GTCCGGCTAACCAGACAACTTC  60 nM  
AIDR   GCTTTCAAAATCCCAACATACGA  100 nM  
BCL-6F  CAGACGCACAGTGACAAACCA  60 nM  
BCL-6R  ACTGCGCTCCACAAATGTTACA 300 nM  
β2-mglobF  CTGCAGAGTTAAGCATGCCAGTAT 100 nM  
β2-mglobR ATCACATGTCTCGATCCCAGTAGA  100 nM  
IRF4F   GGAGGACGCTGCCCTCTT  40nM  
IRF4R  TCTGGCTTGTCGATCCCTTCT   200nM  
 
2.9.2 Probes for single cell RT2 PCR 
Probe  Reporter/   Sequence (Concentration)  
  Quencher 
Blimp-1  FAM/MGB  TCTCTGGAATAGATCCGCCA (125nM) 
 
AID    TET/BHQ  TGCATCTCGCAAGTCATCGACTTCGT                                                              
     (200nM) 
BCL-6  FAM/BHQ  CAGCCACAAGACTGTCCACACGGGT 
(100nM) 
BCL-6  CalFlour 560/BHQ CAGCCACAAGACTGTCCACACGGGT 
(250nM) 
β2-mglob NED/MGB   CGAGCCCAAGACC (125nM) 
 
IRF4  FAM/BHQ             AGGCTTGGGCATTGTTTAAAGGCAAGTTC 
(150nM) 
 
Primers and probes were added to the lysate together with QuantiTect Multiplex RT-
PCR buffer (Qiagen) in a total volume of 4μl. Reactions were run for 45 cycles in a 
7900 Real-Time PCR System (Applied Biosystems). Relative quantification for gene 
expression in single cells was achieved by plotting the Ct from wells that showed a 
β2-microglobulin product in reverse order, corresponding to a log2 scale. 
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2.10 Quantification of cells following histology 
In order to attain a representative figure for the area of the spleen occupied by 
NP+ plasmablasts or NP+ germinal centres (GC) sections of spleen were stained for 
NP and IgD. Using a graticule the number of intercepts that fell on NP+ GC, as well 
as the total number of intercepts that covered the spleen, were counted and from this 
the percentage of grid intercepts occupied by NP+ GC could be calculated. Similarly, 
the number of grid intercepts that fell on cells with NP+ cytoplasmic staining was 
counted and the percentage of intercepts occupied calculated.  
The number of NP+ switched cells per mm2 of spleen section was obtained 
through counting double positive (black) cells when sections were stained for both 
NP binding and the immunoglobulin isotype of interest (e.g. IgG3). The area of the 
spleen section was calculated through the use of a graticule – the length of the side 
of the grid at each magnification was obtained using a haemocytometer.  
In order to count the associations between CD3+ cells and NP+ cells sections 
were stained so as to have CD3+ cells in blue and NP+ cells brown. The number of 
NP+ cells in contact and not in contact with a CD3+ cell were counted for each spleen 
section.   
2.11 Cell proliferation calculations 
In order to calculate the number of cell divisions that responding B cells had 
undergone after NP-Ficoll immunization the number of NP+ B cells prior to, and 48 
hours after immunization was calculated (Table 2.1). 
 
Number of NP+ B cells in spleen =  lymphocyte count   x %lymphocytes NP+ B220+ 
             100 
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If we assume that QM B cells undergo 3 cell divisions after NP-Ficoll by 48 
hours as deduced by Hsu (2004) it is possible to calculate the number of cells that 
must have responded to immunization, and, in the case of the response induced by 































Table 2.1 The number of NP+ B cells at the stated time after immunization with NP-
Ficoll 
The number of NP+ B220+ cells that are CD138+ or CD138- prior to immunization and 
at 48 and 96 hours after immunization with 1g or 30g NP-Ficoll. Numbers were 
calculated from FACS of the samples and cell counts (Section 4. 1.1). 
 
 
Number of cells that enter the response = Number of cells at 48 hours 
           23 
 
For the 30g response: 5.74x106 = 7.17x105  (≈ NP+ B220+ cells at 0 hours) 
           8 
 
For the 1g response:    3.99x106 = 4.99x105  
           8 
 
Therefore the number of NP+ B220+ cells that do not respond in the 1g response is: 
 
7.28x105 – 4.99 x105 = 2.29x105 
 
So, if it is assumed that these cells do not proliferate after 1g NP-Ficoll a 
proportion of cells at 48 hours do not participate in the response. This can be 
calculated thusly: 
 
Number of non responding NP+ B cells  x100 
   Number of NP+ B cells at 48 hours 
 




As CD138 becomes an unreliable marker of plasmablasts as they mature the 
FACS data at 96 hours is less reliable than the counts from histology (Table 2.2). 
Whilst the proportion of NP+ plasmablasts was similar after 1g or 30g NP-Ficoll at 
96 hours there is almost a five fold difference between the proportion observed. 
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Table 2.2 The percentage of spleen area occupied by NP+ plasmablasts at the 
stated time after immunization with NP-Ficoll 
The percentage of grid intercepts that landed on NP+ plasmablasts (as assessed by 
cytoplasmic NP staining) prior to immunization and at 48 and 96 hours after 
immunization with 1g or 30g NP-Ficoll.  
 
To calculate the number of cells that continue in the 1g response after 48 
hours, and hence the number of cells that do not, we can consider the difference in 
the proportion of spleen sections occupied by NP+ plasmablasts. Whilst these are 
equivalent at 48 hours by 96 hours the NP+ plasmablasts occupy 5 times more of the 
spleen area in the 30g NP-Ficoll response than in the 1g response. If we assume 
that these are formed by precursors from the B blasts at 48 hours (at which point 
there are 1.4 times as many in the 30g NP-Ficoll response than in the 1g 
response), and that all the B blasts at 48 hours in the 1g response should go on to 
form plasmablasts, then, given the five-fold difference between the two responses by 
96 hours 70% of the B blasts did not. 
 
B blasts at 48 hours:  Number of 30g B blasts = 1.44(Number of 1g B blasts) 
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Plasmablast area at 96 hours:  30g Plasmablasts = 5(1g Plasmablasts) 
Therefore, proportion of cells that did not expand: 1-(1.44/5) = .712  
2.13 Quantification of B blast location at 48 hours in the carrier primed 
response 
 To ascertain whether there was a genuine difference in the location of B 
blasts at 48 hours after cell transfer in the carrier primed response to either NP-CGG 
or NP-Ficoll sections of spleen that had been stained for NP in blue and IgD in brown 
were photographed using QCapture software at 10x magnification with overlaps 
between each photograph. The resulting images were then aligned in power point 
before being printed out and stuck together (this produced an image approximately 
1m2). From the top left of each spleen the follicle areas (as defined by brown 
staining) were halved and the number of NP+ cells falling either side counted (Fig 
2.1). The ratio of cells on the inner side of the follicle/ the outer side was taken for 
each. These values were added to with each successive follicle until the cumulative 
ratio stabilised (Fig 2.2). These final values were then used to produce the graph in 
Fig 5.5.  
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T zone 
Follicles were measured and 
a line was drawn bisecting 
the follicle along it’s length 
The number of cells on 
the T zone, or marginal 
zone side of each follicle 
was counted 
























































Figure 2.2: The cumulative ratio of NP+ cells in the inner/outer follicle at 48 




Divergent B cell differentiation induced by 30g NP-Ficoll 
 
This project aims to study the divergent differentiation of B cells to germinal centre 
(GC) cells or extrafollicular plasmablasts during the response to antigen.  The 
approach used histology, FACS and RT2 PCR (real-time reverse-transcriptase 
polymerase-chain-reaction) to identify the location and phenotype of the responding 
cells, the stages in extrafollicular and follicular B cell responses and gain insights into 
the mechanisms driving divergent differentiation. 
QMxB6 mice as an experimental model 
5-10% of the B cell complement in QMxB6 mice is specific for NP (section 
1.7.2). After immunization i.p. with 30g of the T cell-independent type 2 (TI-2) 
antigen NP-Ficoll these B cells respond to form either germinal centres or 
extrafollicular AFCs (de Viunesa, et al, 2000).  
This study sought to identify and characterise GC and antibody former cells 
(AFC) precursors early in the response and ascertain when B cells commit to either 
developmental pathway. Additionally it was anticipated that the location of class 
switch recombination (CSR) in the extrafollicular response would be revealed. This 
protocol provided a means to investigate these questions. 
Experimental design 
Spleens of mice were examined 0, 24, 48 and 72 hours after immunization. 
Part of each spleen was snap frozen for immunohistology and the remainder was 
used to produce a single cell suspension. Splenocytes were used for flow cytometric 
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analysis. Phenotypically distinct B cell subsets were sorted either in bulk or as single 
cells for RT2-PCR analysis. 
3.1. Immunohistological analysis of the early response to 30 g NP-Ficoll 
3.1.1. Activated NP binding B cells move from the MZ to the T zone of the spleen 
within 8 hours of immunization 
Prior to immunization NP binding cells are located in the marginal zone (MZ) 
of the white pulp and a few background NP-specific plasma cells can be seen in the 
red pulp (Fig 3.1). Eight hours after immunization the MZ is depleted and NP binding 
cells appear at the boundary of the T zone and follicle. A dramatic sign of early 
phenotypic change is that the NP-specific cells, which lack detectable IRF4 protein 
before immunization, are clearly IRF4-protein-expressing by within 8 hours and this 
will be considered further in section 3.5.  
3.1.2. The NP-specific B cells become blasts in the T zone and remain in the white 
pulp throughout the 2nd day after immunization. 
It has been reported that responding B cells enter S phase within 24 hours of 
immunization (Garcia de Vinuesa, et al, 1999). They complete their first division 
shortly after this and have undergone some 6 cell divisions by 72 hours (Hsu, 2004). 
The B blasts remain mainly in the T zone although by 48 hours this becomes full and 
NP-specific B blasts are also found in the MZ, possibly reflecting overspill from the T 
zone (Fig. 3.2A). Although there are some NP-specific cells in the follicles at this 
stage they do not form a continuum of blasts in the follicle centre and, as described 
later, B cells  
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Figure 3.1 The early redistribution of NP specific cells in response to 
NP-Ficoll 
At 0 hours the NP-specific cells stained blue (top right) and arrowed 
are located in the marginal zones (MZ). There are small numbers of 
dark blue AFC in the red pulp. By 8hrs the MZ are no longer filled 
with NP-specific cells and these are now seen in the outer T zone 
(arrowed in bottom right). The left hand figures highlight the follicles 




with a GC phenotype have not appeared. This is confirmed by the lack of Bcl6 
expression in the follicular, or any other, NP-specific blasts at this stage (not shown). 
Bcl6 protein expression characterizes GC B blasts (Cattoretti, et al, 1995, Onizuka, 
et al, 1995). Strikingly at 48 hours there has been very little migration of NP-specific 
blasts out of the white pulp to the red pulp, although variable but always small, 
numbers of plasmablasts were seen in the red pulp at 48 hours (Fig 3.2A). This is 
shown objectively later in the chapter. 
3.1.3. Germinal centres and abundant AFCs appear on the 3rd day. 
On the third day after immunization GCs develop in the follicles of the white 
pulp (Fig. 3.2B). These are populated with NP-specific cells that express Bcl6 
protein, with which they are associated (Fig. 3.3). As expected these cells lack 
detectable IRF4 protein, in contrast to the remaining T zone B blasts, which are still 
IRF4+ and the now abundant of NP-specific AFCs in the red pulp and extra follicular 
foci. The plasmablasts are CD138+, IRF4high, Ki67+ with cytoplasmic NP-binding 
(IRF4 expression will be addressed further in section 3.5). 
3.2. NP binding B cells responding to NP-Ficoll divided into subsets according 
to their B220 and CD138 expression. 
Flow cytometry was used to identify phenotypic changes in the responding 
populations of B cells. B220, a B cell associated protein (Coffman, et al, 1981) and 
CD138 (syndecan-1), expressed by plasmablasts (Sanderson, et al, 1989), were the 
key molecules studied in conjunction with NP binding. 
Prior to immunization NP binding cells express high levels of B220 and bind 
high levels of NP. Twenty-four hours after immunization B220 expression is 
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Figure 3.2: The expansion of NP specific cells in the splenic white pulp 
during the second day after immunization. 
A. The NP-binding population has increased by 48 hours to fill the T zone. 
There are some plasmablasts in the red pulp but few compared to 72 
hours. B. Germinal centres and plasmablasts are prominent at 72 hours. 
NP-binding cells re-appear in the MZ. IgD in brown and CD3 or NP in blue. 
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 72hrs IRF4 IgD 
GC 
RP AFC 
Figure 3.3: Germinal centre and plasmablast development in the QMxB6 
response to NP-Ficoll 
NP+ germinal centres at 72 hours are Bcl6 and Ki67 positive. Antibody 
forming cells are IRF4+. IgD or Ki67 in brown and CD3, NP or Bcl6 or IRF4 in 
blue. GC= Germinal Centre, F= Follicle, T = T zone/ PALS. 
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unchanged whilst the amount of NP bound has diminished considerably (Fig. 3.4). 
This change in NP binding may be due to competition from the NP-Ficoll with which 
the mice were immunized and perhaps BCR internalization. For 8 and 24 hour time 
points 30g of fluorescent NP-FITC-Ficoll, which induced the same response as NP-
Ficoll, was used to provide clear identification of responding cells. During the first 24 
hours of the response the number of NP-binding cells remains the same (Fig 3.4C) 
consistent with the long G1 observed by Hsu (2004).  
B220 expression declines in NP binding cells as the B cells begin to 
differentiate at 48 hours. At this time the B220 intermediate (int) population 
represents ~30% of the NP binding cells. In agreement with the immunohistological 
data (Fig 3.2) a few CD138+ B220 intermediate, plasmablast, cells are seen. During 
the second day the number of NP-binding cells increases more than 10 fold (Fig 
3.4C). For this to occur all the responding cells at 24 hours need to have undergone 
cell division – this is again consistent with the CFSE studies of Hsu (2004). All three 
NP+ populations - the B220 high, B220int and CD138+ B220int - persist at 72 hours. 
However the CD138+ B220int population now consists of 10-20% of the responding 
cells (Fig 3.4B) and the CD138- intermediate population makes up approximately 
50%. In contrast to the previous day the number of NP+ cells between 48 and 72 
hours increases 2 fold (Fig 3.4C). 
Bulk sorts were made of these populations to allow the mRNA expression 
profiles to be assessed in the responding cells during different stages of the 
response. These consisted of the NP+ B220+ population prior to and 24 hours after 
immunisation, the NP+ B220high and NP+ B220int populations at 48 and 72 hours, and 
the NP+ CD138+ B220int population at 72 hours as previously described. 
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Figure 3.4: FACS analysis of the cells responding to 30g NP-Ficoll 
A. Top row shows B220 positive B cells binding NP-PE. The CD138 
expression of these populations is shown on the bottom row. Responding B 
cells were subdivided into B220high (red diamonds), B220 intermediate (white 
diamonds) and CD138 high (blue diamonds) populations. B. The proportion of 
the responding cells that make up these three populations. C. The number of 
NP+ cells per spleen as the response progresses. 
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3.3. Microarray analysis of mRNA expression within bulk-sorted NP-specific B 
blasts and plasmablasts identified by flow cytometry 
Arrays were designed to assess the mRNA expression of 94 plasmablast and 
germinal centre-associated genes with 18sRNA and 2microglobulin (2m) as 
control genes that are relatively uniformly-expressed. The value of using 2m as this 
standard for mononuclear leucocytes has recently been published by Serre et al in 
our lab (Serre, et al, 2008). These were set out in 384 well microfluidic plates that 
allow RT2-PCR for each of the selected gene products. 
3.3.1. NP-binding sorted populations form distinct populations at the mRNA level 
The data from the gene arrays was analysed and sorted according to mRNA 
expression similarity (Fig. 3.5). This technique plots on a colour scale variation from 
the average result across all the populations analyzed. Green reflects below average 
expression, red above average expression while average values appear black. Such 
analysis does not give absolute levels of expression. It can be seen from the figure 
that there is clear upregulation of a wide range of genes by 24 hours after 
immunization. These are shown as green before immunization and red after. There 
is down regulation of a smaller set of genes reflected by the opposite colour change. 
At 48 hours both the B220high and B220int populations are relatively homogeneous 
and their general black colouration on the scale indicates an approximation to the 
average gene expression levels. At 72 hours all three populations by combinations of 
down regulation and up-regulation of mRNAs show divergent differentiation from the 
48 hours blasts and from each other. To take this analysis further the levels of 
mRNAs relative that of 2microglobulin were assessed for each of the 94 mRNAs. 
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Figure 3.5: Combined gene expression data from low density RT-PCR arrays 
Genes selected from the original array data based on significant expression 
levels. Cell populations are grouped according to similarity in gene expression 
by the TMEV software. Markers to clarify cell populations and groups of genes 
are calibrated by eye. Red indicates an upregulation, and green a 
downregulation (relative to the row average) of gene expression. The range of 
expression indicated by the colour code ranges from 8 fold (23) below 
average (bright green) to 8 fold above average (bright red). Grey indicates no 
expression detected. 
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3.3.2 At 72 hours the B220 intermediate CD138+population expresses mRNA 
associated with plasmablast differentiation and has down regulated mRNAs for 
proteins of the BCR complex 
That the CD138+ population at 72 hours expresses plasmablast associated 
genes confirms that these cells have differentiated to AFC. As would be expected, 
plasmablast and plasmablast precursor associated genes, such as the 
transcriptional regulators Blimp1 (Fukuda, et al, 1997; Muramatsu, et al, 2000; 
Shapriro-Shelef, et al, 2003) and XBP1 (Shaffer, et al, 2004), are upregulated in this 
population. The level of IRF4 (Klein, et al, 2006) is also upregulated (Fig 3.6A).  
Endoplasmic reticulum-associated genes KDERL2 (Tarte, et al, 2003), ELL2 
(Nakayama, et al, 2006) and SSR1 (Wiedmann, et al, 1987) are selectively 
expressed in this population, reflecting their secretion of antibody (Fig 3.6B). This 
function is also indicated by J chain upregulation; J chain is essential for IgM and IgA 
polymerisation (Mestecky, et al, 1971; Shaffer, et al, 20004). The signal transducer 
IL6ST, which is downstream of the IL6 receptor, is also involved in the promotion of 
AFC differentiation (Saito, et al, 1993) and is selectively expressed in the CD138+ 
cells at 72 hours (Fig 3.7A).  
The TNF-family receptors BCMA and TACI are both upregulated whilst BAFF 
receptor is down regulated (Fig 3.7.B). This is in keeping with the published data on 
the role of these genes in plasmablast differentiation. BAFF receptor is associated 
with maintaining survival of recirculating and MZ B cells as well as GC B cells 
(Shulga-Morskaya, et al, 2004; Zhang, et al, 2005). TACI has been implicated in 
early plasmablast development (Zhang, et al, 2005) in TD and TI responses (von  
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Figure 3.6: Plasmablast associated genes are upregulated in the CD138+ 
population at 72 hours 
Genes associated with plasmablast differentiation (A) and the production of 
protein by the endoplasmic reticulum (B) are upregulated at the mRNA 
level at 72 hours in the CD138+ population. Each diamond represents one 
mouse. Red diamonds are B220high CD138- cells, white diamonds, 
B220int cells and blue diamonds are CD138+ B220int. All values are 
relative to 2microglobulin. 
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Figure 3.7: Further genes upregulated in the CD138+ population at 72 hours 
Genes associated with antibody production are upregulated at 72 hours (A). TNF 
family receptors TACI and BCMA are upregulated at 72hours in the plasmablast 
population whilst BAFF receptor is downregulated (B). Each diamond represents one 
mouse. Red diamonds are B220high CD138- cells, white diamonds, B220int cells 
and blue diamonds are CD138+ B220int. All values are relative to 2microglobulin. 
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Bulow, et al, 2001). BCMA is reported to maintain plasma cells in the bone marrow 
(O’Connor, et al, 2004). Interestingly CCRL2 is upregulated in plasmablasts (Fig 
3.7B, bottom right). This chemokine scavenging receptor is associated with mast 
cells in the peritoneal cavity and has been reported to augment inflammation (Zabel, 
et al, 2008).  
A number of proteins associated with the BCR and signal transduction linked 
with BCR engagement are downregulated at the mRNA level in the plasmablast 
population (Fig 3.8). Much of this downregulation relates to the loss of Pax5, a key 
positive regulator of the BCR complex (Horcher, et al, 2001; Nera, et al, 2006). 
CD79 which is essential for the expression of Ig at the cell surface and signal 
transduction from BCR engagement (Lin and Justement, 1992), is down regulated. A 
number of proteins reported to regulate calcium fluxes induced by B cell activation 
are also down regulated; CD20 (Uchida, et al, 2004), CD22 (Nitschke, et al, 1997) 
and CD72 (Pan, et al, 1999) and Bach2, an inhibitor of Blimp1 (Ochiai, et al, 2006; 
Ochiai, et al, 2008), 
The receptor for co-stimulation, CD40, which is key in GC formation and T-
dependent Ig class switching, (Kawabe, et al, 1994) is down-regulated. It would be of 
interest to see if this down-regulation is more pronounced in TI-2-induced 
differentiation of B cells to plasmablasts as CD40-ligation has been reported to be 
unnecessary for TI-2 responses (Xu, et al, 1994). IL4R 
GC (Cunningham, et al, 2004). The enzyme essential for CSR - AID (Muramatsu, et 
al, 2000), is strikingly absent from the plasmablasts. This selective down regulation 
of AID in plasmablasts indicates these cells have lost the capacity to initiate switch 

























































































Figure 3.8: Genes associated with the BCR are downregulated at 72 hours 
in the CD138+ population 
BCR associated proteins (A) and costimulation receptors (B) are 
downregulated in the CD138 population at 72 hours. Each diamond 
represents one mouse. Red diamonds are B220high CD138- cells, white 
diamonds, B220int cells and blue diamonds are CD138+ B220int. All values 






































































Figure 3.9: Further genes downregulated at 72 hours in the CD138 
population 
Each diamond represents one mouse. Red diamonds are B220high CD138-
cells, white diamonds, B220int cells and blue diamonds are CD138+ B220int. 
All values are relative to 2microglobulin. 
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B blasts migrate from the white pulp to extrafollicular foci as they become 
plasmablasts during TI-2 responses. Consequently it is not surprising that both 
CXCR5 and CCR7 are downregulated in the plasmablast population (Fig 3.9).  
CXCR5 is involved in the attraction recirculating B cells, MZ cells B cells as 
well as a subset of primed CD4 T cells into B cell follicles (Cinamon, et al, 2008; 
Ekland, et al, 2004). CCR7 is required for the localisation to and retention of B cells 
at the T zone follicle border in response to antigen (Reif, et al, 2002, Okada, et al, 
2005). CCR10 is a non-signalling chemokine scavenger gene that has been 
associated with the resolution of inflammation (McKimmie, et al, 2008). The data 
show that it is downregulated in plasmblasts, in contrast to the pro-inflammatory 
CCRL2 mentioned above. 
The reduction in Bcl2 mRNA levels (Fig 3.9) may be related to the high death 
rate in plasmablasts that do not gain access to stroma in the red pulp that supports 
their survival (de Vinuesa, et al 2000; Sze, et al 2000).   
Oct-2 activates IL5R (Emslie, et al, 2008) and in this way may promote AFC 
formation (Hasbold, et al, 2003). The down regulation of both of these (Fig 3.10) fits 
with the loss of CSR capacity and acquisition of plasmablast cell fate. IL-10R is 
selectively down-regulated in the plasmablasts. IL-10 has been linked to switching to 
IgA (Fayette, et al, 1997). More recently IL10 has been reported in conjunction with 
the B10 cell subset to repress inflammation (Yanaba, et al, 2008; Fillatreau, et al, 
2002; Tanaka, et al, 1996).  
Blk, a tyrosine kinase implicated in CD72 signalling (Venkataraman, et al, 
1998) and LgalS3/MAC2, which is associated with IgE invoked respiratory bursts in 








































































Figure 3.10: Further genes downregulated at 72 hours in the CD138 
population 
Each diamond represents one mouse. Red diamonds are B220high 
CD138- cells, white diamonds, B220int cells and blue diamonds are 
CD138+ B220int. All values are relative to 2microglobulin. 
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3.9 and 3.10). IL6 has been reported to have roles both in human GC (Burdin, et al, 
1996), and promoting the differentiation to AFC (Hirano, et al, 1985). IL6 ST (gp130) 
is selectively up regulated in the CD138+ population while levels of IL6R are lowered. 
3.3.3. mRNA from cells in the B220 high CD138- B blast population includes mRNAs 
associated with germinal centre B cells 
The population of B blasts at 72 hours that remain B220high starts to express 
GC associated genes (Fig 3.11). This B220high population expresses Bcl6 (Cattoretti, 
et al, 1995), AID (Muramatsu, et al, 1999), Fas (Smith, 1995; Hao, et al, 2008) and 
the germinal centre expressed transcript (GCET) (Christoph, et al, 1994). Also 
upregulated in the B220high population is the BAFF receptor which has been reported 
to be necessary for the maintenance of GC responses (Shulga-Morskaya, et al, 
2004).  RAPGEF, a guanine nucleotide exchange factor, is also upregulated.  
Germinal centre B cells are selected on the basis of antigen binding, 
processing and presentation to CD4 T cells (Liu, et al, 1989; Gulbranson-Judge and 
Maclennan, 1996). Consequently it is not surprising that there is continued 
expression of the BCR complex regulator Pax-5 (Lin, et al, 2002) and CD40 in the 
B220high population at 72 hours (Fig 3.8). 
3.3.4. The CD138- B220 intermediate cells at 72 hours have downregulated GC-
associated genes including DNA repair genes  
In contrast to the CD138+ and the CD138- B220high populations, which 
express plasmablast and GC mRNAs respectively, the B220 intermediate population 
shows little evidence of commitment to become GC B cells or plasmablasts. 








































































Figure 3.11: Genes upregulated in the B220high population at 72 hours are 
associated with germinal centres 
Each diamond represents one mouse. Red diamonds are B220high 
CD138- cells, white diamonds, B220int cells and blue diamonds are 
CD138+ B220int. All values are relative to 2microglobulin. 
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these cells (Fig 3.12). In addition the expression of DNA repair genes such as breast 
cancer 1(BRCA1) (Scully, 2001), breast cancer 2 (BRCA2) (Moynahan, et al, 2001) 
and uracil DNA glycosylase (UNG) (Rada, et al, 2002) decreases which may suggest 
that these cells are unlikely to be involved in active DNA hypermutation (Fig 3.12 and 
3.13). DNA ligase I, which is also downregulated, may also be involved in this 
process; DNA ligase IV, which was not included in our array, is involved in double 
stranded break repair (Pan-Hammarstrom, et al, 2005). 
Two genes linked with cell cycle control show low levels of expression: (i) 
Polo like kinase (plk) is a protein kinase that localises to the mitotic and meiotic 
apparatus during cell division (Lee, et al, 1995); (ii). CDKN2C, in vitro this has been 
shown to be upregulated by IL6 during plasma cell differentiation and is involved in 
bringing plasmablasts out of cell cycle (Morse, et al, 1997). 
In addition, microtubule-associated serine/threonine kinase (MAST2) and Bob 
1 expression declines (Fig 3.13). MAST2 is upregulated by FcR ligation in 
macrophages and leads to their production of IL12 (Zhou, et al, 2004). Bob1 is B cell 
specific and binds Oct-2 to promote antibody production but not CSR or proliferation 
(Qin, et al, 1998; Gstaiger, et al, 1995). 
The response to NP has been shown to produce a NP+B220neg memory 
population within 7 days of the wild type response to NP-keyhole limpet 
heamocyanin (Driver, et al, 2001). By this time it comprises 50% of the responding 
cells and does not express GC or plasmablast markers. Work from our laboratory 
showed that the response to NP-Ficoll could generate memory from the B1 B cell 









































































Figure 3.12: Genes downregulated in the B220 intermediate population at 72 
hours are associated with germinal centres and DNA repair 
Each diamond represents one mouse. Red diamonds are B220high CD138- 
cells, white diamonds, B220int cells and blue diamonds are CD138+ B220int. 


































































Figure 3.13: Genes downregulated in the B220 intermediate population at 
72 hours are associated with germinal centres and DNA repair  
Each diamond represents one mouse. Red diamonds are B220high 
CD138- cells, white diamonds, B220int cells and blue diamonds are 
CD138+ B220int. All values are relative to 2microglobulin. 
 
 69 
Bcl6 and low CDKN2C (Kuo, et al, 2007). The possibility that these cells may 
represent a memory population provides an avenue for further investigation. 
3.3.5 Within 24 hours genes associated with CSR and DNA repair are upregulated 
As previously described, the response to NP-Ficoll provokes considerable 
changes in mRNA expression within 24 hours of immunization (Fig 3.14). Some 
mRNAs of proteins associated with DNA repair such as BRCA1, DNA ligase I and 
UNG (section 3.3.4) are upregulated – perhaps in preparation for class switch 
recombination (Fig 3.14A). J chain, which is necessary for IgM polymerization and g 
protein signalling 13, which is the IL6 signal transducer without which antibody 
responses are impaired (Kumanogoh, et al, 1997), are both upregulated at this time 
(Fig 3.14B). CyclinD2, a protein that allows progression from G1 and is upregulated 
by BCR signalling (Glassford, et al, 2003), also shows an increase in mRNA 
expression (Fig. 3.15). Finally, CD30L, that is expressed by T cells and B cells 
(Shanebeck, et al, 1995; Younes, et al, 1996) and promotes proliferation and 
antibody secretion, expression also increases.  
Given that the responding cells move from the MZ to the T zone during the 
first day of the response (section 3.1) a change in chemokine receptor signalling 
would be expected. The chemokine receptor CXCR4 is implicated both in migration 
to the T zone (Casamayor-Palleja, et al, 2002) and from the T zone to extrafollicular 
foci (Hargreaves, et al, 2001) and so an upregulation of this gene might be expected. 
Unfortunately an assay for this gene was not available for the array at the time of 
design. Twenty-four hours after NP-Ficoll administration C-C chemokine receptor 1 
(CCR1) and CCR8 are both downregulated in responding cells (Fig 3.15). C-C 











































































Figure 3.14: Genes upregulated in the 24 hours of the response are associated 
with DNA repair, CSR, cell cycle and cell movement 
Genes associated with DNA repair (A), class switch recombination and somatic 
hyper mutation (B), antibody production and cell cycle (C) and cell movement (D) 
undergo changes in their mRNA expression during the first day. Each diamond 
represents one mouse. Red diamonds are B220high CD138- cells, white 
diamonds, B220int cells and blue diamonds are CD138+ B220int. All values are 






































































Figure 3.15: Additional genes that show mRNA level changes during the 
first 24 hours of the response 
Each diamond represents one mouse. Red diamonds are B220high 
CD138- cells, white diamonds, B220int cells and blue diamonds are 
CD138+ B220int. All values are relative to 2microglobulin. 
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2002). Integrin alpha 4 allows B cells to bind to stroma (Behr and Schriever, 1995) 
and the downregulation of this molecule at 24 hours may reflect the movement of the 
cells from the MZ. In addition the Chemokine (C-X3-C motif) receptor 1 is 
downregulated at 24 hours. CX3CR1 has been reported in some B cell lymphomas 
and is an adhesion molecule that regulates cell homing (Andreasson, et al, 2008).   
3.3.6 At 48 hours the B220 intermediate population is distinguished by the 
expression of CD30L and CX3CR1 
The slight increase in expression of CD30L, ELL2 and CX3CR1 in the B220 
intermediate cells compared to the B220high cells shows the limitations of the gene 
array, as opposed to a genome wide investigation, when investigating differentiation 
(Fig 3.16). These three genes appear to provide a possible point of differentiation 
between the two populations at this time.  Expression of CX3CR1, a gene involved in 
tissue homing, and CD30L, involved in costimulation (section 3.3.5) may hint at 
interactions with other cells in the T zone during the second day. The lack of 
difference between the two populations might also suggest that the decline in B220 
expression is a false indicator (this is discussed in Section 3.6.4). 
3.3.7. The limitations of gene expression profile analysis 
These gene expression studies were performed on bulk sorts of the identified 
populations. The quantity of mRNA expressed was calculated relative to the 
expression of the control gene 2microglobulin. Because cDNA has been prepared 
from a large number of cells the result only informs about the total mRNA in all the 
cells. It cannot distinguish a small proportion of the cells expressing a high level of 




















































Figure 3.16: Genes that show significant mRNA level changes during the 
second day of the response 
CD30L, CX3CR1 and ELL2 are expressed at 48 hours at a higher level in 
the B220 intermediate population than in the B220 high population. Each 
diamond represents one mouse. Red diamonds are B220high CD138- cells, 
white diamonds, B220int cells and blue diamonds are CD138+ B220int. All 
values are relative to 2microglobulin. 
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small amount of the mRNA. In addition the logarithmic nature of PCR amplification 
biases greatly toward high expressing cells. Consequently whilst this bulk sort 
analysis provides clues about gene expression changes associated with 
differentiation of B cells it cannot be considered to be an accurate reflection of single 
cells participating in the response and may mask important gene expression 
changes. For example, both Blimp1 and Bcl6 mRNA are expressed at 72 hours in 
the CD138- B220high population. It is conceivable that within this population some 
cells will express one mRNA whilst others do not. Bulk sorts mean that such 
subtleties are lost. Without the definition of single cell RT2-PCR, or genomic arrays 
based upon single cell amplification, it is not possible to be accurate in our 
conclusions as to the differentiation of the responding B cells in the populations we 
identified. 
3.4. The use of single cell analysis to define the cells that undergo class 
switching in the extrafollicular response and where and when B Blasts 
differentiate either to germinal centre cells or plasmablasts. 
 Single cell RT2-PCR was utilised to study the differentiation of cells within the 
populations previously described. The expression of four key genes was analysed: 
 1. AID- expression is necessary for class switch recombination to occur 
 2. Bcl6- the transcription factor responsible for GC cell fate 
 3. Blimp1- a key transcription factor responsible for plasmablast cell fate 
4. IRF4 -  a transcription factor necessary for the production of AFC and class 




3.4.1 Class switching in the extrafollicular response occurs in the T zone B blasts 
before they differentiate into AFC. 
First we looked to identify if and when switched cells appear during the 
response to NP-Ficoll. The first switched NP specific cells identified in the spleen by 
immunohistology were plasmablasts in extrafollicular foci 72 hours after NP-Ficoll 
(Fig 3.17A).  
A search using RT2-PCR on bulk sorted responding cells showed that mRNA 
from the CD138- B220high as well as the B220int populations at 48 hours had 
processed transcripts of I that had recombined to C3 (Fig 3.17B). The levels of 
these transcripts had risen in both these populations by 72 hours, when higher levels 
were found in the CD138+ cells. These data indicate that some switching is occurring 
in B blasts, but do not exclude continued switching in plasmablasts. Class switch 
recombination is dependant upon expression of AID (Muramatsu, et al, 2000; section 
1.5.6) and the bulk analysis showed AID mRNA was undetectable in CD138+ cells 
(Fig 3.8). This is confirmed in the single cell analysis. AID was very rarely found in 
CD138+ cells (3 out of 386 cells, Fig 3.18B, middle graph). On the other hand at both 
48 and 72 hours AID mRNA is expressed in ~10% of the CD138- B220high and 
B220int cells. These data show that switching in the extrafollicular response can and 
does occur in B blasts prior to the expression of CD138 protein. In addition, the 
absence of AID in CD138+ cells precludes these cells initiating CSR. Further 
characterization of the CD138+ cells and the emergence of the Bcl6+ AID+ cells in the 
B220high fraction of B cells at 72 hours (Fig 3.18A) is considered in the next section. 
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Figure 3.17: Switch recombination to IgG3 in the response to 30g NP-Ficoll 
A. IgG3 positive NP binding cells per mm2 in the spleen. B. Expression of 
recombined switched transcripts to 3 in the sorted NP+ populations. Class switch 
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Figure 3.18: Expression of AID and Bcl6 at the single cell level during the 
response to NP-Ficoll 
A. Example plots of AID and Bcl6 multiplex RT2-PCR in NP+ B220high cells. Each 
diamond represents one 2 microglobulin positive cell. Numbers show the 
percentages of cells in each quadrant. B. The percentage of Bcl6+ AID-, AID+ 
Bcl6- and AID+Bcl6+ cells in each population after immunization. B220 high cells 
are red diamonds, B220 intermediate cells white diamonds and CD138+ cells are 
blue diamonds. Each diamond represents one mouse. 
 
 78 
3.4.2. Characteristics of the plasmablast cells induced by 30g NP-Ficoll. 
As described, a small CD138+ B220 intermediate population is first apparent 
at 48 hours and is prominent by 72 hours. In addition these cells are IRF4high (Fig. 
3.19A and section 3.5). 
95% of CD138+ cells express Blimp1 consistent with published data on AFC 
(Fig, 3.19B, Sanderson, et al, 1989). 5% of cells in the CD138+ fraction are Blimp1-. 
This is consistent with the possibilities that CD138 expression precedes expression 
of Blimp1 or that a small subset of CD138+ cells exist that do not require Blimp1. 
Almost no CD138+ B220 intermediate cells express AID or Bcl6 (fig 3.18B).  
3.4.3 Germinal centre precursors first appear in the B220 high CD138- subset at 72 
hours 
The B220high CD138- population at 72 hours includes 10-60% Bcl6+ AID+ cells 
(fig 3.18B).  This phenotype is characteristic of GC (Muramatsu, et al, 1999). It is 
unclear whether the remaining cells CD138-, B220high cells are destined become 
either GC cells or plasmablasts. As mentioned above some express AID and a few 
express Bcl6 without AID. 
The cells of the CD138- B220int population do not express Blimp1 nor do they 
have a GC phenotype (Bcl6+AID+). However, a small proportion of these cells 
express AID (Fig 3.18B). These experiments do not clarify the role of the B220 
intermediate subset. That they might differentiate into plasmablasts or GC cells, or 
that they might be a separate population of B1b cells apparent at 48 hours, will be 
discussed.
 79 


























































































































Figure 3.19: Plasmablast populations in the QMxB6 response to 30g NP-Ficoll 
A. Expression of IRF4 at 72 hours. Germinal centres (GC) appear largely IRF4 
negative whilst red pulp plasmablasts are IRF4 high. IgD is brown, CD3, NP and 
IRF4 in blue. F= Follicle, T = T zone/ PALS, GC = germinal centre, RP = red 
pulp. B. An example plot of Blimp1 and AID RT2-PCR on CD138 positive cells at 
72 hours. C. Blimp1 expression in all the sorted populations. Blimp1 is only 
expressed at 72 hours in the CD138 response. 
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3.4.4. The significance of Bcl6 mRNA expression in naïve B cells in the absence of 
Bcl6 protein. 
Prior to immunization ~60% of NP-binding cells express Bcl6 mRNA. This has 
declined to ~20% by 24 hours and at 48 hours is in 10-20% of the responding B cell 
subsets (Fig 3.18B). Bcl6 protein is only observed at 72 hours (Fig 3.3). The 
significance of the expression of Bcl6 mRNA prior to immunisation remains obscure, 
but data presented in chapter 4 suggest that it does not mark cells that are only able 
to become GC cells on activation. 
3.5. IRF4 expression throughout the response to 30g NP-Ficoll 
IRF4 protein is associated with production of plasmablasts from both the GC 
and extrafollicular response and is implicated in the induction of CSR; for these 
processes do not occur in mice deficient in IRF4 (Mittrücker, et al, 1997; Klein, et al, 
2006). It has been suggested that the induction of low level expression of IRF4 
protein may drive B cells into CSR through activation of AID, while higher expression 
levels induce AFC formation (Sciammas, et al, 2006). Apart from a few cells – 
perhaps committed to AFC differentiation, IRF4 is not expressed in GC B cells 
(Falini, et al, 2000) and this is confirmed in the GC present at 72 hours (Fig 3.19). 
These data suggest that IRF4 expression might be a factor in determining whether B 
cells recruited into antibody responses differentiate into GC cells or form 
plasmablasts in an extrafollicular response. 
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3.5.1 IRF4 expression in the NP binding cells during the first day of their response to 
NP-Ficoll. 
In non immunized mice immunohistology reveals that IRF4 protein is 
expressed in some cells in the red pulp and extrafollicular foci. The location of these 
cells is consistent with them being background plasma cells (Fig 3.20A and B). 
Importantly there are only very occasional IRF4+ cells in the MZ and follicles (Fig 
3.20B). The number of these IRF4+ cells is far lower than the numbers of NP-specific 
cells in either the follicles or MZ. Eight hours after immunization immunohistology 
shows that IRF4 protein is expressed in most if not all NP binding cells in the T zone 
(Fig 3.20C and D). Some NP-specific B cells are still in the MZ at 8 hours and these 
are also IRF4+. These IRF4+ NP+ MZ cells probably are about to migrate to the T 
zone, for the MZ is clear of NP-specific or IRF4+ cells at 24 hours (not shown). The 
upregulation of IRF4 within 6 hours of B cell activation in vitro has previously been 
reported in response to either BCR ligation (Matsuyama, et al, 1995) or CD40 
ligation in the presence of IL4 (Gupta, et al, 1999). 
The immunohistological studies indicate that at best IRF4 protein expression 
is low in mature recirculating and MZ B cells that have not been recruited into 
antibody responses and that this is upregulated in most, if not all, cells within 8 hours 
of being recruited into the response to NP-Ficoll. These studies do not quantify the 
increases in IRF4 expression and the proportions of cells upregulating IRF4. To 
obtain quantification the expression of IRF4 was assessed in permiabilized NP-
specific B cells by flow cytometry. Prior to immunization FACS analysis shows that 
most NP-binding cells express levels of IRF4 that are within the 95 percentile 



















Figure 3.20: IRF4 expression in NP binding cells 8 hours after NP-Ficoll 
A. NP binding cells in the marginal zone (MS) of the white pulp prior to 
immunization. B. IRF4+ cells prior to immunization in extra follicular and red pulp 
(RP) plasmablasts. C. NP+ cells at the T zone follicle boundary 8 hours after 
immunzation. D. IRF4+ cells at the T zone/follicle boundary 8 hours after 
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Figure 3.21: IRF4 protein is present prior to immunization but increases after NP-Ficoll 
immunization 
A. IRF4 protein prior to and 8 hours after immunisation in NP binding cells. Before 
immunization a variable but always small population of IRF4 expressing cells can be 
seen. After immunization IRF4 the amount of IRF4+ cells increases. Graphs are 
representative of 8 pre-immunization and 6 post immunization mice. B. The percentage 
of NP binding cells that are IRF4+ compared to expression in NP-, non responding, 
cells. As is detailed in the methods the IRF-4 staining by the majority of NP-, B220+ cells 
conforms with the isotype control staining and provides a good internal negative control 
in the FACS analysis. Bars represent median values. These groups are significantly 
different p=0.001, Mann-Whitney U test. C. IRF4 expression in vitro in response to NP-
Fitc-Ficoll with or without cyclohexamide (CHX). The increase in IRF4 expression seen 
at 24 hours is inhibited by the addition of cyclohexamide. 
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few of the NP-specific B cells contain some IRF4; these cells are seen as a peak to 
the right hand side of the curve (Fig 3.21A, top row). The levels of IRF4 expressed 
by this low proportion of NP+ B220+ cells are clearly lower than those of AFC 
(compare with 3.23B, green curve). Consequently it seems this low level of IRF4 
expression by NP-specific B cells from non-immunized mice does not reflect the 
background AFC. These NP-specific AFC are almost all Ki67- mature plasma cells 
(not shown), which do not express high levels of surface anti-NP antibody. It remains 
to be determined if the low level IRF4 protein expression in some NP-specific splenic 
B cells from non-immunized QMxB6 mice is due to a background of activated cells or 
low level expression by a small, but variable, proportion of non-activated B cells. 
After BCR engagement a shift in IRF4 protein expression is seen whereby 
between 30 and 70% (median 50%) of NP+ cells have levels above that of 95% of 
NP- cells (Fig 3.21A and B). The median level of staining among these IRF4+ cells is 
around 3 fold the greater than the negative control, but as mentioned above and 
considered further in the next section, is well below that by AFC. Preliminary in vitro 
experiments with and without the ribosome inhibiting cyclohexamide indicate that this 
increase in expression is dependent upon de novo production of IRF4 (Fig 3.21C).  
In contrast to the increase seen in IRF4 protein the array data for IRF4 mRNA 
expression did not show an increase in expression between 0 and 24 hours (Fig. 
3.6). This would suggest that IRF4 protein expression was regulated at the 
translational level. This conclusion is not supported by analysis of RT2-PCR for IRF4 
by single cells.  Levels of IRF4 mRNA prior to and 24 hours after immunization are 
not significantly different (Fig 3.22), but IRF4 mRNA expression increases during the 
first 8 hours of the response and is significantly higher than that at 0 and 24 hours, 

















































Figure 3.22: IRF4 mRNA expression does not follow IRF4 protein levels during 
the first 24 hours of the response to 30g NP-Ficoll. 
Box plots to show the expression of IRF4 mRNA in the sorted NP+ B220+ 2m 
positive cells prior to immunization, and at 8 and 24 hours after immunization. 
Each box is representative of  30-170 cells from one mouse. The centre of the 
box indicates the median, the ends the quartile range. Whiskers show the 99 
percentile. Cells with an IRF4 ct less than 40 are treated as negative. The 
percentage of cells that are negative is indicated under each plot.  
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3.5.2. IRF4 expression in relation to the formation of plasmablasts,germinal centre 
cells and switching as assessed by co-expression of AID and Bcl-6 on the second 
and third days of the response 
At 72 hours three populations can be distinguished by flow cytometry in NP+ 
cells (Fig 3.23.A) i) a distinct IRF4 high population which is CD138+ (Fig 3.23B), ii) 
an IRF4 low/negative population which is CD138-, and iii) the persisting IRF4 
intermediate, CD138- population that emerged at 8 hours.  
Plasmablast formation:  The IRF4 high, CD138+ population is first apparent 
at 48 hours (Fig.3.23C) and constitutes some 20% of the responding cells by 72 
hours. This is coincident with the emergence of IRF4+ NP+ plasmablasts that are 
visible by immunohistology in the red pulp in small numbers at 48 hours and fill large 
areas of red pulp by 72 hours (Fig 3.19). The proportion of responding cells that are 
NP+ IRF4 high at 72 hours is slightly higher than the proportion of NP+ CD138+ cells 
(Fig 3.4B). This is consistent with the concept that the upregulation of IRF4 to high 
levels precedes the expression of CD138. This was previously suggested by Falini, 
et al, (2000). Further evidence that is consistent with this concept is provided by 
single cell RT2-PCR of sorted populations of NP+ cells at 48 hours after NP-Ficoll 
(Figure 3.24). In this figure it can be seen that the CD138+ NP+ cells at 72 hours 
have very few IRF4low/- cells and a substantial proportion of IRF4high cells. These 
IFR4high cells, which have ct values of fewer than 31 cycles, are boxed in Figure 
3.24. Cells with these high levels of IRF4 mRNA are also seen in the NP+ cells 
sorted at 48 hours, but are very rare in the NP+ CD138+populations sorted at 72 
























































































































































































Figure 3.23: IRF4 expression by FACS in NP binding cells after immunization. 
A. IRF4 expression in NP binding cells prior to immunization and at  8, and 72 
hours. Non immunized NP- B220high cells are grey, NP+ cells prior to 
immunization are red. Responding cells at 8 hours are orange, and at 72 hours 
are green. Most NP binding cells have upregulated IRF4 at 8 hours. By 72 hours 
an IRF4 high and negative population is seen as well as some intermediate cells. 
B. NP+ IRF4 high cells at 72 hours are mostly CD138+ whilst IRF4 low cells are 
CD138-. Left hand graph shows expression of IRF4 in NP+ cells at 72 hours. 
Grey curve shows IRF4 expression of NP-B220+ cells. Right hand graph shows 
the IRF4 and CD138 expression of NP+ cells.  C. The % of NP+ cells that are 
IRF4 high (green), IRF4 intermediate (orange) and IRF4 low (grey). An IRF4 
intermediate population persists from 8 hours IRF4 high cells, that are CD138 
positive, emerge between 48 and 72 hours. IRF4 low cells are within the IRF4 
expression of (95%) NP-B220high cells. IRF4 high cells are defined by their clear 
IRF4 high B220 intermediate phenotype.  
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Figure 3.24: IRF4 expression in responding NP+ populations at 48 and 72 hours  
The number of cells that express IRF4 mRNA at the indicated Ct. Cells that are 
IRF4+ are turquoise and those that are IRF4+AID+ are purple. Cells at 48 hours 
(A) show a greater range of IRF4 expression than the CD138- cells at 72 hours 
(B). CD138+ cells at both times (C) show high IRF4 expression but some cells 
express levels similar to those in B.  
 89 
Germinal centre formation:  As mentioned above GC cells do not obviously 
contain IRF4 protein as detected by immunohistochemistry (Figure 3.19). Is it 
possible to identify germinal centre precursors as IRF4low/neg cells? The median 
proportion of IRF4low/neg cells NP+ cells decreases after immunisation from 90% to 
50% at 8 hours and reaches 29% at 48 hours. By 72 hours the number of IRF4 
negative cells has increased to 40%. Among the B220high population this is likely in 
part to reflect the emergence of NP+ IRF4- GC cells, which lack IRF4 protein as 
assessed by immunohistochemistry (Fig. 3.19). On the other hand, as is exemplified 
in Fig 3.23C, a substantial proportion of the IRF4low/neg NP+, CD138- cells at 72 hours 
are B220int and this subset does not contain Bcl6/AID double positive GC cells. This 
result indicates that it is unsafe to conclude that all responding NP+ cells which are 
IRF4 protein low/neg are GC precursor cells. The same conclusion has to be drawn 
from the histograms of single cells IRF4 mRNA expression (Fig 3.24B). Overall the 
data highlight the difficulty in using levels of IRF4 mRNA expression to determine the 
future fate of NP+ B cells recruited into the response to NP-Ficoll. This is shown by 
the substantial proportion of IRF4 intermediate cells among those cells that already 
show features of being plasmablasts and GC cells (Fig 3.24B and C). It will be seen 
that a substantial proportion of the CD138- cells are AID+ and that these divide into 
IRF4+ cells and IRF4int cells (Fig 3.25.A and B). Although for technical reasons IRF4, 
AID and Bcl6 mRNA levels were not assessed in the same cell extrapolation of the 
proportion of AID+/Bcl6+ cells among the B220high NP+ population (Fig 3.25C) shows 
that many of the AID+/IRF4int cells must have also expressed Bcl6. 
Switching:  Earlier it was shown that switching occurs in B blasts before 
they differentiate to become plasmablasts. As switching is absent from IRF4-



































































































































































Figure 3.25: IRF4 and AID mRNA are co-expressed in CD138- cells at 48 and 72 hours  
Representative plots showing IRF4 and AID mRNA expression in single cells from the NP+ 
CD138- B220high and CD138- B220int cells at 48 (A) and 72 (B) hours after immunization. Each 
diamond represents one cell. Cell numbers are in blue and median IRF4 values are in black. 
C. Combined data to show the percentage of cells that express IRF4 alone (blue diamonds), 
AID alone (red diamonds) or both (green diamonds) in all sorted populations. The percentage 
of Bcl6+AID+ cells are indicated by blue triangles and Blimp1+ by orange triangles.  
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hour NP+ B blasts that express AID. These results are shown in Figure 3.25. There 
are many AID- cells that express similar intermediate levels of IRF4 mRNA indicating 
that this level of expression is not exclusively associated with switching cells. It will 
be seen that all of the AID+ cells express intermediate levels of IRF4 mRNA. It will be 
noted from these figures that the level of AID expression in the GC cells at 72 hours 
is generally higher than the level in 48 hour B blasts. This is confirmed in the earlier 
studies of AID and Bcl-6 expression (Figure 3.18) 
3.6. Discussion 
3.6.1 Class switching in the plasmablast response 
CD138+ Blimp1+ cells in the response to NP-Ficoll do not express AID yet 
switched IgG3 transcripts are expressed in all NP
+ populations at 72 hours. As AID 
has been reported to be essential for class switching to occur (Muramatsu, et al, 
2000) it would be logical to assume that these plasmablasts can no longer undergo 
CSR and that this process must have occurred prior to their differentiation. 
Nevertheless there has been a recent report that CSR may occur in the absence of 
AID (Arudchandran, et al, 2008). At 48 hours, whilst the responding B cells are in the 
T zone and MZ, AID+ cells are seen in both CD138- populations co-current with the 
first expression of switched transcripts. IRF4 has been linked to AID upregulation 
and class switching in B cells (Klein, et al, 2006; Sciammas, et al, 2006) and all AID+ 
cells at 48 hours were IRF4+ at the mRNA level. At 48 hours when AID+, Bcl6+ GC 
cells have not yet emerged there no obvious or even statistical correlation between 
IRF4 mRNA levels and AID expression. How CSR is induced on the second day 
remains to be determined. Strong BCR ligation has been shown to provoke CSR 
alone in vitro (Deenick, et al, 1999) however additional stimuli may be required for 
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the process to occur.  Both CD138- populations at 48 hours express TACI and 
BAFF-R (Fig 3.7); when these receptors are engaged they can transmit signals that 
promote CSR (Castigli, et al, 2005; von Bulow, et al, 2001) although TI-2 responses 
are independent of BAFF-R (Shulga-Morskaya, et al, 2004). Interleukins such as Il-4 
(Cunningham, et al, 2004) and IFN1 (Le Bon, et al, 2001) might also provide 
additional stimuli for CSR.  
3.6.2 The hierarchy of IRF4, Blimp1 and CD138 expression in plasmablast 
development 
It is clear that we have identified the NP+ plasmablast population as CD138+ 
IRF4high, Blimp1+ cells observed in small numbers at 48 hours and frequent at 72 
hours (Sections 3.2, 3.3.2, 3.4.2 and 3.5.2). However, it was hoped that in the 
process of these studies precursors to these cells would be identified. Examination 
of IRF4 mRNA expression of CD138- NP-binding cells at 48 hours identified an 
IRF4high subset that was no longer present among the CD138- NP-binding cells at 
72 hours. It is possible that this IRF4high subset are cells that are about to 
differentiate into plasmablasts and this is an early indicator of plasma cell 
differentiation (Section 3.5.2), although this assumes that higher levels of IRF4 
mRNA expression preclude protein down regulation. This is in agreement with the 
published literature on IRF4; IRF4 expression has been shown to up regulate Blimp1 
and CD138 (Teng, et al, 2007; Sciammas, et al, 2006). Our results suggest a 
hierarchy of CD138, Blimp1 and IRF4 expression as cells differentiate towards 
plasmablasts. As previously suggested (Section 3.4.2), the presence of Blimp1 
negative CD138+ cells may indicate that CD138 is upregulated prior to Blimp1 
expression. However, the relationship between CD138 and IRF4 is more 
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complicated. Not all CD138+ cells express IRF4 mRNA (Fig 3.23B), yet IRF4 protein 
is expressed prior to CD138 in GC cells differentiating into AFC (fig 3.19A; Falini, et 
al, 2000). Whilst IRF4 is necessary for plasma cell generation (Klein, et al, 2006) it 
has been reported that IRF4 is not always expressed in CD138+ plasma cells, and 
vice versa (Falini, et al, 2000). Perhaps differentiated plasma cells do not require 
continuous IRF4 protein expression. The expression of these three plasmablast 
markers will be examined further in the following chapters. 
3.6.3. The identification of germinal centre cells and their precursors 
Despite the limitations of using bulk sorts the array analysis indicated that GC 
cells were contained within the B220high population at 72 hours (Sections 3.3.3 and 
3.4.3). Single cell RT2-PCR identified these cells as Bcl6, AID double-positive cells. 
These cells were not present at 48 hours and this finding correlates with the 
immunohistology, which fails to identify clusters of cells expressing Bcl6 protein in 
follicle centres before 72 hours. By 72 hours the B220high subset has selectively 
upregulated Bcl6, FAS, GCET2, RAPGAF1 and BAFFR which are all associated with 
GC B cells, but the array data fail to show upregulation of any of these mRNAs 
between 24 and 48 hours. The exception to this trend is AID, but it can be argued 
that the low-level AID expressed in a significant minority of cells at 48 hours reflects 
switching activity. Thus although the results obtained point to candidate AFC 
precursors at 48 hours they fail to identify cells that are about to become GC B cells. 
The process of selection following somatic hypermutation in GC requires antigen 
recognition through the BCR and subsequent cognate interaction with CD4 T cells 
(Liu, et al, 1989; and Maclennan, 1994). BCR expression is maintained through the 
continued expression of Pax-5 (Fukuda, et al, 1997; Lin, et al, 2002), while the 
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production of Bcl6 protein represses the expression of genes that promote 
differentiation to AFC (Reljic, et al, 2000). The decline in IRF4 expression in GC cells 
does not appear to induce Bcl6 expression (Section 3.5.2). However, excess Bcl6 
protein has no effect on IRF4 activity in vitro (Teng, et al, 2007) so the 
downregulation of IRF4 may be induced through some other mechanism. A model in 
which strong GC responses are induced with few cells becoming AFC outside GC is 
used to search for the phenotype of GC B cell precursors in chapter 5. 
3.6.4 The role and origins of the CD138+ B220 intermediate population 
A large NP+ B220 intermediate, CD138 negative population emerges at 48 
hours (section 3.2). Their B220 phenotype might suggest a B1b population 
(Montecino-Rodriguez, et al, 2006), the differentiation of B cells towards 
plasmablasts (Sanderson, et al, 1989) or the emergence of B cell memory (Driver, et 
al, 2001). There is evidence for all of these events. The gene array data on the 
CD138- B220int cells at 72 hours shows a few similarities with memory B cells 
(section 3.3.4; Kuo, et al, 2007). However, the nature of this study has meant that a 
NP+ memory population as a result of this immunization protocol has not been 
confirmed. B1b cells participate in responses to TI-2 antigens (Martin, et al, 2001) 
and have been shown to provide long term memory to NP-Ficoll in chimeric mice 
(Hsu, et al, 2006). Most of the NP+ B cells in the spleen of non-immunized mice are 
MZ B cells and these are likely to be the major contributors to the early response to 
NP-Ficoll. Nevertheless, it is possible that B1b cells are recruited into the spleen 
from the periptoneal cavity. The B1b response to antigen is swift (Itakura, et al, 
2005) and it been reported that B1 cells express Blimp1 protein within 28 hours of 
stimulation, far quicker than B2 cells (Fairfax, et al, 2007). If this is the case then it 
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seems unlikely that the large B220 intermediate population that has emerged by 48 
after 30g NP-Ficoll is comprised of responding B1b cells for they do not express 
Blimp-1 mRNA. Further analysis of B1b cell markers by FACS may help identify B1 
and B2 cells that are present in already identified populations and confirm the 
presence of B1 cells. There is also the possibility that these cells are still in the 
process of differentiation. Indeed, the CD138+ B220int population is most closely 
related to the CD138- B220int population according to TMEV analysis (Fig 3.5), which 
might imply that these cells are differentiating towards AFC. The large number of 
cells that participate in the response could mean that the factors associated with 
AFC development such as cell-cell contact or interleukin/chemokine receptor binding 
(Gao, et al, 2008; Kim, et al, 2008) are diluted and consequently the process is 
delayed, or never fully induced. 
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Chapter 4: 
Varying the proportion of cells becoming plasmablasts and 
switching in the extrafollicular response to study 
molecules influencing these processes 
 
The response to 30g NP-Ficoll produces both a large extrafollicular plasmablast 
response and germinal centres (GC). To study further the roles of Bcl6, Blimp1, AID 
and IRF4 in class switch recombination (CSR), and the induction of B blast 
differentiation to plasmablasts or GC B cells, new immunization protocols were 
devised that alter the proportions of NP-specific cells differentiating in these different 
ways. In addition, it was hoped that these variations in the response could be used 
as a means to identify other molecules that are involved in directing differentiation. 
Three models were selected and the relative impact on follicular and extrafollicular 
responses and class switching of the first two of these is shown in Table 4.1.  
i) To provoke an antibody forming cell (AFC) response without class 
switching and little GC formation a low dose of NP-Ficoll was administered 
to the QMxB6 mouse. This protocol has previously been reported to 
selectively induce an extrafollicular response without GC (Garcia de 
Vinuesa, et al, 2000). In the event, the switch off of GC was relative rather 
than absolute, but the low dose immunization has provided an 
extrafollicular response with little or no switching. 
ii) Higher levels of class switching were induced through the co-
administration of PolyI:C and 30g NP-Ficoll. This manipulation was based 
on previous studies by Le Bon et al (2001).  
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iii) A strong NP-specific GC response with few NP-specific plasmablasts was 
induced using the carrier primed system (Toellner, et al, 1996). In this 
system congenic wild type C57Bl6 mice were primed with chicken gamma 
globulin (CGG). Five weeks later these mice received QM B cells i.v. 
followed by challenge with soluble NP-CGG i.p. (section 2.2). As the 
carrier primed response in QM B cell-reconstituted C57Bl6 mice is not 
directly comparable to those invoked in CGG-primed QMxB6 mice, control 
chimeras were immunized with 30g NP-Ficoll. These experiments in 
carrier primed chimeras are reported in Chapter 5.  
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<1% 4% 1% 
30g dose 
NP-Ficoll + 
poly I:C. in 
QMxB6 
38% 9% 6% 
 
Table 4.1: The proportions of NP-specific cells in the three QMxB6 immunization 
protocols that at 96 hours after immunization (a) had undergone switch 
recombination to IgG3, (b) had entered germinal centres, or (c) had become 




4.1. A low dose of NP-Ficoll induces B blasts and by 96 hours has induced 
plasmablasts but these have not undergone class switch recombination and 
only small or no germinal centres are formed. 
It has previously been reported that by altering the dose of NP-Ficoll 
administered to QMxB6 mice the proportions of GC and extrafollicular AFC 
generated can be changed (Garcia de Vinuesa, et al, 2000). As the dose of NP-Ficoll 
decreases the area occupied by NP specific GC declines until only the extrafollicular 
plasmablast response remains. This report did not mention the affect of NP-Ficoll 
administration on CSR. However, we observed that immunization with 1g NP-Ficoll 
induced a plasmablast response without a detectable number of these plasmablasts 
switching Ig class, as will be described later in this chapter (Section 4.1.2). This 
provided an opportunity to test a number of hypotheses relating to CSR that were 
generated from the results of single cell RT-PCR described in chapter 3. First, the 
AID+ cells observed at 48 hours in the response to 30g NP-Ficoll might be 
plasmablast precursors undergoing CSR, or GC precursor cells. These are not 
necessarily mutually exclusive possibilities. As both switching and somatic 
hypermutation in GC B cells require AID it is anticipated that the response of QMxB6 
mice following immunization with 1g NP-Ficoll would be unlikely to be associated 
with AID positive B blasts at 48 hours after immunization. Second, as GC formation 
is greatly reduced, is the proportion of B Blasts expressing Bcl6 mRNA at 48 hours 
reduced? This might be expected if those B cells from non-immunized mice that 
express Bcl-6 mRNA are predestined to become GC forming cells. Third, as most B 
blasts become plasmablasts in response to 1g NP-Ficoll do these B blasts have a 
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higher average level of IRF4 expression than is seen following immunization with 
30g NP-Ficoll? In the latter case as both plasmablasts and GC are formed one 
might expect to see a mixture of IRF4high and IRF4low B blasts at 48 hours. Fourth, is 
there a loss of a subset of B blasts with distinctive IRF4 expression that are about to 
undergo CSR? To try to answer the above questions B blasts were studied 48 hours 
after immunization as this is the time immediately before the point when most Blimp-
1+ plasmablasts or AID+, Bcl-6+, GC B cells emerge (Figure 3.18; Figure 3.19). 
A titration of NP-Ficoll was performed in QMxB6 mice and the GC and 
plasmablast responses were counted at 96 hours (Fig 4.1.A); this is the peak of the 
GC response to NP-Ficoll and is before they undergo involution (Garcia de Vinuesa, 
et al, 2000). The results obtained broadly confirm the findings of Garcia de Vinuesa, 
et al¸ 2000 – counts from immunohistology showed the spleen area occupied by NP+ 
GC and AFC decreased as the amount of NP-Ficoll was reduced (Fig. 4.1A). When 
immunized with 1g NP-Ficoll there was still an appreciable plasmablast response 
but very little in the way of GC in 2 of 3 mice (Fig 4.1A). The plasmablast response at 
this dose was more marked than can be deduced by counting the total number of 
AFC (Fig 4.1.B). The appreciable background number of AFC in non-immunized 
mice are predominantly Ki67 plasma cells, while the AFC in the mice immunized with 
1μg NP-Ficoll were Ki67+ plasmablasts (Fig 4.1.C and 4.2). This indicates that there 
was a definite plasmablast response even if this was smaller than that induced with 
30μg NP-Ficoll. The data from Garcia de Vinuesa, et al, (2000), show that no GC 
were formed in response to 1μg NP-Ficoll, however, our data do show that in 1 of 3 
mice small but definite GC formed. Importantly, as indicated in the previous section, 
in contrast to the response to 30g NP-Ficoll none of the plasmablasts from mice 96 















































































































































































































































Figure 4.1: Low dose NP-Ficoll produces an extrafollicular plasmablast response 
with minimal germinal centre formation or Ig class switching 
A. The 1g response to NP-Ficoll results in plasmablasts (open diamonds) but 
very few germinal centres (closed diamonds). B. Both the CD138+ and CD138 
populations expand in response to 1g NP-Ficoll (orange symbols) but less than 
that seen in the 30g response (blue symbols). C. The cells that stain for 
cytoplasmic NP are mostly Ki67 prior to immunization but are KI67+ 
plasmablasts at 96 hours after 1g NP-Ficoll. Photomicrographs showing this are 
presented in Figure 4.2. D. At 96 hours very little, if any class switching has 
occurred in response to 1g NP-Ficoll (orange diamonds) compared to 30g NP-

















Figure 4.2: Plasmablasts are present at 96 hours in response to 1g NP-Ficoll. 
A. In the non-immunized QMxB6 spleen the NP+ AFC present in the red pulp 
(RP) and these are mostly Ki67.  The majority of NP binding B cells are in the 
marginal zone (MZ). B. 96 hours after 1g NP-Ficoll there has been an increase 
in the plasmablasts in the red pulp and these are mostly Ki67+. NP+, Ki67+ cells 
have blue cytoplasm and a brown nucleus. NP+, Ki67- cells have blue cytoplasm 
and a clear nucleus. T = T zone/ PALS. IgD or Ki67 in brown and NP in blue.  
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4.1.1 The characteristics of the B blasts located in the T zone at 48 hours after 1g 
NP-Ficoll 
Forty eight hours after immunization with 1g NP-Ficoll NP+ B blasts were located at 
the boundary of the T zone and the follicle. These stain positive with the antibody 
Ki67, which binds to intercellular proteins expressed during replication, indicating cell 
division and, on the basis of analysis in serial sections, most of these expressed 
IRF4 protein, (Fig. 4.3, red boxes). As we observed NP+ plasmablasts at 96 hours in 
the response to 1g of NP-Ficoll and a small or absent GC response it would be 
expected that these B blasts are predominantly plasmablast precursors. 
Consequently these cells might be expected to show gene and protein expression 
patterns associated with the plasmablast differentiation pathway. For example, most 
of the B blasts after 1g NP-Ficoll might be expected to be IRF4high at the protein 
and/or mRNA level while those after 30g NP-Ficoll might be mixtures of IRF4high 
and IRF4low cells.  
There was an appreciable population of Ki67- IRF4-, NP+ cells present in the 
marginal zone at 48 hours. These are presumed to be non-responding cells; the 
smaller B blast response in the 1g as compared with the 30g response observed 
at this time is likely to reflect a reduction in cross linking of BCRs compared to the 
response to 30μg NP-Ficoll. The presence of a NP-binding, non proliferative 
population at 48 hours requires that the proportion of these cells should be 
determined before meaningful analysis of the FACS and RT2 PCR data can occur. 
The median number of NP-binding cells 48 hours after 1g NP-Ficoll was 
around 5 times greater than the median number prior to immunization (Fig 4.3B). 
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Figure 4.3: At 48 hours the 1g NP-Ficoll response induces B blasts at the T 
zone/follicular boundary. 
A. 48 hours after administration of 1g NP-Ficoll (right column) NP binding cells 
are seen at the boundary of the T zone (T) and follicle (F). A number of IRF4high, 
Ki67+ plasmablasts are seen in the red pulp (RP) and these are more numerous 
than those present prior to immunization (left column). The marginal zone (MZ) 
retains some NP binding cells in the immunized mice and these are IRF4neg. B. 
The number of both CD138 and CD138+ cells increases between 0 and 48 
hours. 
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as estimated by Hsu (2004) in her analysis of the response to 30g NP-Ficoll. This is 
consistent with the observed increase in the number of NP+ cells in the 30g 
response between 0 and 48 hours (Fig 4.3). If it is assumed that the same 
proliferation rate occurs following immunization with 1g NP-Ficoll it can be 
calculated that ~40% of the NP+ cells failed to respond and these amount to ~6% of 
the NP+ cells at 48 hours (the way this was calculated is set out in the methods).  
The relative proportion of AFC in the 30g as opposed to 1g response can 
best be deduced from the quantitative immunohistology reported in Fig 4.1A. This is 
because surface CD138 expression ceases to identify all AFC after 72 hours into the 
responses to NP-Ficoll. By comparing the median number of graticule intercepts 
(see methods) falling on cells expressing cytoplasmic anti-NP antibody it can be 
estimated that there are ~5 times as many AFC in the spleen at 96 hours in the 
higher NP-Ficoll response than at the same time in the lower-dose response. This 
contrasts with the number of CD138-, NPhigh B blasts at 48 hours, which is about 1.4 
times higher in the 30g response (Fig. 4.3.B). These data are consistent with the 
conclusion that some of the B blasts induced in the response to 1g NP-Ficoll at 48 
hours die without differentiating into plasmablasts. On the basis of the difference in 
the number of cells in both responses at 48 and 96 hours it can be estimated that 
some 70% of the B blasts present in the 1g response at 48 hours will die without 
becoming plasmablasts (the means used to make this calculation is set out in the 
methods). This conclusion has to be tentative as the number of observations in the 
immunohistology was only 3 spleens per group and there is large variation between 
mice in these small groups. Nevertheless it seems likely that a considerable number 
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of B blasts die by apoptosis without differentiating into plasmablasts in the lower 
dose response.  
4.1.1.1 The expression of B220 and IRF4 in relation to the activation state of NP+ 
blasts at 48 hours 
FACS analysis of NP+ B cells at 48 hours in response to 1μg compared to 
30g NP-Ficoll is shown in Fig 4.4. Most NP+ cells 48 hours after 1μg NP-Ficoll were 
B220high; in contrast to the 30μg only a tiny B220int population emerged. This implies 
that most of the plasmablasts that developed on the 3rd and 4th day of the 1μg 
response came from B220high rather than B220int NP+ B blasts. The size of the 
B220int population in the two responses is broadly proportional to the number of 
plasmablasts produced in the response. The data are consistent with the possibility 
that the B220int cells are plasmablast precursors, but provide no direct evidence to 
support this conclusion. It cannot be excluded that this population also includes cells 
that will form GC. The origin and role of the B220int, NP+, B blast population was 
discussed at the end of Chapter 3 and, in the light of its unimpressive size in the 1μg 
response, is considered further in the discussion to the present chapter. 
The expression of IRF4 protein by the NP+ cells at 48 hours after 1μg NP-
Ficoll was variable (Fig 4.4B). More than half the cells contained little or no IRF4 
protein. The majority of the other cells were IRF4int. The small fraction of IRF4high 
cells in the 1μg response was similar in size to the CD138+ population (Fig 4.4A) and 
may represent cells that have already differentiated into plasmablasts. Ki67+ NP+ 
cells with cytoplasmic staining characteristic of plasmablasts and strong IRF4 






























































































































































































































Figure 4.4: The B blast response to 1g NP-Ficoll consists of a large B220high, 
IRF4neg population 
A. FACS plots of lymphocytes gated on NP-PE binding and B220 expression. 
Plots are typical of the six mice observed. The responding cells are further gated 
to show CD138 expression. The responding NP+ cells are mostly B220high  with 
few B220int and CD138+ cells and comparison is made to non-immunized mice 
and those in the 30g response at 48 hours. B. The gating of NP+ B blasts IRF4 
expression is shown, the plot is typical of the six mice observed. The proportion 
of responding cells that are IRF4neg, IRF4int and IRF4high in non immunized 
QMxB6 mice and the 1g and 30g at 48 hours. The horizontal line indicates the 
percentage of cells that are not participating in the response (6%). 
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data support the concept that high IRF4 expression is a consequence of plasmablast 
development and not the initial cause. There are a number of possible reasons for 
there being fewer IRF4int and more IRF4low/neg NP+ cells in the 1μg response 
compared to the 30μg response. A minority of the IRF4 low/neg cells in the 1μg 
response can be accounted for as being non- responding NP+ cells. The previous 
section identified that a median of some 6% of the NP+ cells at 48 hours are non 
responders. After allowing for the non-responders there is still a larger proportion of 
IRF4low/neg among the NP+ cells in the 1μg response. As this response yields small or 
no GC it is not possible to link more than a small fraction of these IRF4 low/neg cells 
with GC formation. It could be that these IRF4low/neg cells are B blasts that received 
only a weak BCR signal with the low does of NP-Ficoll used. These IRF4low/neg B 
blasts might be the substantial population that dies without making the transition to 
plasmablasts. In order for B blasts to transition to plasmablasts additional signals are 
required. This was illustrated through studies of the response to NP-Ficoll in Btk-
deficient mice (Vinuesa, et al, 2001). This will be considered in the discussion to this 
chapter. There  was a small proportion of IRF4low/neg NP+ cells at 48 hours in the 
30g response. These might be one or a combination of the following: GC 
precursors, non-responding cells or cells that have received a low BCR signal and 
are destined to die without further differentiation. The data provide no direct evidence 
for or against any of these possibilities. 
As mentioned earlier IRF4 is necessary for CSR (Sciammas, et al, 2006). The 
lack of CSR induced by the 1g response where a substantial IRF4int population of B 
blasts is induced shows that low level expression of this protein by itself is not 
sufficient to induce CSR. In the next section the association between AID expression 
and switching is tested in the 1g response. 
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4.1.2 A lack of B blasts expressing AID mRNA in the response to 1ug NP-Ficoll is 
consistent with the observed lack of switching 
At 48 hours in the response to 30μg NP-Ficoll a population of Bcl6- AID+ cells 
was observed (Fig 3.18).  Under these conditions we also observed 3 switched 
transcripts, i.e. processed transcripts of I rearranged to C 3, in some NP
+ cells (Fig 
3.1.B). After 72 hours we also observed the appearance of AFC with cytoplasmic 
IgG3 (Figures 3.13 & 3.14). In the response to 1μg NP-Ficoll none of the 252 B blasts 
collected at 48 hours from 2 of 3 mice expressed AID, but in the third mouse 3/159 B 
blasts (2 B220high and 1 B220int) contained AID mRNA. This low proportion of the 
NP+ B blasts that express AID mRNA 48 hours after 1g NP-Ficoll is consistent with 
the paucity of switched cells observed at 96 hours (Fig. 4.5.B). As mentioned, low 
expression of IRF4 has been associated with CSR in B cells (Sciammas, et al, 
2006). That there is intermediate expression of IRF4 in 25-45% of B blasts at 48 
hours indicates that this level of IRF4 expression by responding cells is not sufficient 
to drive AID expression in the vast majority of these blasts. This is consistent with 
data from the response to 30μg NP-Ficoll that shows no correlation between IRF4 
expression and AID mRNA levels in 48 hour B blasts (Fig 3.25).  
4.1.3. Why do more 48 hour NP+ cells express Bcl6 mRNA in the 1μg than the 30g 
response? 
The proportion of cells that express Bcl6 mRNA is higher than that observed 
in response in the 30μg response (Fig 4.5.A). The median number of NP+ cells 
expressing Bcl6 mRNA at 48 hours in response to 1μg is ~19% whilst in the 30μg 
response it’s ~6%. The non responding cells, which comprise ~6% of the NP+ cells 
at 48 hours, can only account for about 1/3rd of these cells. Also, it is unlikely that the 
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Figure 4.5: Single cell RT2-PCR analysis of NP+ cells shows low AID expression 
at 48 hours that correlates with reduced class switching at 96 hours. 
A. The response to 1g NP-Ficoll shows low expression of AID and Blimp1 but 
high Bcl6 expression in comparison to the 30g response. The percentage of 
cells expressing the genes either singly or together is shown. CD138+ cells are 
blue, B220high cells red and B220 intermediate cells are white. B. The lack of 
class switch recombination at 96 hours is perhaps a result of the lack of AID 
expression. The number of switched cells at 96 hours is shown for the 1g 
(orange diamonds) and 30g NP-Ficoll response (blue diamonds). 
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Bcl6+ cells in the B220int population are non-responders as the B220int cells only 
emerge after immunization. It seems plausible that the responding B220high 
population might include those cells recruited into the response that disappear, 
probably by undergoing apoptosis, without differentiating into plasmablasts or GC 
blasts. Bcl6 mRNA expression was also seen in 3-12% of the CD138+ NP+ cells 48 
hours after 1g NP-Ficoll. This finding suggests that downregulation of Bcl6 is a 
consequence of commitment to plasmablast differentiation and not the cause. 
Importantly, no Bcl6 mRNA expressing CD138+ plasmablasts were found to co-
express Blimp1. Although Blimp1 and Bcl6 proteins have been shown to down-
regulate the expression of each other (Reljic, et al, 2000; Tunyaplin, et al, 2004; 
Shaffer, et al, 2002) in this situation Bcl-6 mRNA levels fall without the influence of 
Blimp1. These finding indicate a clear order of maturation during plasmablast 
formation in the response to 1g NP-Ficoll. CD138 is first up-regulated; this is 
followed by down regulation of Bcl-6 mRNA in those cells expressing this message; 
only after these first two stages are completed is Blimp1 mRNA up-regulated. 
4.1.4 Probing the relationship of high level IRF4 expression to plasmablast 
development 
On the basis of immunohistology, flow cytometry and RT2-PCR there is a 
consistent finding that AFC express high levels of IRF4. This section probes the 
temporal relationship between the upregulation of IRF4 protein and/or IRF4 mRNA 
and the transition from B blast to plasmablast. Flow cytometric dot plots of 48 hour 
NP+ cells both from the 1 and 30g responses shows that in 5 of 9 mice more cells 
expressed high levels of IRF4 protein than expressed surface CD138 (Fig 4.6A). In 
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Figure 4.6: Expression of IRF4 precedes CD138 expression at 48 hours 
A. The percentage of NP+ cells that express CD138 and IRF4 at 48 hours in 
response to 30g (blue diamonds) or 1g (orange diamonds) NP-Ficoll. It would 
appear that IRF4 is expressed prior to CD138 protein. B. CD138+ cells in the 
response to both 1g and 30g NP-Ficoll show high expression of IRF4 mRNA. 
D. CD138- cells in the response to 30g NP-Ficoll show a proportion of cells that 
are in the same range as CD138+ cells (indicated by the green rectangle). C. 
CD138 cells in the response to 1g NP-Ficoll shows very few of these IRF4high 
cells. The number of cells that express IRF4 mRNA at the indicated Ct is 
indicated in each graph. 
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expression was low. Thus while IRF4 protein is up-regulated from intermediate to 
high levels before CD138 in many cells this is not always the case. When the 
number of CD138+ cells is higher than the number of IRF4+ cells might this be due to 
numerous background plasma cells? This is unlikely; CD138 expression is lost as 
AFC mature and Ki67 negative plasmablasts, mature plasma cells, remain IRF4 
high.  
Among CD138+ NP+ cells at 48 hours after either 1 or 30 g NP-Ficoll there is 
a broadly normal distribution of IRF4 mRNA expression (Fig 4.6B). This figure boxes 
the peak of the distribution of IRF4 mRNA levels (green rectangle). As was 
described in the previous chapter a small proportion of NP+ CD138- B blasts at 48 
hours after 30g NP-Ficoll have this high level of IRF4 mRNA. When the 1g 
response is studied in this way almost no NP+ CD138- B blasts were found that had 
this high level of IRF4 mRNA. Taken together these data show that while IFR4 
mRNA may be upregulated to high levels in B blasts before they differentiate into 
plasmablasts this is not always the case. The data seem to support a tentative 
conclusion that high level IRF4 protein expression is not essential for the production 
of CD138+, Blimp1+ Ki67+ plasmablasts. On the other hand it seems likely that most 
if not all cells that differentiate into plasmablasts express at least intermediate levels 
of IRF4 protein before making the transition to plasmablast.  
4.1.5. Why is there a reduction in the B220 int population in response to 1μg NP-
Ficoll? 
Compared to the response to 30μg NP-Ficoll the proportion of B220int cells in 
the response to 1μg NP-Ficoll is greatly reduced (Fig 4.4). This, coupled with the 
high Bcl6 mRNA expression observed in this population (Fig 4.5) calls into question 
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the origins of these cells. There seem two possible explanations for this that are 
based on whether the B220int cells are derived from cells that were B220high at the 
time of immunization, or are cells were that were B220 int ab initio. The second 
possibility requires there to be a B220int NP+ population outside the spleen, for 
essentially all the NP+ cells in the spleen from naïve QMxB6 mice are B220high. The 
most obvious B200int B cell population are B1 cells. In support of this a strong B1b 
cell response to NP-Ficoll is well documented (Hsu, et al, 2004). However, reports of 
such responses by QM B cells have not been published. The two possibilities 
suggested are not mutually exclusive and require further study. In either case the 
relatively small production of B220int B blasts after 1g NP-Ficoll seems likely to be 
the consequence of a weaker BCR signal induced by this low dose of antigen.  
4.1.6. Discussion 
4.1.6.1. What role does antigen signalling play in the development of B blasts to 
plasmablasts? 
Calculations of the number of cells that respond to 1μg NP-Ficoll suggest that 
two thirds of the NP-binding cells in the spleen participate in the response. However, 
at 48 hours post immunization a number of the NP-binding cells express levels of 
B220 and IRF4 protein that are similar to those seen prior to immunization (Fig4.4A 
and B). Plasmablasts do form but they are much reduced compared to that observed 
in the 30μg response, indeed, the numbers only slightly increase between 48 and 96 
hours (Fig 4.1B). It would appear that the majority of the cells that move and 
proliferate in response to antigen undergo apoptosis or exit the response. In the 
response to NP-Ficoll, B cells specific for NP but deficient in btk (a protein kinase 
downstream of the BCR), proliferate and migrate to the T zone but do not 
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differentiate into plasmablasts (Vinuesa¸ et al, 2001). This deficiency is over come 
through the use of anti CD40 treatment which provides a secondary signal to 
stimulate further proliferation and development. This data and the observed effect of 
the amount of antigen and responding precursors on the formation of GC and 
plasmablasts in response to NP-Ficoll (Garcia de Vinuesa, et al, 2000; Fig 4.1) 
highlight the importance of a strong BCR signal on B cell differentiation and also the 
ability of secondary signals, intrinsic or external, to affect the outcome of the 
response.   
The absence of CSR and AID expression in this response may be due to poor 
signalling from the BCR. Indeed, it has been reported that in vitro CSR is an intrinsic 
event and related to proliferation of the responding cell (Deenick, et al, 1999). In the 
response to 1μg NP-Ficoll the cells proliferate but appear to exit the response and 
this may indeed be consistent with this finding. However, there have also been a 
number of studies that emphasise the role of accessory cells and the milieu on CSR 
in the T independent response (Xu, et al, 2008; Litinkskiy, et al, 2002; Xu, et al, 
2007; Gao, et al, 2008). These cells act either in response to factors secreted by 
activated B cells, or by the antigen itself. As such, reduced antigen affects not just 
the B cells, but also the environment that might otherwise progress the response. 
This study did not provide separation of both factors but they are not mutually 
exclusive.  
4.1.6.2 What role does IRF4 play in the response to antigen? 
Studies of the role of IRF4 in conditional knock out mice, and protein 
expression during a normal response have indicated that IRF4 is necessary for CSR 
and the differentiation of B blasts into plasma cells (Klein, et al, 2006; Sciammas, et 
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al, 2006; Falini, et al, 2000). Although IRF4 is certainly necessary for these 
processes to occur, the response to 1μg NP-Ficoll indicates that expression of IRF4 
is not sufficient for either CSR or plasmablast differentiation. Indeed, whilst CSR is 
associated with B cells that express intermediate levels of IRF4 it clearly not 
causative as intermediate levels were observed in responding NP+ cells without any 
substantial AID expression.  
Low levels of IRF4 are associated with GC (Falini, et al, 2000) and IRF4neg 
cells are observed within GC in response to 30μg NP-Ficoll (Fig. 3.19). However, the 
large proportion of IRF4neg  cells at 48 hours in the 1μg response, in which few GC 
are formed and many cells cease to participate, suggests that not all the IRF4neg 
cells in the 30μg response hours go on to found GC.  
4.1.6.3 What is the role and origin of the B220 intpopulation in the response to NP-
Ficoll? 
Whilst B220int cells made up around 40% of the responding cells at 48 hours 
in response to 30μg NP-Ficoll the B220int population is greatly reduced in the 
response to 1μg (Fig 4.4). Intermediate expression of B220 is associated with 
memory B cells, B1 cells and B cell differentiation to antigen (Section 3.6.4). In the 
response to 30μg NP-Ficoll none of these possibilities could be ruled out. The main 
clue as to the origins of the B220int population perhaps lies in their expression of Bcl6 
mRNA. In both the 30μg and 1μg responses the B220high and intermediate 
populations expressed identical levels of Bcl6 and AID mRNA at 48 hours (Fig. 4.5). 
It would appear reasonable to suggest that they are behaving in a similar fashion. Is 
this because B220int cells are derived from B220high precursors and down regulate 
B220 in a stochastic fashion, or, if the B220int population is derived from B1 cells, 
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they react to antigen in the same way as the splenic MZ cells, or both? B1 cells are 
reported to have lower levels of Bcl6 expression and are quicker to express Blimp1 
(Fairfax, et al, 2007) than B2 cells. Indeed, a peak in Blimp1 expression is seen at 18 
hours after administration of NP-Ficoll (Vinuesa, et al, 2001). Perhaps, in the 
absence of a strong antigenic stimulus, the involvement of B1 cells is restricted to 
form the plasmablasts population observed at 48 hours. Greater availability of 
antigen and BCR cross linking in the 30μg response allows the response to progress 
and the involvement of B1 cells, or differentiation of splenic B cells, to occur and 
expand.  
4.2. If there is a higher proportion of switched AFC at 96 hours is this reflected 
in a higher proportion of B blasts expressing AID at 48 hours after 
immunization? 
Class switching was observed in the response to 30g NP-Ficoll at 48 hours 
in ~10% of the responding CD138- cells. As this was co-incident with the detection of 
switched transcripts to IgG3 it was concluded that it is likely that there was a 
functional association between the AID expression and CSR. The response to 1g 
NP-Ficoll in QMxB6 almost eliminated class switching and very little or no AID 
expression was observed. To provide further evidence for the role of AID in CSR in 
the early plasmablast response a model was set up where the proportion of cells 
responding to NP-Ficoll that undergoing CSR is increased. Polyinosinic:polycytidylic 
acid (poly I:C) has been shown to act as potentiator of class switching when given at 
the time of immunization (Le Bon, et al, 2001). It was thought that co-immunization 
with poly I:C and 30g NP-Ficoll might increase class switching compared to the 
original response to 30g NP-Ficoll alone, thereby providing a means to see if a 
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higher proportion of cells switching is associated with an increased proportion of B 
blasts expressing AID. 
4.2.1. Co-immunization with poly I:C and NP-Ficoll increases the proportion of 
switched AFC 
The response of the QMxB6 mice to 30μg NP-Ficoll alone or with poly I:C 
looked similar at 48 hours after immunization (Fig 4.7, top row). Both have large 
numbers of NP+ B blasts in the T zone and MZ with a similar number of plasmablasts 
in the red pulp. At this stage there is no GC formation in either response. At 96 hours 
after immunization both the response to NP-Ficoll alone and that with poly I:C 
produced large NP-specific GC and red pulp plasmablasts (Fig 4.7, bottom row). The 
size of the GC is comparable in the two groups (Fig 4.8A). By contrast the mice 
given poly I:C with NP-Ficoll had significantly fewer plasmablasts at 96 hours (Fig 
4.7 bottom row and 4.8A). T cell independent responses typically result in a crash in 
plasmablast numbers as the supporting cells in red pulp are overloaded (Garcia de 
Vinuesa, et al, 1999). The decline in plasmablasts at 96 hours might indicate that in 
the co-immunized response this crash in plasmablast number is advanced compared 
to the response induced by NP-Ficoll alone. 
A comparison of the number of cells switched to IgG3 and IgG1 at 48 and 96 
hours shows that co-immunization with poly I:C and NP-Ficoll induces greater CSR 
than immunization with 30μg NP-Ficoll alone (Fig 4.8B). Of particular interest is that 
NP+ cells expressing IgG3 protein are observed at 48 hours in the mice given poly 
I:C with NP-Ficoll. Thus the poly I:C given with NP-Ficoll not only increases the 
proportion of cells undergoing CSR but induces CSR at an earlier time than when 

























Figure 4.7: Co-immunization with 30g NP-Ficoll and 10g poly I:C induces 
germinal centre, plasmablasts and a larger switched response. 
The response to NP-Ficoll with poly I:C (right hand photomicrographs) is similar 
to that of NP-Ficoll alone (left) at 48 hours with NP binding cells are seen in 
throughout the T zone (T) and marginal zone with some NP+ cells located 
among the brown-stained IgD+ B cells in the follicle (F). Plasmablasts are 
induced in both instances in the red pulp (RP) and at extrafollicular sites but by 
96 hours there appear to be fewer NP-specific AFC in the mice given poly I:C 
with NP-Ficoll. Germinal centres (GC) are present in both groups at 96 hours and 
appear to be of comparable size. Quantification of the extent of the germinal 

























































































































































































































Figure 4.8: The germinal centre and plasmablast response to 30g NP-Ficoll 
with polyi:c or alone in QMxB6 mice 
A. The proportion of spleen area occupied by NP+ germinal centres in the 
response to 30g NP-Ficoll with, or without poly I:C is similar at both 48 and 
96 hours, while the proportion of the spleen occupied by plasmablasts as 
assessed by strong cytoplasmic NP binding is reduced in mice given poly I:C 
with NP-Ficoll. Co-immunization is indicated by purple diamonds, 30g NP-
Ficoll alone by blue diamonds. B. When poly I:C is given with NP-Ficoll a 




4.2.1.1 FACS analysis shows that mice given poly I:C with NP-Ficoll have more 
plasmablasts at 48 hours than mice given NP-Ficoll alone 
Flow cytometric analysis shows that the number of CD138+ NP+ cells 48 
hours post immunization is significantly greater when poly I:C is added with 30μg 
NP-Ficoll (Fig 4.9A, right hand graph). The number of CD138- NP+ 
48 hours is similar in the groups of mice. The proportion of B220 int NP+ cells at this 
time is smaller when poly I:C is added with 30μg NP-Ficoll and the proportion of 
B220high NP+ cells is increased (Fig. 4.9A).  
The number of NP+ cells that are IRF4high 48 hours is greater when poly I:C is 
added with 30μg NP-Ficoll (Fig 4.9B). The increased number of IRF4high and CD138+ 
cells at 48 hours in the group that received poly I:C indicates the AFC response has 
been slightly advanced compared to that in the mice given NP-Ficoll only. The 
increased number of plasmablasts induced by 48 hours when poly I:C is added with 
NP-Ficoll is consistent with poly I:C causing one or a combination of the following: i) 
increasing the number of B cells recruited into the response, ii) accelerating the 
process of B blast differentiation into plasmablasts, iii) increasing the rate of 
proliferation of the responding cells, iv) reducing apoptosis among the responding 
cells. That the number of CD138+ cells at 48 hours is the same in response to both 
NP-Ficoll alone and with poly I:C suggests that this increase in proliferation was not 
universal. In addition, no acceleration of GC response was seen. Poly I:C is a know 
inducer of type 1 interferons and these have been shown to reduce apoptosis of CD4 
T cells in inflammatory responses (Scheel-Toellner, et al, 1999). 
The FACS data also show another key difference between the co-immunized 
and NP-Ficoll alone response. As in the response to 1g NP-Ficoll (section 4.1.5) 
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Figure 4.9: The co-immunized response has an advanced plasmablast response 
compared to 30g NP-Ficoll alone.  
A. The proportions of NP responding cells that are CD138+, B220high CD138- and 
B220int CD138- in the response to 30g NP-Ficoll and 30g NP-Ficoll with poly 
I:C. The addition of poly I:C results in the production of a significantly greater 
number of NP+, CD138+ cells at 48 hours although the number of  NP+ CD138 
cells is similar. B. The effect of co-immunization of poly I:C with NP-Ficoll to the 
expression of IRF4 by NP+ cells 48 hours post immunizations. The FACS dot 
plots and histogram show data for a mouse that had received poly I:C with NP-
Ficoll. The gates used to quantify high, intermediate and low IRF4 expression are 
shown in the FACS dot plots. There are significantly more IRF4Hi NP+ cells in the 
poly I:C group at 48 hours. 
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there is a dramatically reduced B220int population at 48 hours (Fig 4.10A). Further 
studies are required to determine if the co-immunized response reduces or prevents 
the recruitment of B220int B1b cells, or reduces the differentiation of B220high cells 
recruited into the response into B220int, CD138- cells. In this response with high dose 
NP-Ficoll it is unlikely that there is a significant number of non-responding NP+ cells. 
These points are discussed further in section 4.3.2.  
 There appears to be a reduction in the number of cells that express 
intermediate levels of IRF4 at 48 hours when poly I:C is given with NP-Ficoll (Fig 
4.9B). This may be due to the early differentiation IRF4 int cells into IRF4high cells, for 
the total proportion of cells expressing IRF4 protein is not significantly different 
between the two groups. The similar proportion of IRF4 low/neg cells in both groups at 
48 hours is consistent with the concept that this population of B blasts in responses 
to high-dose 30μg NP-Ficoll are destined to differentiate into GC cells; for as is 
shown in Fig 4.8A the GC response is of similar magnitude in the two groups.  
4.2.2. Co-immunization increases the amount of switching without an increase in AID 
expression at 48 hours 
As described above and shown in Fig 4.8 poly I:C added with NP-Ficoll 
resulted in a doubling of the median number of AFC that were producing IgG3 at 96 
hours (Inset, Fig 4.10). It was therefore surprising to find that the proportion of B 
blasts expressing AID at 48 hours, as assessed by RT2-PCR, was much smaller 
when poly I:C had been added to NP-Ficoll (Fig 4.10). Thus in the poly I:C group of 
280 B blasts were 12 expressed AID, while in the group receiving NP-Ficoll only of 
700 B blasts analyzed 83 were AID+; this difference is significant p<0.0003 (two 
sided Chi square test). 
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Figure 4.10: Single cell RT2-PCR on NP-Ficoll and polyI:C co-immunized NP+ 
cells at 48 hours shows lower AID expression than that seen in response to 
30gNP-Ficoll alone. 
The expression of Blimp1 and AID+ with BCl6+ is similar in the co-immunized 
and NP-Ficoll responses whilst there is a greater proportion of Bcl6 expression in 
co-immunized cells and less AID expression. The percentage of cells expressing 
the genes either singly or together as shown. CD138+ cells are blue diamonds, 
B220high cells red diamonds, B220int cells are white diamonds. Inset shows 
switching at 48 hours in both responses. 
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4.2.3. Expression of Bcl6 at 48 hours is greater than that observed in the response to 
NP-Ficoll alone 
The response of the QMxB6 mouse to 1g and 30g NP-Ficoll showed that 
Bcl6 mRNA expression does not exclude cells from the AFC pathway, and is 
therefore not a certain marker of GC cell commitment. This experiment was not 
expected to address the role of Bcl6 in the B cell response to antigen, however, a 
higher level of Bcl6 expression was seen in the CD138- cells 48 hours post 
immunization than in the response to 30g NP-Ficoll (Fig 4.10). This proportion is 
coincident with the slightly increased IRF4low/neg population seen at this time (Fig 4.9) 
although that may be co-incidental. The increased proportion of Bcl6+ cells is not 
associated with the induction of larger GC in the mice immunized with NP-Ficoll plus 
poly I:C, making it unlikely that the excess Bcl6+ cells were destined to becoming GC 
cells. GC formation was not accelerated as no NP+ cells co-expressing AID and Bcl6 
mRNA were seen at 48 hours (Fig 4.10). As 30g NP-Ficoll were given it is unlikely 
that the increased proportion of Bcl6+ cells among NP+ cells at 48 hours is 
attributable to non-responding cells. The role of Bcl6 mRNA in all three models is 
discussed in Section 4.3.2. 
4.2.4 None of the CD138 population in response to co-immunization expresses Bcl6 
As in the other responses studied, the response to poly I:C with 30g NP-
Ficoll induced Blimp1 expression solely in CD138+ cells. In the 30g and 1g NP-
Ficoll responses without added poly I:C a small proportion of Bcl6+ cells were seen 
at 48 hours in the small NP+ CD138+ population in some mice (Fig 4.5.A). By 
contrast, neither of the mice given co-immunized with poly I:C and NP-Ficoll 
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analyzed by single cell RT2-PCR had any Bcl-6+ cells in the CD138+ fraction. If, as 
suggested by earlier data (Section 3.6.2), CD138 is upregulated prior to expression 
of Blimp1 and downregulation of Bcl6, this furthers the suggestion co-immunization 
advances the plasmablast response.  
4.3 Discussion 
4.3.2. The effect of TLR co-stimulation on class switch recombination and 
plasmablast proliferation. 
Co-immunized QMxB6 mice showed a population of IgG3 positive cells at 48 
hours prior to their appearance in response to NP-Ficoll alone. In addition, there 
were greater numbers of both IgG3 and IgG1 cells in the co-immunized response at 
96 hours (Fig. 4.9A). For CSR to have occurred at 48 hours AID must have been 
expressed during the first day, unless the switching in this situation followed a novel 
and highly iconoclastic AID-independent switching process. In future experiments it 
will be necessary to look for AID expression during the second day of this response. 
AID independent ssDNA break events that have been reported (Arudchandran, et al, 
2008). Perhaps these are responsible for the low expression of AID mRNA.  
Although this does provide an alternative, or complimentary, means to achieve CSR 
the most prudent experiment would be the investigation of earlier time points during 
the co-immunized response.  
There was an increased proportion and number of plasmablasts at 48 hours 
in the co-immunized response compared to that induced by NP-Ficoll alone without 
an obvious overall increase in the number of responding cells (Fig 4.10). This 
favours earlier differentiation to plasmablasts or a higher proportion of cells 
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committing to becoming plasmablasts or a combination of these. Theoretically there 
might also have been selective increased proliferation in the plasmablast precursors. 
These possibilities could be investigated further, but this was not considered a 
priority in the present programme. This especially applied as the results with the 1g 
NP-Ficoll response show that AID is not expressed in 48 hour B blasts in a response 
that is not associated with switching.  
The role of poly I:C has on plasmablasts and proliferation of B blasts has 
been the subject of a number of studies. Poly I:C binds TLR3 (Alexopoulou, et al, 
2001) and in doing so increases -IFN secretion by macrophages and splenocytes 
(Field, et al, 1967; Gisler, et al, 1974; Alexopoulou, et al, 2001, Le Bon, et al, 2001). 
In a similar fashion human tonsil B cells stimulated with poly I:C and IL-10 undergo 
proliferation and are induced to express AID in a T cell independent manner. This is 
accentuated by BAFF, which is released by DC after poly I:C exposure (Xu, et al, 
2008). In the present study the effect of poly I:C on the spleen may have increase 
the external signals provided by the milieu as well as increasing the cell autonomous 
switch signals. Alternatively proliferation in switched plasmablast precursors may 
provide the increased numbers. Perhaps BAFF, important for plasmablast survival 
(Balazs, et al, 2002), is induced by poly I:C and increases retention of switched 
plasmablasts. Both suggestions could be validated through RT2-PCR at earlier time 
points in the response, with the effect of poly I:C on proliferation (through CFSE 
studies) or quantification of BAFFR and BAFF expression paid particular attention. 
4.3.3. What role does Bcl6 play in the co-immunized response? 
In comparison to the 30g NP-Ficoll response both the 1g and co-
immunized responses had high levels of Bcl6 at 48 hours (Fig. 4.5 and 4.11). In the 
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co-immunization response, the finding of an increased proportion of cells expressing 
Bcl6 mRNA in CD138- cells was not anticipated and is not easily explained. This may 
well be due to delay in the down-regulation of Bcl6 mRNA expressed by about half 
the splenic B cells in QMxB6 mice, rather than de-novo expression of the mRNA. 
Cells expressing Bcl6 protein could not be identified using immunohistochemistry at 
this stage, indicating that this mRNA expressed in the 48 hour B blasts, as in pre-
immunization B cells is not being translated. The receptor for poly I:C, TLR3, is 
present on B1and MZ B cells at high levels and lower levels on recirculating B cells 
(Barr, et al, 2007). As the B cells responding to NP-Ficoll with poly I:C are likely to be 
B1 and MZ B cells it seems reasonable to conclude that any signaling through TLR3 
is contributing to the delay in down-regulation of Bcl-6. Fairfax, et al, (2007) reported 
that peritoneal B1 and splenic MZ cells constitutively express less Bcl6 mRNA than 
splenic B2 cells. At least a proportion of the NP+ cells in the spleen of QMxB6 mice 
must express Bcl6 mRNA, as there are more NP+ cells with Bcl6 mRNA than there 
are NP+ recirculating B cells in these mice.  
4.3.4. The low proportion of B200int NP+ B blasts at 48 hours in the combined 
response 
The markedly low proportion of B220int cells in the response to 30g NP-Ficoll 
with poly I:C compared to the high proportion of these cells induced with 30g NP-
Ficoll alone is intriguing and deserves further study. Does this reflect a negative 
effect of poly I:C on the recruitment of B1b cells from the peritoneal cavity into the 
splenic response? Indirect evidence against the B220int population being B1b cells 
has already been discussed in Chapter 3. It might be possible to study the role of 
B1b cells by passive transfer of genetically-tagged NP-specific B1b cells into QMxB6 
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mice and looking to see if there is differential recruitment in the response to NP-Ficoll 





B blasts in a germinal centre-biased response 
5.1 The development of a germinal centre-biased B cell response model 
The aim of this chapter has been to study the origin, locations and 
phenotypes of B blasts that are destined to differentiate into germinal centre (GC) B 
cells. The model used in these experiments was developed in the following way: 
large GC are formed in rodents primed with alum-precipitated carrier protein given 
with killed B. pertussis and subsequently challenged with soluble hapenated carrier 
(Liu, et al, 1991; Toellner, et al, 1996). These GC form in a synchronized manner, 
are hapten-specific, and reach peak size by 96 hours after immunization. These 
predictable features of the response have made this an ideal system to analyze the 
kinetics of GC formation (Liu, et al, 1991; Toellner, et al, 1996). In wild-type mice this 
carrier primed response also produces a large synchronized and predictable 
extrafollicular antibody response (Toellner, et al, 1996; Sze, et al, 2000). 
Serendipitously, pilot experiments found that if Quasi Monoclonal (QM) B cells are 
transferred into carrier primed mice that are then immunized with soluble hapten 
protein the response is highly biased toward GC formation and extrafollicular 
responses are only small and erratic. This protocol provides a model to study a 
response where most of the B blasts are destined to form GC. 
The GC-biased response was an adaptation of the carrier primed response 
model was used (Toellner, et al, 2002). Wild type mice are immunised with alum-
precipitated chicken gamma globulin (CGG) with killed B. pertussis and left for 5 
weeks. Congenic QM B cells, which are >60% NP-specific (Cascallo, et al, 1996), 
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are transferred into these mice and 24 hours later they are challenged with intra 
peritoneal (i.p.) soluble NP-CGG. 
The carrier primed, GC biased T cell dependent (TD) response allowed the 
following questions to be addressed: 
 
i. As a high proportion of the NP-specific B blasts become GC, how does this 
affect the phenotype of B blasts 48 hours after challenge with hapten carrier? 
ii. Does the GC bias affect the proportion of cells that express low and high 
levels of IRF4 protein? 
iii. Is AID mRNA expressed in the absence of Bcl6 mRNA in a response that 
is TD and if so does this relate to the proportion of GC with switched NP-
specific B cells? 
iv. Does reducing the number of responding cells affect the outcome of the 
response? 
 
The QMxB6 response to 30μg NP-Ficoll showed that NP+ B cells migrate to 
the T zone shortly after immunization and then proliferate to fill the T zone and 
overspill into the marginal zone (Section 3.1.2). By 72 hours the NP-binding cells 
have also formed GC and plasmablasts are present in the red pulp (Section 3.1.3). 
This model does not provide a reliable control for the carrier primed response as the 
number of responding cells is much lower when QM cells are transferred into primed 
C57Bl6 mice. Consequently some carrier primed mice that had received a transfer of 
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QM B cells were immunized with 30g NP-Ficoll. This also allows assessment of 
how the response to NP-Ficoll is affected by having a markedly smaller number of 
responding B cells. 
5.1 The carrier primed response to NP-CGG is biased towards germinal 
centres with few plasmablasts. 
As described above C57Bl6 mice were primed with 30g alum-precipitated 
CGG with 5x108 heat-killed B. pertussis i.p. Five weeks later the mice received 
between 5x105 and 2x106 NP-specific cells contained in QM x QM splenocyte 
suspensions. The affect of number of cells transferred is discussed in section 5.7.2. 
These chimeras were then challenged i.p. with 50g soluble NP-CGG. Seventy two 
hours after this challenge immunohistochemistry on the chimeras’ spleens shows 
NP-binding cells have begun to enter GC (Fig. 5.1A and B). In most GC the NP-
specific cells are located around the edge of preformed GC, but some GC are 
already filled with NP-specific cells. The GC at this stage contain few if any CGG-
specific cells (Fig 5.1C & 5.2C). In addition to the NP-specific blasts in GC there are 
still many NP binding cells located in the follicular mantle (Figure 5.1A). These 
follicular mantle NP+ cells are Ki67+ (Fig 5.1B) but most do not express Bcl6 protein. 
This contrasts with the cells in the GC, which, as expected, express Bcl6 (Fig 5.1C). 
The size of the NP+ GC at 72 hours are quantified in Fig 5.2 A. In 4 of 6 mice there 
were some NP+ plasmablasts located in extrafollicular foci at the boundary of the T 
zone and the red pulp; the remaining 2 mice had few if any NP+ plasmablasts. The 
relative paucity of NP+ plasmablasts compared with NP+ GC is quantified in Fig. 5.2 
A&B. Whilst the carrier primed NP+ GC cover a fifth of the area of those produced 





























Figure 5.1: The carrier primed response to NP-CGG is biased towards NP+ 
germinal centres. 
A and B. 72 hours after immunization with NP-CGG, NP binding cells are found 
in germinal centres (GC). However, NP binding cells are still found in the outer 
half of the follicle (F) and some appear to have entered the marginal zone. C. 
The response to CGG is characterised by extrafollicular foci of plasmablasts. 




































































































































































































































































































Figure 5.2: The NP+ carrier primed response to NP-CGG is predominantly 
germinal centre biased although some early plasmablasts are induced. 
A. NP binding cells (green diamonds) appear in germinal centres on the third day 
after challenge with NP-CGG. B. The proportion of plasmablasts induced by the 
response to NP-CGG is small compared to the 30g NP-Ficoll response in 
QMxB6 mice. C. The B cell response to CCG produces no germinal centres. D. 
The response to CGG is plasmablast based. 
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cells at 72 hours is 50 times smaller than the number of NP+ cells in the QMxB6 
response to 30μg NP-Ficoll at the same time (data not shown). By contrast, the 
memory CGG-specific response to NP-CGG is associated with the formation of 
extrafollicular plasmablasts (Fig. 5.2D) without GC formation (Fig. 5.2 C). This is very 
similar to the CGG response to NP-CGG in carrier primed C57Bl6 mice that have not 
received QM B cells (Toellner, et al, 1996). 
5.2 NP-CGG induces NP-specific B cells to migrate to follicles and associate 
with follicular T cells in CGG-primed mice that have received QM B cells 
Twenty four hours after immunization with NP-CGG the responding NP-
binding cells were characteristically seen clustered at the corners of the follicles 
nearest the area where the T zone abuts the red pulp (Fig 5.3). In addition, some 
were dotted within the follicle. Only occasional NP-binding cells were seen at the 
boundary between the base of the follicle and the T zone. The significance of the 
clustering of responding B cells at the corner of follicles was investigated by looking 
to see if these cells were associated with follicular T cells. In naïve mice there are 
very few follicular T cells, but a subset of responding CD4 T cells start to colonise 
follicles 72 hours after primary immunization and within 24 hours of secondary 
immunization (Gulbranson-Judge and MacLennan, 1996; Serre, et al, 2009). Figure 
5.4A identifies a cluster of NP-binding cells located among IgD+ follicular B cells 24 
hours after primed mice had been challenged with NP-CGG. Most of these NP-
binding cells are Ki67 positive. It can be seen that some, but not all of NP-binding 
cells are close to, or directly in contact with, CD3 positive cells (Fig 5.4B). There 
appears to be follicular commitment of these responding NP-binding cells for they 
have colonized the whole of the outer proportion of the follicles by 48 hours (Fig  
 135 



















Figure 5.3: NP binding cells appear at the edge of the follicle at the border with 
the T zone 24 hours after immunization with NP-CGG.  
Whilst some NP+ cells are seen in  the follicle (F), there is a trend for NP binding 
cells to be located at the end of the follicle at the border of the T zone (T) and the 
red pulp (RP).  These are indicated by an asterix (*). GC= background germinal 
centre. Staining as indicated. 
 
 136 














24 hrs NP IgD
Figure 5.4: NP binding cells are Ki67 and some 
are associated with CD3 T cells at the boundary of 
the T zone and the red pulp. 
A. At 24 hours most not all the NP binding cells at 
24 hours are Ki67 positive. B. In addition many of 
the NP binding cells are located adjacent to T 
cells. T = T zone, F = follicle, RP = red pulp, 
staining as indicated. 
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5.5A). At this stage the majority (median 71% range 59-81%) are in contact with 
follicular T cells (Fig 5.5C). As these studies used a two dimensional histological 
slide it could be assumed that some of the non-associated cells may make contact 
with T cells above or below the plane observed and so this may be an 
underestimate. The follicular distribution of the responding NP+ B cells contrasts 
strikingly with that observed in QMxB6 response to NP-Ficoll, where the responding 
B cells translocate to the border between the base of follicles and the T zone 
(described in chapter 3). This difference still applies when the response of carrier 
primed chimeras to NP-Ficoll was studied (Fig. 5.5B). There is a highly significant 
difference between the location of NP-binding cells 48 hours after immunizing these 
chimeras with NP-Ficoll compared with NP-CGG (Fig 5.5D).  
This co-location of B blasts and T cells in follicles early in the response of 
carrier primed chimeras to NP-CGG does not appear to have been described 
previously. It was not noted in the responses of carrier primed C57Bl6 to NP-CGG 
(Toellner, et al, 1996). This discrepancy may be in part because precursor B cell 
numbers have been increased by QM B cell transfer and in part because the 
response is heavily biased to GC formation. This will be considered further in the 
discussion.  
5.3. Cell activation and differentiation as assessed by flow cytometry  
Flow cytometry of the transferred QM B cells responding to NP-CGG in CGG 
primed recipients shows that a small CD138 population has emerged by 48 hours. 
Strikingly this has hardly increased by 72 hours (Fig 5.6A). This is confirmed by the 
immunohistology on the spleens of chimeras at 72 hours after receiving NP-CGG; 4 








































































































































































































Figure 5.5: The location of NP-binding cells in the follicle at 48 hours during the 
carrier primed response 50g NP-CGG or 30g NP-Ficoll. 
A. The carrier primed response at 48 hours after immunization with NP-CGG 
shows that NP+ cells are located towards the outer follicle. B. After NP-ficoll 
administration  NP+ cells are located at the T zone follicular boundary. NP 
stained in blue and IgD,  illustrating the follicle, in brown. T= T zone, F= follicle. 
C. The difference between the locations was determined as described in 
methods (2.13). The statistical difference between the groups was tested using 
the Mann-Whitney U test result: P<0.01, n1 = 9 and n2= 3. D. Most NP binding 




































































30g NP-Ficoll in QMxB6 Carrier primed mice after NP-CGG 
p<0.001

















































Figure 5.6: The proportion of B220 and CD138+ subsets in NP binding cells 
reflects the small number of plasmablasts and large numbers of germinal centres 
produced by the response. 
A. The proportion of B220high , B220int and CD138+ populations amongst the NP 
binding cells shows very few CD138+ or B220int cells. B. The percentage of NP+ 
cells that are CD138+ at 48 and 72 hours after immunization with 30g NP-Ficoll 
in QMxB6 mice (blue diamonds) and NP-CGG or NP-Ficoll in carrier primed mice 
that have received QM cells (green and pink diamonds). Whilst there is a large 
increase in the proportion of CD138+ cells in the QMxB6 response to NP-Ficoll 
there is no increase in the proportion of CD138+ cells observed in the NP-CGG 
carrier primed response.
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none of these cells. By contrast, all 6 of these 72 hour chimeras had developed NP+ 
GC. The failure to increase the number of plasmablasts between 48 and 72 hours 
contrasts with the increase in the proportion of plasmablasts seen between 48 and 
72 hours in QM x B6 mice immunized with 30g NP-Ficoll (Fig 5.6B). On the other 
hand it resembles the response of QM x B6 mice to 1g NP-Ficoll (Chapter 4). This 
finding was considered compatible with the conclusion that many of the responding 
B blasts underwent apoptosis on the third day after immunization, without 
differentiating into plasmablasts or GC B cells. In 6 of the 9 mice assessed at 48 
hours in the carrier primed response of chimeras to NP-CGG a high proportion of the 
NP-specific cells were IRF4low/neg (Fig. 5.7A). As a median of 90% of the NP-specific 
blasts at 48 hours were Ki67+ it might be assumed that most of these cells were 
participants in the response despite their low IRF4 expression. This also accords 
with the low dose response to NP-Ficoll in QMxB6 mice, however, that may be co-
incidental. The three chimeric mice responding to NP-CGG that had a much higher 
proportion of the B blasts at 48 hours that were IRF4 int might reflect a subgroup 
where, if these mice had survived, a higher proportion of B blasts would have 
differentiated to plasmablasts. As described above 4 of 6 mice analyzed at 72 hours 
had extrafollicular foci of NP-specific plasmablasts, while 2 had none. Low or no 
expression of IRF4 is associated with GC B cells (Falini, et al 2000). It might be that 
a proportion of the IRF4low/neg cells at 48 hours are GC B cell precursors, but this is 
not the case for the 48 hour IRF4low/neg B blasts in the 1μg NP-Ficoll response, which 
induced negligible GC. Because it is not possible to predict the proportion of B blasts 
analyzed at 48 hours that would have gone on to die, become plasmablasts or form 
GC, the available data do not allow one to conclude that the level of IRF4 expression 























































































































































Figure 5.7: Expression of IRF4 reflects the small number of 
plasmablasts and large numbers of germinal centres produced by 
the carrier primed response to NP-CGG 
A. The proportion of NP+ cells that express high, intermediate and 
low levels of IRF4 protein. At 48 hours a high proportion of cells are 
IRF4low and very few are IRF4high. B. The proportion of NP+ cells at 




The 30 g NP-Ficoll response in QMxB6 consistently induced a large B220int B blast 
population. Strikingly this is not induced in carrier primed chimeras receiving 30g 
NP-Ficoll or NP-CGG (compare Fig 5.6A with 3.4B). This difference may reflect, at 
least in part, the difference in number of NP-binding cells in chimeras and QM x B6 
mice before immunization. A strong effect of altering NP-specific B cell numbers was 
noted by Garcia de Vinuesa et al (2000) where GC formation in response to NP-
Ficoll was seen to fall off when precursor cell numbers were reduced. In this study it 
was suggested that high NP-specific B cell numbers might lead to stronger BCR 
signals through cells cross-linking one to the other. On the other hand it might be 
that cell-cell cross-linking impairs BCR clustering and signalling and that the B220 int 
population are anergic B cells. Further studies are required to probe the significance 
of the B220int NP-specific cells. 
5.4 The expression of Bcl6 and AID mRNA in germinal centre precursors 
In order to examine the expression of Bcl6, AID, Blimp and IRF4 mRNA in 
NP+ cells that participate in the carrier primed response to NP-CGG or NP-Ficoll we 
sorted NP-binding cells from the spleens at 48 and 72 hours after immunization. To 
prevent contamination from CGG plasmablasts, and because there were too few 
NP+ CD138+ cells to sort reliably, all the sorts excluded CD138+ cells. The small 
number of cells in the response meant that the NP+ CD138- cells were treated as 
one population and not subdivided into B220high and B220int populations. 
As was anticipated, there were NP-binding cells that express both Bcl6 and 
AID mRNA at 72 hours after NP-CGG administration (Fig 5.8). In contrast to all the 
immunization protocols studied in the QMxB6 mouse, up to ~10% of the NP-binding 
cells in the carrier primed response to NP-CGG express Bcl6 and AID mRNA at 48  
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NP+ cells in carrier primed NP-
CGG response
NP+ cells in the carrier primed NP-
Ficoll response
NP+ B220high cells in QMxB6 mice 
Figure 5.8: A comparison of Bcl6, AID and Blimp1 expression in NP+ cells in the 
QM x B6 response to 30g and 1g NP-Ficoll and the carrier primed NP 
response to NP-CGG and NP-Ficoll.  
The percentage of cells with expression for each gene is indicated for each 
response at 48 or 72 hours. In the QMx B6 responses B220high  are red. In the 
carrier primed response those responding to NP-CGG are green whilst the 
response to NP-Ficoll is pink. 
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hours (Fig. 5.8). Careful scrutiny of the immunohistology on the 4 of 8 spleens taken 
at 48 hours from which Bcl6/AID mRNA double positive cells had been sorted 
showed that at best < 1% of the NP-biding cells in the follicles had moved to pre-
formed GC. In all of these 48 hour mice the overwhelming majority of the NP-binding 
cells were focussed towards the outer edge of the follicles. Together these data 
indicate that at least a proportion of GC precursors in this response co-express AID 
and Bcl6 mRNA before they enter GC. On the other hand these cells are already in 
the follicular mantles or among the IgD+ cells in primary follicles. This early 
expression of the GC B cell phenotype may reflect the availability of T cell help and 
the formation of GC precursors in this response. Despite the GC bias of the 
response it is interesting that the percentage of cells that express both AID and Bcl6 
mRNA at 72 hours is similar to that of the 30μg NP-Ficoll QMxB6 response (Fig 5.8). 
The response to NP-Ficoll in carrier primed mice was not tested at 72 hours and so a 
direct comparison between the two responses can not be made. However, at 48 
hours there were no cells that expressed both Bcl6 and AID mRNA after NP-Ficoll 
challenge in the transferred QM cell response to 30μg NP-Ficoll (Fig. 5.8). 
The proportion of NP+ cells that express Bcl6 mRNA but not AID mRNA is 
~30% on the second day of the carrier primed response to NP-CGG (Fig. 5.8). This 
is significantly greater than that seen in the QMxB6 response to 30μg NP-Ficoll 
(~10%) and much greater than the response of transferred cells to NP-Ficoll 
(~1.5%). The large proportion of cells that express Bcl6 mRNA may reflect an 
inhibition of Bcl6 mRNA downregulation, perhaps due to the increase in GC 
precursors and decrease in plasmablast precursors.  
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5.5 Class switching and AID expression occur in the absence of Bcl6 
expression in the NP+ carrier primed response. 
In 7 of the 8 mice in the carrier primed response to NP-CGG at 48 hours had 
a small proportion (median 3%) of AID+,Bcl6- cells (Fig. 5.8) and in 3 mice tested at 
72 hours the proportion of these cells was between 5-23% of NP-binding cells during 
the third day. Only one of these three mice had appreciable numbers of NP-specific 
plasmablasts visible on spleen sections. It must remain a matter of speculation 
whether the AID+, Bcl6- cells in these 48 and 72 hour mice are pre-plasmablasts, GC 
precursor cells or cells that will die without further differentiation. Sections from three 
of the mice at 72 hours that had appreciable, but still low, numbers of plasmablasts 
were assessed for evidence of CSR and a small proportion of these had switched Ig 
class (Fig. 5.9). Although one can speculate that GC precursors may undergo CSR 
there is no obvious way to test this as the first identifiable GC cells are AID+, Bcl6+ 
cells and the AID expression associated with being a GC cell could theoretically 
trigger CSR.  
5.6 Expression of Blimp1 in occasional CD138- NP+ cells  
In all the previous immunization protocols studied single cells expressing 
Blimp1 were almost exclusively among the CD138+ cells and >90% of CD138+ cells 
were Blimp1+. This led to the conclusion that Blimp1 expression post dates the 
expression of CD138. Rare exceptions to this rule are seen among the CD138 - B 
blasts at 48 hours in the NP-CGG response of carrier primed chimeras. This is 
particularly surprising as this is the response associated with the smallest number of 








































Figure 5.9: Class switch recombination to 1 and 3 in NP+ B 
cells participating in the carrier primed response to NP-CGG 
The percentage of NP+ cells that have switched to IgG3  
(black diamonds) or IgG1 (red triangles) in the carrier primed 




5.7.1. B cells interact with follicular T cells prior to the infiltration of germinal centres 
in the response to NP-CGG 
It was striking that NP-binding cells participating in the carrier primed NP-
CGG response were located in the outer half of the follicle at 48 hours. In the QMxB6 
TI responses to NP-Ficoll B cells at 48 hours were seen to be located at the 
boundary of the T zone and the follicle (Fig 3.2; 4.3; 4.10). Many studies have 
identified the outer T zone as the location where primed T cells interact with B cells 
that have taken up antigen (Liu, et al, 1991; Toellner, et al, 1996; Garside, et al, 
1998). Indeed, the transferred QM response to NP-Ficoll at 48 hours showed the 
responding cells at the T zone/follicular boundary (section 5.5).  Around 70% of the 
NP-binding B cells in the outer half of the follicle 48 hours after NP-CGG are in 
contact with a CD3+ T cell (Fig, 5.5) and 90% of these cells express Ki67 indicating 
that they are in cell cycle (Fig 5.7). This is prior to the entry of NP-binding cells into 
GC which only starts during the third day after immunization.  
The location of the transferred QM cells in the outer half of the follicle after 
NP-CGG can not be ascribed to differences in the affinity of the BCR as QM cells 
were transferred into both the NP-Ficoll and NP-CGG immunized recipients. A 
difference between the NP-Ficoll and NP-CGG response by transferred QM cells (if 
we assume that in both cases antigen was not limiting) is that only NP-CGG could be 
taken up, processes and presented in a way recognised by the primed follicular T 
cells induced by prior immunization with CGG. Although this would allow cognate 
interaction between the primed T cells and the B cells presenting CGG peptide it 
does not explain how these B cells were attracted into the follicles. Clearly BCR 
 148 
ligation alone is not sufficient to achieve this as both NP-Ficoll and NP-CGG would 
have cross-linked the BCR of transferred NP-specific B cells. Perhaps the location of 
the NP-specific cells 24 after immunizing with NP-CGG provides a clue. At this stage 
the NP-specific cells tended to by sited in the edge of follicles adjacent to bridging 
channels. Some of these cells were seen to be adjacent to T cells at that time. Could 
it be that cognate interaction occurring in this T zone follicular boundary area 
directed the B cells into the outer aspect of the follicles? In my experimental system 
the majority of the transgenic B cells transferred originated in the MZ. Marginal zone 
B cells have been shown to provide greater T cell activation than those of follicular 
origin (Attanavanich and Kearney, 2004). This combination of memory T cells and 
increased activation may promote pre-GC entry in to the follicle rather than the 
expected proliferation in the T zone. Migration to the edge of the follicle may have 
been induced following up regulation of CXCR5 (and down-regulation of CCR7) on 
the responding T and B cells (Hardtke, et al, 2005) permitting movement along the 
CCL21 gradient established between the follicle and the T zone (Okada, et al, 2005). 
A similar pattern of B cell location, at the outer edge of the follicle, has also been 
induced by the ablation of dendritic cells prior to virus infection (Scandella, et al, 
2007). This might indicate a bypass of DC in transferred cell response to NP-CGG or 
may be a coincidence. Whatever the explanation this novel finding of the early 
association of antigen-specific CD4 T cells and B cells in the outer part of follicles in 
carrier primed chimeras deserves further investigation. 
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5.7.2. The effect of precursor cell number on B cell migration within the carrier 
primed NP-CGG response. 
In the course of these carrier primed experiments cell transfers were 
performed using either 2x106 or 105 NP+ B cells from QM mice.  Histological analysis 
of the NP-CGG response showed that the change in precursor number had no clear 
influence on the migration of cells within the follicle, or on the formation of GC or 
plasmablasts (Fig 5.1C, 5.2A and B). However, the three mice examined at 48 hours 
after NP-CGG that received fewer cells do appear to have an advanced mRNA 
response to antigen as the proportion of the cells that co-express Bcl6 and AID 
mRNA and AID mRNA alone is higher in these mice (section 5.4).  
That a response with fewer B cells might express differentiation markers 
before a response with a greater number initially appears strange. Work by Garcia 
de Vinuesa (2000) has shown that the number of cells that are involved in a TI 
response can affect the outcome of the response; lower precursor numbers result in 
fewer GC and plasmablasts. In contrast, the B cell response to a T cell dependant 
antigen requires that a very small number of specific B cells first bind antigen and 
then make contact with a specific T cells (Liu, et al, 1991; Okada, et al, 2005) and 
the secondary response proceeds with faster kinetics (Liu, et al, 1991). In relation to 
a “normal” secondary TD response my model system has many more precursors. 
However, as previously stated, the high proportion of Ki67 expression and location 
next to T cells would suggest that the transfer of a large number of B cells in the 
response does not overwhelm the T cell help. This does not provide an explanation 
for the increase in AID mRNA alone or the earlier expression of AID with Bcl6, none 
the less, the difference exists.   
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6. Conclusions and Future Work 
 
The work describe in this thesis has added to our knowledge of the way B 
cells are recruited into antibody responses and the stages they go through before 
either forming germinal centres (GC) or differentiating into plasmablasts. The study 
also pinpoints where class switch recombination (CSR) occurs during the 
extrafollicular response. Inevitably the results have identified a number of points that 
require further study. 
6.1 The location of B cells 24 hours after antigen engagement is dependent on 
the type of response induced and the help available 
Whilst immunization with NP-Ficoll induced migration of NP+ B cells from the 
marginal zone (MZ) across the follicle to the T zone/follicular boundary within 24 
hours (Fig 3.1, Y. Zhang, pers. com), the carrier primed response in chimeric C57Bl6 
mice appears to show that after 24 hours the responding NP+ B cells are found at the 
edge of the follicles where they abut to both the T zone and bridging channels (Fig 
5.3). B cells have been reported to migrate to the boundary of the T zone and the 
follicle in many studies (Vinuesa, et al, 2001; Okada, et al, 2005; Grey, et al, 1984; 
Liu, et al, 1991, Figure 3.1) so why do the NP+ B cells in the T cell dependent 
response in my studies migrate differently? Marked recirculating B cells transferred 
into syngeneic rats were found to migrate from the marginal sinus past the edge of 
follicles adjacent to bridging channels before progressing to the outer T zone 
(Nieuwenhuis and Ford, 1976). It seems plausible, in the carrier-primed mice used in 
the studies of the responses to NP-CGG, that primed CGG specific T cells located at 
the edge of the follicles make cognate interaction with the relatively small numbers of 
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transferred QM B cells as they pass through this area. The expected result of this 
would be to stop the progress of the B cells. By contrast the massive numbers of NP-
specific B cells that are recruited into the response of QM x B6 are in no position to 
make cognate interaction with T cells. This is because NP-Ficoll cannot be 
processed and presented to T cells. Consequently the NP-specific cells in this 
situation will continue to the outer T zone. Similarly in primary T cell-dependent 
responses the responding B cells, despite taking up antigen they can process will 
pass the edge of follicles before follicular T cells have been induced. These T cells 
only appear from the 3rd day after immunization (Serre, et al, 2009).  
6.1.1  Weak BCR signalling induced by low-dose NP-Ficoll generates some B blasts 
that die without maturing into either plasmablasts or GC B cells 
The similarity between the QMxB6 response to 1g NP-Ficoll and that of the 
btk response to 30g NP-Ficoll (Vinuesa, et al, 2001) must be considered. The 
response of btk-deficient QM heterozygous male mice to NP-Ficoll induces B cells to 
migrate to the T zones and enter cell cycle but the cells die apoptosis after around 
48 hours without differentiating into plasmablasts or GC. Similarly, the 1g NP-Ficoll 
QMxB6 response produced B blasts in the T zone at 48 hours only for the majority to 
become apoptotic with a small plasmablast response present at 96 hours. The 
similarities between the two response models suggest that inadequate BCR cross 
linking after 1g NP-Ficoll does not instigate sufficient signalling through the BCR to 
allow differentiation. Whether this relates to failure to activate signalling through btk 
deserves further study. This might be confirmed through a comparison of the 
phosophorylation states of btk in both the 30g and 1g NP-Ficoll QMxB6 responses 
to see if it is inadequate in the latter. In the experimental system described by 
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Vinuesa, et al, the block in B cell differentiation induced by NP-Ficoll in Btk-deficient 
mice is overcome through ligation of CD40. It would be interesting to test whether 
the B Blast apoptosis associated with 1g NP-Ficoll response can be prevented in 
the same way.  Array data from both btk QM heterozygotes after 30g NP-Ficoll with 
that of the 1g NP-Ficoll QMxB6 response at 24 might also provide fertile grounds 
for a comparison between the two responses. 
My data suggest that the provision of additional signals (in this case TLR3 
ligation by polyI:C) may increase the speed of the response to 30g NP-Ficoll and 
induce a greater amount of CSR (Fig 4.9). Toll-like ligand receptor engagement 
affects both the activated B cells and the milieu (Xu, et al, 2008; Xu, et al, 2007; 
Gao, et al, 2008). However, whether this is important in the first 24 hours, as a 
supplement to BCR ligation, or later, in the T zone or follicle, during the response is 
not covered by my work. This is an important avenue for future study. 
6.2. Transcriptional changes within the first 24 hours may yet reveal 
plasmablast and germinal centre precursors.  
 Within the first 24 hours of the QMxB6 response to 30g NP-Ficoll, a 
response that resulted in the production of both germinal centres and plasmablasts, 
all, or almost all, of the responding B cells upregulated IRF4 protein. They also 
increased expression of genes involved in DNA repair and the production of antibody 
while downregulating chemokine receptor mRNA (Figures 3.1; 3.14; 3.15). During 
the first 24 hours of the response to NP-Ficoll the responding B cells do not 
proliferate (Hsu, et al, 2004; and the present study). This might provide a means of 
initiating the large transcriptional changes required during differentiation. It is an 
intriguing possibility that during this long G1 epigenetic changes occur that dictate 
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subsequent transcriptional and differentiation patterns during the subsequent phase 
of rapid proliferation. Comparison of epigenetic changes between the responding B 
cells at 24 hours into the 1g NP-Ficoll response, with those in the TD carrier primed 
response to NP-CGG, or in the QMxB6 response to 30g would be intriguing. Such 
studies, however, could easily occupy another 3 years’ study and were beyond the 
feasibility of this PhD programme.  
Further information on early differentiation changes could be achieved using 
multiplex single cell RT2-PCR to provide more accurate data on changes within the 
population sorted (Lambolez, et al, 2002). However, this technique does have some 
limitations. Performing RT2-PCR for more than 3 genes at one time is hindered by 
mechanical discrepancy between fluorochromes, the competition of competing PCR 
reactions for reagents and in situ interference between primers and probes. Analysis 
of the expression of large numbers of genes from a single cell requires a primary 
phase of amplification without fluorochromes, followed by aliquoting the primary 
amplificate and then a series of duplex or triplex RT2-PCR. Validating such 
technology will be a major task. 
6.3 Expression of AID at 48 hours allows class switch recombination to occur 
in undifferentiated B blasts 
Single cell RT2-PCR studies in QMxB6 mice immunized with NP-Ficoll show 
that AID is expressed in responding B Blasts at 48 hours independently of GC 
formation and CD138 or Blimp1 expression. The finding of transcripts of switched 
heavy-chain among these blasts at this stage of the response confirms that some of 
these cells have undergone CSR. Furthermore, after administration of 1g NP-Ficoll 
in QMxB6 mice, in which there is no CSR, AID expression is negligible (Fig 4.5). 
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Sciammas, et al, (2006) showed that the expression of intermediate levels of IRF4 
was necessary for AID to be expressed and CSR to occur. The present studies 
indicate that this level of expression is not sufficient to induce switching as most, if 
not all, responding B blasts in the first 2 days of the response express IRF4 at 
intermediate levels, but only a proportion up-regulate AID (Fig 3.25). Paradoxically 
the relationship between expression of IRF4 and AID is the inverse of this when the 
B blasts mature to become GC-founders or plasmablasts. GC founding cells cease 
to express IRF4 and co-express AID with Bcl6 protein while plasmablasts express 
high level IRF4, but are universally AID negative.  
The addition of polyI:C to 30g NP-Ficoll increased proportion of switched 
cells at 96 hours, but this did not yield a greater proportion of B cells expressing AID 
mRNA on the second day of the response. It is possible that this finding reflects 
switching occurring earlier when PolyI:C is given. This can be tested by analysing 
earlier time points within this response. An alternative explanation is that an AID 
independent CSR pathway is used (Arudchandran, et al, 2008).  
It is interesting that the location of CSR in the response to antigen does not 
appear to rely upon a specific location within the white pulp. Forty-eight hours after 
administration of 30g NP-Ficoll in the QMxB6 mouse, the majority of cells were in 
the T zone (Fig 3.2.A). However, the TD carrier primed response to NP-CGG, which 
was also associated with switching, showed responding cells in the outer half of the 
follicle at 48 hours (Fig 5.5.A). This discrepancy is likely to reflect the different 
signalling patterns in these two responses, for in the carrier-primed response to NP-
CGG there was evidence of interaction between the responding B cells and T 
follicular helper cells. The absence of switching after 1g NP-Ficoll probably reflects 
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the weak BCR signal delivered (Fig 4.5). A relationship of BCR engagement strength 
to CSR induction has been reported by Rush, et al, (2005) based on studies in vitro. 
However, signals from the microenvironment provided by, for example, dendritic 
cells, natural killer cells or BAFF and APRIL can induce CSR during the immune 
response (Gao, et al, 2008; Xu, et al, 2007; Castigli, et al, 2005). Studies in mice 
have shown the importance of signals through TNF ligand receptors in order to 
maintain CSR with age (Frasca, et al, 2007).   
6.4 The B220 intermediate population at 48 hours – a meaningless distinction 
or a relevant phenotype? 
Examination of the arrays used in this study show few differences in mRNA 
expression between the B220high and B220int populations studied at 48 hours (Fig. 
3.5). It is tempting to conclude that, prior to differentiation at 72 hours, the 
responding NP+ B cells are largely homogeneous.  Nevertheless, the number of any 
precursors with unique gene expression patterns might be masked in the array 
analysis. Single cell RT2-PCR of all the QMxB6 responses studied at 48 hours both 
the B220high and B220int populations showed similar AID, IRF4 and Bcl6 mRNA 
expression (Figs 3.18, 4.5 and 4.11). Both the B220int and B220high populations 
contain a small proportion of cells with raised levels of IRF4. This indicates that 
plasmablasts can form and are forming from both of these subsets. Nevertheless, for 
most of the cells at 48 hours the above markers assessed at the single cell level fail 
to provide evidence that the cells or a fraction of the cells is committed to 
differentiate to either GC founding cells or plasmablasts.  
While the B220int population formed 20-40% of the responding B cells in the 
QMxB6 response to 30g NP-Ficoll at 48 hours it comprised less than 10% after 1g 
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NP-Ficoll, co-immunization with poly I:C and 30g NP-Ficoll, and during the carrier 
primed response to NP-CGG (Section 3.4B; Figures 4.4.A; 4.10.A; 5.6.A). The 
possibility that some of this B220int population have been induced to be anergic 
deserves consideration. Anergy is reported to occur in B cells that do not receive 
additional survival signals from T or other accessory cells after BCR engagement 
(Bretscher and Cohn, 1970; Cook, et al, 1998; Goodnow, et al, 1989). The 
phenomena of anergy has been well studied in transgenic B cell mouse models in 
which a surplus of antigen, either intrinsic to the animal or applied from outside, 
leads to the development of an anergic B cell population that does not respond to 
antigen yet remains in circulation (Goodnow, et al, 1989; Goodnow, et al, 1988; 
Gauld, et al, 2005; Borrero and Clarke, 2002). The QMxB6 30g NP-Ficoll response 
mimics these conditions; an excess of antigen is combined with large numbers of 
responding cells and a lack of second signal. If it is the case that the 30g NP-Ficoll 
response induces anergy it is tempting to suggest that the additional TLR signal 
provided by polyI:C in the co-immunized QMxB6 response is responsible for reduced 
the size of the B220int population. Equally the carrier primed response provides T cell 
help in the T zone and subsequently the B220int population was very small 
(Bretscher and Cohn, 1970). Furthermore, it has been reported that anergic B cells 
express Cyclin D2 and integrin 4 (Glynne, et al, 2000) which were expressed at 
slightly higher amounts in the B220int population at 48 hours (Fig. 3.15). Another 
possibility is that the B220int cells are responding B1b cells. In this case the 
difference in the proportions of B220int cells in the different immunization schedules 
might reflect a need for a high threshold of BCR cross-linking to activate these cells. 
Further flow cytometry, single cell RT2-PCR analysis of the B220int population 
together with functional studies are required to address these possibilities. Cell 
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transfer into Rag recipient mice would provide a means to phenotype the daughter 
cells of the B220int population.  
6.5 The level of expression of IRF4 indicates plasmablast precursors at 48 
hours but does not obviously identify germinal centre precursors 
Close examination of IRF4 mRNA expression has shown that higher levels of 
IRF4 mRNA at 48 hours correlate with the presence of plasmablasts at 72 and 96 
hours. This, combined with the role of IRF4 in AFC development (Mittrucker, et al, 
1997; Klein, et al, 2006) suggests that these cells are plasmablast precursors. These 
experiments go some way to confirm the model of B cell activation proposed by 
Sciammas (2006) whereby higher levels of IRF4 induce plasmablast cell fate.  Whilst 
GC B cells do not express IRF4 (Falini, et al, 2000; Fig 3.19.A) it is not certain that 
low levels of IRF4 mRNA at 48 hours indicate a GC precursor (Fig 4.4B). The 
distribution of IRF4 expression levels in responding NP-specific cells at 48 hours 
shows the putative plasmablast precursors with high levels of IRF4 and a Gausian 
distribution of IRF4 in the remaining cells. It could be that the cells on the left hand 
tail of this curve are enriched for GC forming cells. Unfortunately as IRF4 is 
expressed within the cell this could only be addressed by cell sorting and cell 
transfer unless an internal reporting system for IRF4 expression was developed.  
Whether IRF4 levels are responsible for plasmablast and GC precursor B 
cells, and how this relates to the BCR affinity for the antigen, might be confirmed 
through the use of a competition model such as that used by Shih, et al (2002a). 
Studies in mice with B cells that either had high or low affinity for NP, such as the 
B18 high and lo mice used by Shih, have shown that those cells with high affinity for 
the antigen are preferentially selected to form GC in TD responses, whilst lower 
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affinity B cells enter the plasmablast pathway (Shih, et al, 2002b). This would allow 
the two pathways to be analysed in TD responses in a way analogous to that 
achieved in the present thesis using high and low doses of a TI-2 antigen. A 
comparison of IRF4 mRNA expression in the high with low affinity mice responding 
to NP-CGG might allow a more detailed examination of the role or IRF4. 
 How does IRF4 fit into the hierarchy of plasmablast differentiation markers 
(IRF4, Blimp1 and CD138)? My data suggests that the IRF4 mRNAhigh cells arise 
prior to CD138 protein expression. CD138 cells are predominantly Blimp1 mRNA 
positive and a negligible number of Blimp1 cells are not CD138, consequently it may 
be stated with some confidence that CD138 expression precedes that of Blimp1 and 
both are preceded by the upregulation of IRF4 to high levels.  
6.6 Bcl6 mRNA expression is continuous in inactive B cells and does not 
identify GC precursors or the outcome of the response. 
Bcl6 mRNA is present in ~40% of NP binding B cells in non-immunized 
QMxB6 mice (Fig 3.18.B). As these B cells do not express Bcl6 protein it raises the 
question as to why post transcriptional repression occurs in these cells. The decline 
in Bcl6 mRNA expression as the response progresses (Fig. 3.18) may be as a result 
of the global action of IRF4 which has been reported to inhibit Bcl6 (Teng, et al, 
2007; Saito, et al, 2007) allowing early plasmablast formation. Further studies are 
required to identify if there is function significance to those naive B cells that express 
Bcl6 mRNA and those that do not. Are the Bcl6 mRNA positive cells one of the 
known subsets of B cells? 
The proportion of cells that expressed Bcl6 mRNA at 48 hours after 
immunization was seen to be largest in the chimeric response to NP-CGG (Fig 5.8) 
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suggesting a correlation between Bcl6 expression and GC formation later in the 
response. The known oligoclonality of GC, perhaps makes it unlikely that all the Bcl6 
mRNA expressing NP-specific naive cells in QMxB6 mice are committed to germinal 
centre formation.  
In conclusion the studies reported in this thesis have added to our 
understanding of divergent B cell differentiation during antibody responses. The time 
when divergent differentiation becomes overt has been defined. It remains to be 
seen if the level of commitment to GC or plasmablast differentiation is apparent at 
the molecular level in the first 36 hours of the response. The thesis highlights the 
importance of single cell analysis to probe for this early heterogeneity. Flow 
cytometry and immunohistology are powerful tools for studying heterogeneity, but 
the number of parameters that can be analyzed in single cells by these techniques is 
limited. In this study RT2-PCR on single cells was also restricted. This technology 
has the potential to be developed for the analysis of transcription of many more 
genes within a single cell. As such it may offer the most promising approach for 
identifying putative key molecular events during the development of heterogeneity in 
lymphocytes in immune responses. Once identified the functional significance of 
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ii. Array contents: 
Gene    Reference ABI Assay Number   
Plasma Cell Specific   
TACI      Mm00840182_m1 
Bcl-xl      Mm00437783_m1 
IL1R1      Mm00434237_m1 
IL10Rα      Mm00434151_m1 
IL10Rβ      Mm00434157_m1 
c-myc    2  Mm00487803_m1 
Cyclin D1    2  Mm00432359_m1 
Fas     2  Mm00433237_m1 
IL6R    2  Mm00439653_m1 
CHOP C/EBP homologous prtn 2  Mm00492097_m1  
XBP-1    2  Mm00457359_m1 
IL4Rα    3  Mm00439634_m1 
Bob-1      Mm00448326_m1 
Oct-2      Mm00448346_m1 
Pu.1      Mm00488140_m1 
Blk       Mm00432074_m1  
sit       Mm00450829_g1 
Bcl-2     4  Mm00477631_m1 
Caspase 6    4  Mm00438053_m1 
CD40     4  Mm00441895_m1 
CD79α     4  Mm00432423_m1 
Cyclin D2    4  Mm00438071_m1 
PC-1     4  Mm00501097_m1 
BAFF rec     Mm00840578_g1 
Blimp-1      Mm00476128_m1 
J-chain      Mm00461780_m1 
gp130      Mm00439668_m1 
IL5R      Mm00434284_m1  
GAS6    3  Mm00490378_m1 
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ELL2     3  Mm00507237_m1 
MAN1A1    3  Mm00484754_m1 
IRF4      3  Mm00516431_m1 
SSR1     3  Mm00503135_m1 
LGALS3     3  Mm00802901_m1 
PDXK     3  Mm00552031_m1 
BCMA    3  Mm00495683_m1 
DCN 3     Mm00514535_m1 
KDELR2    3  Mm00482212_m1 
 
Chemokine receptors   
CCR1      Mm00438260_s1 
CCR3      Mm00515543_s1 
CCR4      Mm00438271_m1 
CCR7, CD197     Mm00432608_m1 
CCR8      Mm00843415_s1 
CCR10      Mm00445551_m1 
CCR11      Mm00521339_m1 
CCRL2      Mm00516914_g1 
CXCR2, IL8Rβ, CD128    Mm00438258_m1 
CXCR3, CD183     Mm00438259_m1 
CXCR5 2     Mm00432086_m1 
CXCR6      Mm00472858_m1 
CX3CR1     Mm00438354_m1 
XCR1, GPR5, Ccxcr1    Mm00442206_s1 
GC specific    
GCET1      Mm00510959_m1  
GCET2      Mm00492306_m1 
BLNK      Mm00456139_m1 
Bach2      Mm00464379_m1 
Pax5    2  Mm00435501_m1 
Bcl-6    2  Mm00477633_m1 
AID     2  Mm00507774_m1 
 163 
Gene      Reference ABI Assay Number 
CD72      2  Mm00514270_m1 
UNG        Mm00449156_m1 
Ku80        Mm00550147_m1 
Telomerase       Mm00436931_m1 
ARTEMIS       Mm00455364_m1 
XRCC4        Mm00459213_m1  
DNA-PKcs       Mm00465092_m1 
Rag-2        Mm00501300_m1 
Human SAK      1  Mm00550358_m1 
Human CDKN2C     1  Mm00483243_m1 
Human BRCA-1     1  Mm00515386_m1 
Human DNA glycosylase     1  Mm00501781_m1 
Human DNA ligase I     1  Mm00495331_m1 
Human CD30L     1  Mm00437153_m1 
Human CALLA     1  Mm00485028_m1 
Human RGS13     1  Mm00462629_m1 
Human prolyl 4-hydroxylase α (II) subunit 1  Mm00477940_m1 
Human KIAA0277      1  Mm00616228_m1 
Human γ 1 isoform of 61kDa reg. subunit of PP2A  1 Mm00442556_m1 
Human Cam Kinase I     1  Mm00449560_m1 
Human RSRFC2      1  Mm00484950_m1 
Human AML1     1  Mm00486762_m1 
Human: zx55e01.r1     1  Mm00479224_m1 
Human Alpha-Catenin-Like Protein   1  Mm00490001_m1 
Human PGP 9.5      1  Mm00495900_m1 
Human mRNA for KIAA0807 protein  1  Mm00485291_m1 
Human CLI     1  Mm00442773_m1 
Human cDNA DKFZp586F1018    1  Mm00460563_m1 
Human BRCA2     1  Mm00464783_m1  
Both    
β-actin        Mm00607939_s1 
β-2 microglobulin       Mm00437762_m1 
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Gene      Reference ABI Assay Number 
TLR4        Mm00445274_m1 
CD20        Mm00545909_m1 
CD22        Mm00515432_m1 
CD11α        Mm00801807_m1 
Integrin α4       Mm00439770_m1 
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